Study of Hydrogel based Controlled Release Drug Delivery System for Captopril and its in-vitro, in-vivo Evaluation by Furqan Muhammad, Iqbal
  1 
 
 
Study of Hydrogel based Controlled Release 
Drug Delivery System for Captopril and 
its in-vitro, in-vivo Evaluation 
 
                           
                    A dissertation submitted in  
         partial fulfillment of the requirements for the degree of 
                 
DOCTOR OF PHILOSOPHY 
(Pharmaceutics) 
 
by 
 
                   Furqan Muhammad Iqbal 
  2 
                                                                                B.Pharm., M.Phil. 
 
 
                          Department of Pharmacy 
         Faculty of Pharmacy and Alternative Medicine 
The Islamia University of Bahawalpur 
                                        PAKISTAN 
                                        (2012-2015)  
 
 
 
       
 
 
    In the name of Allah, the Most Merciful, the Most Kind 
 
 
 
 
 
  3 
 
 
 
 
 
 
 
 
 
 
 
                    
                              DEDICATION 
 
                    
 
 
 
 
 
 
 
 
 
 
Dedicated to my beloved 
     parents, wife and children 
 
  4 
 
 
                                   ACKNOWLEDGEMENT 
 
Foremost, I should bow to ALLAH ALMIGHTY who made me able to work and 
accomplish my work within time .All respects are for The Last Prophet, HAZRAT 
MUHAMMAD (Peace Be Upon Him),who enable us to recognize our Creator.   
          
I owe a profound debt of gratitude and heartful thanks to my research supervisor, 
Prof. Dr. Mahmood Ahmad, the Dean of Pharmacy and alternative medicine, Islamia 
University Bahawalpur. His unique welcoming, affectionate and encouraging style 
played a vital role in harnessing my potentialities and capabilities to accomplish this 
research project.  
           
I am highly thankful to Prof. Dr. Naveed Akhtar (Chairman, Department of 
Pharmacy) for his facilitation to complete the enterprising assignment.  
 
I appreciate the cooperation and moral support of my research fellows Ume Ruqia 
Tulain and Ayesha Rasheed. I am thankful to Dr. Malik Zubair, Dr. Raees Akhtar, 
and Fahad Pervaiz for providing me the expertise for completion of this project. I am 
also thankful to Dr. Usman Minhas and Ikrima Khalid for their cooperation.  
 
I am thankful to all those who are exerting themselves for the advancement of 
knowledge and specially devising and designing the new drug delivery systems to 
serve the humanity. 
 
                                                                                 
                                                                                           Furqan Muhammad Iqbal 
 
 
  5 
 
 
 
                                            List of Contents 
   Description    Page 
no. 
    Title I 
   Bismillah II 
   Dedication III 
   Acknowledgement IV 
   List of Contents V 
   Abstract X 
Chapter- 1. Introduction 1 
Chapter- 2. Literature Review 5 
2.1 Types of hydrogels 6 
2.1.1 pH sensitive or ionic hydrogels 6 
2.1.2  Temperature sensitive hydrogels 7 
2.1.3  Glucose sensitive hydrogels 8 
  6 
2.2.1.4 Crosslinking using enzymes 15 
2.2.2 Physical crosslinking methods 15 
2.2.2.1 Crosslinking by ionic interactions 16 
2.2.2.2 Crosslinking by crystallization 16 
2.2.2.3 Crosslinking by hydrogen bonds 17 
2.2.2.4 Crosslinking by protein interactions 18 
2.3 Characterization of hydrogels 18 
2.3.1 Scanning electron micrography (SEM) 20 
2.3.2 X-ray diffraction (XRD) 20 
2.3.3 Magnetic Resonance Imaging (MRI) 20 
2.3.4 Fourier transform infrared (FTIR) 21 
2.3.5 Thermal Analysis  22 
2.3.6 Swelling behavior 22 
2.3.7 Gel Fraction 23 
2.3.8 Porosity 24 
2.3.9 Rheology 24 
2.3.10 In-vitro Release Studies 25 
2.3.11 In-vivo Evaluation 25 
2.4 Hydrogels for pharmaceutical and biomedical applications 26 
2.4.1 Transdermal drug delivery  26 
2.4.2 Orally administered hydrogels 27 
2.4.3 Ocular delivery 28 
2.4.4 Subcutaneous delivery 28 
2.4.5 Rectal and vaginal delivery 30 
2.4.6 Hydrogels for tissue engineering 30 
2.5 Drug 31 
2.5.1 Physical properties 34 
2.5.2 Captopril Stability 34 
2.5.3 Pharmacokinetics 35 
2.5.4 Clinical Uses 35 
2.5.5 Adverse Drug Reaction 36 
2.6 Excepients and Formulations 36 
2.6.1 Polymers and monomers 37 
2.1.4 Other stimuli sensitive hydrogels 9 
2.1.4.1 Electro-sensitive hydrogels 9 
2.1.4.2 Light-sensitive hydrogels 9 
2.1.4.3 Pressure-sensitive hydrogels 10 
2.1.4.4 Protein-sensitive hydrogels 10 
2.1.4.5 Microgels and nanogels 11 
2.2 Methods of hydrogel preparation 12 
2.2.1 Chemical Crosslinking methods 13 
2.2.1.2 Crosslinking by chemical reaction of functional groups 13 
2.2.1.3 Crosslinking by high-energy irradiation 14 
  7 
2.6.1.1 Hydroxypropyl methylcellose (HPMC) 38 
2.6.1.2 Poly vinyl alcohol (PVA)  41 
2.6.1.3 Acrylic acid (AA) 43 
2.6.1.4 2-Acrylamido-2-methylpropane sulfonic acid (AMPS) 45 
2.6.1.5 Potassium persulfate (KPS) 47 
2.6.1.6 N,N'-Methylenebisacrylamide (MBAm or MBAA) 48 
Chapter-3. Synthesis of Hydroxypropyl methylcellulose-graft-poly(vinyl alcohol)-
co-poly(acrylic acid) hydrogels for the Controlled Release of captopril 
and its in-vitro Evaluation 
50 
3.1 Introduction 52 
3.2 Materials & Methods 54 
3.2.1 Chemicals 54 
3.2.2 Preparation of Hydrogel 54 
3.2.2.1 Method using Thermostatic Water Bath 54 
3.2.2.1.1 Hydrogel Formulations prepared  using different concentration of Acrylic     
acid and crosslinking agent 
55 
3.2.2.1.2 Hydrogel Formulations using different proportions and       concentrations 
of Polymers 
56 
3.2.2.2 Hydrogel formulation prepared by Microwave Radiation     57 
3.3 In vitro Evaluation 59 
3.3.1 Fourier Transform Infrared Spectroscopy (FT-IR) 59 
3.3.2 Scanning Electron Microscopy (SEM) 59 
3.3.3 X-Ray Diffraction (XRD) 60 
3.3.4 Thermal analysis 60 
3.3.5 Swelling Study  60 
3.3.6 Drug loading  61 
3.3.7 Determination of Gel Fraction 61 
3.3.8 Drug Release 62 
3.3.9 Drug release kinetics 62 
3.4 Results and Discussions 63 
3.4.1 FTIR 63 
3.4.2 SEM 65 
3.4.3 XRD 67 
3.4.4 Thermogravimetric analysis (TGA) and Differential scanning calorimetry 
(DSC) 
69 
3.4.5 Swelling Study 72 
3.4.6 Comparative Swelling of F and R hydrogels 74 
3.4.7 Gel Fraction 77 
3.4.8 Drug loading and release studies 79 
Chapter-4. Synthesis and in-vitro characterization of Hydroxy propyl methyl-
cellulose-g-poly(acrylic acid-co-2-Acrylamido-2-methylpropane 
sulfonic acid) polymeric network for controlled release of captopril  
84 
4.1 Introduction 86 
  8 
4.2 Materials and Methods 87 
4.2.1 Chemicals 87 
4.2.2 Preparation of hydrogel 87 
4.3 In-vitro Evaluation 90 
4.3.1 Fourier Transform Infrared Spectroscopy (FT-IR) 90 
4.3.2 Scanning Electron Microscopy (SEM) 90 
4.3.3 X-Ray Diffraction (XRD) 90 
4.3.4 Thermal analysis 90 
4.3.5 Swelling Study 91 
4.3.6 Drug loading 91 
4.3.7 Drug release 92 
4.3.8 Drug release kinetics 92 
4.4 Results and Discussions 94 
4.4.1 FT-IR Spectroscopy 94 
4.4.2 SEM 96 
4.4.3 XRD 97 
4.4.4 Thermal analysis 98 
4.4.5 Swelling Study 100 
4.4.6 Drug loading and release studies 105 
Chapter-5. Poly(vinyl alcohol)-co-poly (2-acrylamido-2-methyl-1-propane- 
                    sulfonic acid) gastro-retentive hydrogel by microwave radiation 
109 
5.1 Introduction 111 
5.2 Materials & Methods 112 
5.2.1 Chemicals 112 
5.2.2 Hydrogel Synthesis 112 
5.3 In vitro Evaluation 114 
5.3.1 Fourier Transform Infrared Spectroscopy (FT-IR) 114 
5.3.2 Scanning Electron Microscopy (SEM) 114 
5.3.3 X-Ray Diffraction (XRD) 115 
5.3.4 Thermal analysis 115 
5.3.5 Swelling Study 115 
5.3.6 Drug loading 116 
5.3.7 Drug Release 116 
5.4 Results and Discussion 117 
5.4.1 FTIR Spectroscopy 117 
5.4.2 SEM 119 
5.4.3 XRD 121 
5.4.4 Thermal analysis 122 
5.4.5 Swelling Study 126 
5.4.6 In-vitro drug release studies 133 
Chapter-6. In-vivo Evaluation of hydrogel formulations for Controlled Release  
                   Drug Delivery of Captopril 
137 
6.1 Introduction 139 
6.2 Experimental Methods 140 
6.2.1 Instrumentation and analytical conditions 140 
  9 
         
 
          Research Article accepted in HEC Recognized/ Impact factor Journal 
 
1) Furqan Muhammad Iqbal,  Mahmood Ahmad and Aysha Rashid. 
Synthesis and in-vitro characterization of Hydroxypropyl 
methylcellulose-graft-poly(acrylic acid/2-Acrylamido-2-methylpropane 
sulfonic acid) polymeric network for controlled release of captopril. 
Accepted for publication in Acta Poloniae Pharmaceutica – Drug 
Research. vol. 73 (2016), issue no. 1. 
 
2) Furqan Muhammad Iqbal, Mahmood Ahmad, Malik Muhammad Zubair,  
Ume Ruqia Tulain and Aysha Rashid. Determination of captopril in 
plasma by high-performance liquid chromatography: Application in an 
6.2.2 Materials 140 
6.2.3 Preparation of the Mobile Phase 140 
6.2.4 Stock and working solutions 141 
6.2.5 Drug-plasma solution 141 
6.2.6 Chromatographic Analytical Conditions 141 
6.2.7 Sample Extraction 141 
6.3 Method validation 142 
6.3.1 Specificity 142 
6.3.2 Linearity and Standard Curve Preparation 142 
6.3.3 Lowest Limit of detection (LLOD) and quantitation (LLOQ) 142 
6.3.4 Precision and accuracy 143 
6.3.5 Extraction efficacy 143 
6.4 Results and Discussions 143 
6.4.1 Specificity 143 
6.4.2 Lowest Limit of detection (LLOD) and quantification (LLOQ) 147 
6.4.3 Linearity and Calibration Curve 147 
6.4.4 Precision and accuracy 149 
6.4.5 Extraction efficacy 151 
6.5 Application of the Method 152 
6.5.1 Operating conditions 153 
6.5.2 Plasma Concentrations Profile and Pharmacokinetic parameters of Captopril 153 
6.5.2.1 GROUP 1 154 
6.5.2.2 GROUP 2 156 
6.5.2.3 GROUP 3 158 
6.5.2.4 GROUP4 160 
Overall conclusion 165 
References  168 
  10 
in-vivo Evaluation of drug release from hydrogel. Accepted for 
publication in Latin American Journal of Pharmacy. 34 (5): (2015) 
 
3) Microwave radiation induced synthesis of hydrogel for the Controlled 
Release of captopril and its in-vitro Evaluation. Submitted in AAPS 
Pharm SciTech. 
 
4) Synthesis and in-vitro evaluation of Polvinyl alcohol- co- 2-acrylamido-
2-methyl-1-propanesulfonic acid gastro-retentive hydrogel by microwave 
radiation. Submitted in Journal of Pharmaceutical innovations. 
 
5) Synthesis, Characterizations, Current and Future Potential Applications 
of Hydrogel: A Review. Under preparation. 
 
6) In vitro and In vivo correlation study of Captopril loaded hydrogels.  
Under preparation. 
 
 
 
 
 
 
 
 
 
 
 
 
  11 
 
 
 
 
 
                                            Chapter no.1 
 
 
 
 
 
 
 
 
 
Introduction 
  12 
 
 
 
 
 
 
 
INTRODUCTION 
A remarkable advancement has been made in dosage form design; more progress is yet to be 
made for treating a number of clinical diseases. The drug administration should be in a 
manner that its concentration achieved matches the physiological needs at predefined periods 
of time and at proper site for desired therapeutic action. An optimum concentration of drug 
will overcome the side effects related to conventional dosage forms. This can ultimately lead 
to cost effective treatment by minimizing the overall expenses. Evolution of an existing drug 
molecule from a conventional form to a novel delivery system can significantly improve its 
performance in terms of patient compliance, safety, and efficacy. These days, drug 
manufacturing companies are engaged in the development of multiple platform technologies 
to get competitive advantage, extend patent life, and increase market share of their products. 
Various controlled release drug delivery systems have been formulated and are under 
progress, e.g. matrix systems, hydrogels, microcapsules, microspheres, liposomes, 
nanoparticles and many more. Developing new drug delivery technologies and utilizing them 
in product development is critical for pharmaceutical companies to survive. Advances in 
drug delivery are occurring at a rapid pace, and it is important to keep up with innovations 
and applications of these technologies. Considerable progress has been made in hydrogels 
syntheses and applications, that is playing a key role in controlled drug delivery technology. 
The polymers coming from natural, renewable sources, nontoxicity and biocompatibility, 
hydrogels also have economic advantages over other drug delivery systems. They are easy 
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and economical to synthesize requiring simple preparation methods to crosslink the 
polymers. The Hydrogels have been extensively used in the development of smart drug 
delivery systems. Synthesis of new polymers, polymer combinations in different ratios, 
crosslinking agents with more biocompatibility and better biodegradability would be 
essential for successful applications.  
With ever-growing advancement of research in the field of pharmaceutical technology, 
hydrogels have received considerable attention as convenient, biocompatible and stable 
carrier for a wide range of drugs, such as NSAIDs (non-steroidal anti-inflammatory drugs), 
antihypertensives, pharmaceutical proteins and peptides. Hydrogels protect the degradation 
of drugs from unfavorable conditions and control the drug release by changing the gel 
structure in response to environmental stimuli such as temperature, pH, ionic strength, solute 
concentration, electric field, magnetic field, light, sound etc. This ensures acceptable drug 
stability conforming official standards. Hydrogels are known to reduce the problems of both 
conventional and novel drug delivery systems.1,2 They are extensively used in the area of 
pharmaceutical and medical applications such as for controlled drug release and delivery, 
tissue engineering and regenerative medicine. They have been designed for drug targeting by 
using biocompatible polymers along with drug in micronized form and attaching “homing 
devices” like antibodies. It protects the normal cells and targets the diseased ones.3,4 
Hydrogels are generally defined as two- or multicomponent systems consisting of a three-
dimensional network of hydrophilic polymers bound by crosslinking or other cohesive 
forces, and can absorb large quantities of water while maintaining the structure. The 
crosslinking of the hydrophilic polymer chains prevent their dissolution. Depending on the 
properties of the polymer(s) used, as well as on the nature and density of the network joints, 
such structures in equilibrium can swell and retain a significant portion of water when placed 
in an aqueous solution. In the swollen state, the mass fraction of water in a hydrogel is much 
higher than the mass fraction of polymer.  Their affinity to absorb water is due to the 
presence of hydrophilic groups such as –OH, -CONH, -CONH2, -SO3H etc. in the polymers 
forming hydrogel structures.5-7 Depending upon the nature of aqueous environment and 
polymer composition, the polymer can be hydrated up to more than 90% due to the 
contribution of these groups and domains in the polymer’s network.8 Hydrogels can be 
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formed by physical or chemical crosslinking of homopolymers or copolymers. Two general 
classes of hydrogels can be defined - physical gels (pseudogels), as well as chemical gels 
(true, permanent). In physical hydrogels, the networks are connected by non-covalent 
interactions, such as electrostatic forces, hydrogen bonds, protein interactions, hydrophobic 
interactions or chain entanglements (such gels are non-permanent and usually they can be 
converted to polymer solutions by stress/heating). The other is chemical hydrogels with 
covalent bonds (replacing hydrogen bond by a stronger and stable covalent bonds) linking 
the chains. Chemical crosslinking methods include radical polymerization, chemical 
reactions of functional groups, high-energy radiations and enzyme usage. They attain an 
equilibrium swelling state which is dependent upon interaction polymer with water of and the 
crosslink density.9-11 
A broad range of synthetic and also natural polymers have been used in the synthesis of 
hydrogels. Usually the materials applied for general-purpose hydrogels are poly (ethylene 
oxide), poly(vinyl alcohol), polyvinylpyrrolidone, poly(hydroxyethyl methacrylate) and 
cellulose derivatives such as Hydroxypropyl methylcellulose (HPMC), Methylcellulose 
(MC), Carboxymethylcellulose (CMC) etc.  Owing to this, a new class of hydrogels known 
as environment sensitive hydrogels, capable of reacting to various physical and chemical 
stimuli such as temperature, pH, ionic strength, solute concentration, electric field, magnetic 
field, light, sound etc., have been tested for use in the so-called "intelligent biomaterials".12-15 
In Pharmaceutical technology, the research study has objectives related to betterment of the 
health care system to improve the quality of life. This research project is concerned with the 
formulation and characterization of hydrogels. Hydrogels are known to reduce the problems 
of both conventional and novel drug delivery systems. They are extensively used in the area 
of pharmaceutical and medical applications such as for controlled drug release and delivery, 
tissue engineering and regenerative medicine.  
This work was aimed to develop an orally administered controlled release hydrogel 
formation loading an antihypertensive drug “Captopril”. Different polymers, monomers were 
used in various combinations and subjected to In-vitro and In-vivo characterizations. Oral 
controlled release dosage forms have been developed over the past three decades due to their 
considerable therapeutic advantages such as ease of administration, patient compliance, cost 
  15 
effective manufacturing process and flexibility in formulation. Extensive studies are required 
to examine the factors that play role in development of controlled release formulations. 
Despite of the already existing research work, there are likely to be no well-established 
captopril controlled release formulations reported in the market. Development of a once daily 
captopril oral formulation would be a significant advantage for patient compliance 
accompanied by minimization of the drug side effects as a result of reduction in the drug 
blood concentration fluctuations, especially in long-term therapy. The hydrogel based dosage 
system that provides sustained release without the need to use special coatings or structures, 
both of which also add to the cost of manufacturing. Hence, a cost effective treatment will be 
provided in hypertension management. 
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Hydrogels are crosslinked polymeric networks with the ability to swell in an aqueous 
medium. Crosslinking in hydrogels occurs by chemical or physical means depending on the 
properties of various polymers, monomers, crosslinking agents and experimental conditions 
adopted for their synthesis. Due to different types of chemical structure and variety of 
crosslinking methods, a wide range of hydrogels have been prepared for various applications 
in pharmaceutical and biomedical fields. This chapter describes hydrogel classification, their 
methods of preparation, characterizations and applications. 
The swelling behavior of hydrogel formulations depends upon various factors, such as the 
nature of the polymer, the polymer-solvent compatibility and the degree of crosslinking. The 
polymeric network becomes more hydrophilic as the degree of ionization increases and the 
drug loading as well as release is dependent upon the swellability of the polymer. Depending 
upon the polymer’s structure, the hydrogels can undergo significant volume changes in 
response to slight changes in environment which can involve pH, temperature, the 
composition of the surrounding liquid etc.  The hydrogels are usually classified according to 
their response to their response to environmental stimuli as given below: 
2.1 Types of hydrogels 
2.1.1 pH sensitive or ionic hydrogels 
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The ionic hydrogels respond to changes in pH of the external environment. They can be 
anionic or cationic, due to the presence of certain ionic groups. Some of the pH sensitive 
polymers used in hydrogels’ preparations are polymethyl methacrylate (PMMA), 
polyacrylamide (PAAm), methacrylic acid (MAA), polyacrylic acid (PAA), polyethylene 
glycol and poly dimethlaminoethylmethacrylate (PDEAEMA). Acrylic acid (AA) and 
methacrylic acid (MAA) are the most commonly used monomer to fabricate anionic 
hydrogels.16-18 The copolymer of bacterial cellulose and acrylic acid, which are anionic 
copolymers, swell high in neutral or high pH but do not swell in acidic medium.19 On the 
other hand, poly-dimethyl-amino-ethylmethacrylate (PDEAEMA)20 and some cellulose 
derivatives have been used in cationic hydrogel formation. Two cationic 
hydroxyethylcelluloses of different hydroxyethyl and ammonium group contents were 
crosslinked and loaded with diclofenac sodium, with which they interacted through ionic and 
hydrophobic bonding at acidic pH. As the pH is increased up to 8 the interactions break and 
release process was sustained for more than four hours.21 
The pH- sensitive hydrogels have mainly been used to encapsulate proteins and peptides for 
oral administration. Other drugs have been delivered such as ketoprofen, caffeine, diclofenac 
sodium and anticancer drugs. The composite hydrogel, based on a methacrylated and 
succinic derivatives due to its pH-sensitive swelling and enzymatic degradability, together 
with mucoadhesion and cell compatibility, could be potentially useful as system for the oral 
treatment of colonic cancer, choosing 2-methoxyestradiol as a model of anticancer drug.22 
2.1.2 Temperature sensitive hydrogels 
These environment sensitive hydrogels have ability to swell or/and deswell as a result of 
changes in temperature. Thermoresponsive hydrogels have led to dramatic advances in the 
bioengineering and biotechnological fields.23,24 They have gained considerable attention for 
delivering large number of temperature sensitive drugs. The release and mechanical 
characteristics of both drug and hydrogels are altered with the change in the temperature of 
external environment.25 The hydrogel of polymers bearing N-isopropylacrylamide 
(NIPAAm) and acrylamide (AAm) so synthesized showed variable physical appearance from 
transparent solution to translucent gel depending upon temperature and was utilized to entrap 
insulin for prolonged release.26,27 Another thermo-sensitive hydrogel comprising of 
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polyorganophosphazene with amino- omegamethylpolyethylene glycol was formulated for 
delivering human growth hormone.28, 29 
Many polymers exhibit a temperature-responsive phase transition property. The common 
characteristics of these hydrogels are the presence of hydrophobic groups such as methyl, 
ethyl and propyl groups. Most commonly used are poly N-isopropylacrylamide (PNIPAAm), 
Poly (N, N-diethylacrylamide (PDEAAm), copolymers of NIPAAm can also be made using 
other monomers, e.g. butyl methacrylate (BMA), to alter the lower critical solution 
temperature (LCST). They can be sub-categorized into negatively thermosensitive and 
positively thermosensitive gels. Negative thermo-sensitive hydrogels contract upon heating 
above their low critical solution temperature. The poly N-isopropylacrylamide (PNIPAAm) 
hydrogel is well-known thermosensitive hydrogels for biomedical applications, because of its 
lower critical solution temperature (LCST) at around 32 ºC in aqueous solution. When 
solution temperature is below LCST, the network expands; it is extremely soluble in water 
and appears transparent. PNIPAAm chains contract and dehydrated when heated to a 
temperature above its LCST. At this point, PNIPAAm precipitates out from the aqueous 
solution, appearing opaque.30 
Certain hydrogels swell at high temperature and shrink at low temperature are termed as 
positive thermosensitivity. For example, inter penetrating polymer networks (IPNs) of poly 
(acrylic acid) and polyacrylamide (PAAm) or Poly(AAm–co-BMA) exhibits positive 
temperature dependence of swelling.31 
2.1.3 Glucose sensitive hydrogels 
Glucose-responsive hydrogels, exhibiting response to glucose concentration, are widely 
applicable in biosensing, microfluidics and bio-microelectromechanical systems, as well as 
implantable drug delivery systems for diabetes management applications.32-34 Four types of 
glucose-sensitive hydrogels have been intensively investigated, which are on the basis of 
glucose oxidase,35 concanavalin A,36 phenylboronic acid37 and glucose binding protein.38 
The development of modulated insulin delivery systems is one of the challenging problems 
in controlled drug delivery area, as insulin has to be delivered in exact amount and time. Due 
to outstanding mechanical swelling properties, the glucose-sensitive hydrogels are promising 
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biomaterials for development of smart insulin delivery systems. As the glucose concentration 
increases, the crosslinking density of the gel decreases and the gel swells or erodes to release 
the insulin.39, 40 
These hydrogels are usually based on glucose biosensor, which is sensitized to glucose 
concentration. A series of glucose-sensitive hydrogels based on glycidyl methacrylate 
modified dextran (Dex-G), ethylene glycol acrylate methacrylate modified concanavalin A 
(Con A–E) and poly (ethylene glycol) dimethacrylate (PEGDMA) were synthesized by 
photopolymerization. The hydrogels were highly glucose sensitive and biocompatibile, 
which could be prospectively applied as glucose biosensor and intelligent insulin delivery 
carrier.41 
Glucose-sensitive hydrogels (GSHs) responsive to both pH value and glucose concentration 
have also been prepared by polymerizing solutions containing hydroxypropyl methacrylate, 
(N, N-dimethylamino) ethyl methacrylate, and tetraethylene glycol dimethacrylate in the 
mole ratio 70:30:2.42 
2.1.4 Other stimuli sensitive hydrogels  
Temperature, pH and glucose sensitive hydrogels, have gained considerable attention in the 
field of drug delivery. However, other stimuli like light, electric field, pressure, protein 
sensitive hydrogels have been utilized in formulation of responsive hydrogels, but these have 
limited applications in this area.43,44 
2.1.4.1 Electro-sensitive hydrogels 
Electric current is another envoirnmental signal to induce responses in hydrogel. These 
electro-sensitive hydrogels are usually synthesized from polyelectrolytes, which undergo 
shrinking or swelling in the presence of an applied electric field. Various conditions affect 
the swelling, shrinkage and bending of hydrogels. The hydrogels may show variation in 
responses when placed in water (or acetone- water mixture) in contact with electrode to that 
without touching the electrode. The presence or absence of electrolytes in the aqueous 
solution can also influence the results.  
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Application of electric field causes the shrinkage of hydrogels, which recover their original 
size as the electric field is turned off. This property of   has been used for the modulated drug 
delivery by ‘on–off’ of the electric field.45 Poly (2-acrylamido-2-methylpropane sulfonic 
acid– co-n-butylmethacrylate). Hydrogels have ablity to release edrophonium chloride and 
hydrocortisone in a pulsatile manner using electric current.46 
2.1.4.2 Light-sensitive hydrogels 
Light-sensitive hydrogels have potential applications in developing optical switches, display 
units and ophthalmic drug delivery devices. Light-sensitive hydrogels can either be UV-
sensitive or visible light-sensitive hydrogels.47 
The UV-sensitive hydrogels were synthesized by introducing a leuco derivative molecule, 
bis(4-dimethylamino) phenylmethyl leucocyanide, into the polymeric network. The UV 
light-induced swelling was due to an increase in osmotic pressure within the gel due to the 
appearance of cyanide ions formed by UV irradiations. 
Visible light-sensitive hydrogels were prepared by introducing a light-sensitive chromophore 
(e.g. trisodium salt of copper chlorophyllin) to poly (N-isopropylacrylamide) hydrogels.48 
The Visible light exposure (e.g. 488 nm), of Hydrogels causes light absorption in 
chromophore, where it is dissipated as heat and raises the local temperature. It alters the 
swelling behavior of poly (N-iso propylacrylamide) hydrogels, which are thermo sensitive 
hydrogels. 
2.1.4.3 Pressure-sensitive hydrogels 
The pressure sensitivity appeared to be a common characteristic of temperature-sensitive 
gels. It was concluded that the pressure sensitivity of the temperature-sensitive gels was due 
to an increase in their LCST value with pressure.49 
The degree of swelling of poly (N-isopropylacrylamide) hydrogels increased under hydro 
static pressure when the temperature is close to its LCST. Other hydrogels, such as poly (N-
n-propylacrylamide), poly (N, N-diethylacrylamide) and   poly (N-isopropylacrylamide), all 
showed the pressure sensitivity near their LCSTs.50 
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2.1.4.4 Protein-sensitive hydrogels 
Stimuli-sensitive hydrogels can sense environmental changes and induce structural changes 
by themselves. They have attracted considerable attention as intelligent materials in the 
biochemical and biomedical fields. In particular, biomolecule sensitive hydrogels that 
respond to specific biomolecules have become increasingly important because of their 
potential applications in the development of biomaterials and drug delivery systems. The 
protein-sensitive hydrogels including enzymatically degradable hydrogels and antigen 
sensitive hydrogels undergo swelling changes in response to larger biomolecules.51 
Biodegradable polymers have high potential in biomedical fields because of their increasing 
importance in genetic engineering and drug delivery systems. They can be digested by 
specific enzymes, for this they are used in formulation of enzyme sensitive hydrogels. 
Hovgaard et al.52 focused on the fact that microbial enzymes in the colon, such as 
dextranases, can degrade the polysaccharide dextran. They prepared dextran hydrogels cross-
linked with diisocyanate for colon specific drug delivery.  
An antibody has recognition sites to bind with a specific antigen through multiple 
noncovalent bonds such as electrostatic interactions, hydrogen bonds, hydrophobic 
interactions, and van der Waals interactions. Antigen-sensitive hydrogels were prepared by 
using antigen–antibody bonds at cross-linking points in the hydrogels.53, 54 
To investigate the possibility of an antigen-sensitive hydrogel as an intelligent system for 
novel drug delivery applications, the permeation of a model drug through an antigen–
antibody semi-interpenetrating polymer network (semi-IPN) hydrogel membrane was 
investigated in the presence and absence of rabbit IgG as a free antigen.54 
2.1.4.5 Microgels and nanogels  
Apart from the synthesis of macroscopic networks, the hydrogels can be confined into 
smaller dimensions such as microgels. When the microgel particles are submicronized, they 
are known as nanogels. They have unique advantage of tunable size from nanometers to 
micrometers.55,56 They possess high water content, biocompatibility and adjustable 
mechanical properties. The properties provide a unique mode for targeted delivery of 
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encapsulated drugs via blood circulation. Nanocarriers due to their size smaller than typical 
blood cells can be administered intravenously. They can freely float in the bloodstream into 
the smallest vessels/capillaries and achieve the target site- or tissue-specific delivery.57, 58 
There are recent developments of microgel or nanogel particles as drug delivery carriers for 
biological, biomedical and drug delivery applications. They have also received attention as 
environmentally responsive systems and now are widely used as carriers for therapeutic 
drugs and diagnostic agents. They release the entrapped drug by swelling caused by change 
in the pH of the surrounding environment. For example, an anticancer drug adriamycin 
delivered to tumor cells showed the highest release at pH below 6.8.59 
 
2.2 Methods of hydrogel preparation  
As discussed earlier, both chemical and physical methods have been used by scientists to 
develop chemical and physical hydrogels, respectively. The widely used novel crosslinking 
methods to create the hydrogels are mentioned in figure 1 and they will be briefly discussed.   
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                                   Figure 1. Methods for hydrogel preparation  
2.2.1 Chemical Crosslinking methods 
2.2.1.1 Crosslinking by radical polymerization 
During polymerization process the monomer molecules are crosslinked chemically, resulting 
in the formation of either linear chains or a three-dimensional network of polymer chains. 
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Radical polymerization is one of the commonly used methods to synthesize the hydrogels, 
where low molecular weight monomers are crosslinked in the presence of crosslinking 
agents. A variety of hydrogels can be designed by this procedure, for example, different 
stimuli sensitive materials, hydrogels using water-soluble (synthetic, semi-synthetic and 
natural) polymers.11 
In an attempt to determine the optimum conditions for hydrogel synthesis by the free-radical 
polymerization of sorbitan methacrylate (SMA), the hydrogel used in this study was well 
polymerized under the following conditions: 50% (w/v) SMA as monomer, 1% (w/w), α, α’-
azo-bis (isobutyro-nitrile) as thermal initiator, and 1% (w/w) ethylene glycol dimethacrylate 
as cross-linking agent. Under these conditions, the moisture content of the polymerized SMA 
hydrogel was higher than in the other conditions and also from poly (methyl methacrylate 
[MMA]) hydrogels.60 
Triblock copolymers prepared via consecutive atom transfer radical polymerizations using 
monomers, N-isopropylacrylamide (NIPAAm), (2-dimethyl amino) ethyl methacrylate 
(DMAEMA) and 2-hydroxyethyl methacrylate (HEMA), in the presence of ethylene glycol 
di-2-bromoisobutyrate as initiator. The so-prepared hydrogels exhibited both temperature- 
and pH-sensitive behavior.61 
2.2.1.2 Crosslinking by chemical reaction of functional groups 
The water solubility of the polymers is attributed to the presence of functional groups like -
OH, -COOH, -NH2, used to create hydrogels.  The hydrogels are formed by the covalent 
bonding between the polymer chains and functional groups, such as amine-carboxylic acid, 
isocyanate-OH/NH2 or by Schiff base formation. Water-soluble polymers with hydroxyl 
groups can be crosslinked with aldehydes e.g. crosslinking of poly (vinyl alcohol) can be 
crosslinked using glutaraldehyde.  
Crosslinking of water soluble polymers can also occur by the addition reactions, where the 
hydrogels are formed using higher functional cross linking agents such as 1,6-
hexamethylene-diisocyanate, di-vinyl sulfone and many other reagents react with functional 
groups of water-soluble polymers. Other frequently applied synthesis of hydrogels involves 
condensation reactions between hydroxyl groups or amines with carboxylic acids or 
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derivatives to yield polyesters and polyamides, respectively. N, N-(3-dimethylaminopropyl)-
N-ethyl carbodiimide (EDC) is an efficient reagent to establish chemical crosslinking of 
water-soluble polymers with amide bonds in the preparation of gelatin hydrogels.62, 63 
2.2.1.3 Crosslinking by high-energy irradiation 
Nevertheless, owing to unique advantages such as shorter reaction times, crosslinking under 
mild conditions (room temperature and physiological pH), higher yields; limited generation 
of by-products and relatively easy scale-up without detrimental effects, radiation-assisted 
preparation of hydrogels have become an appealing synthetic tool. In addition, simultaneous 
synthesis and sterilization of hydrogels are the unique advantages of radiation processing.64-69 
The permeability and swelling characteristics of the formed gel are dependent upon the 
amount of polymer and radiation intensity. Usually the crosslink density increases with 
increasing polymer concentration and radiation dose.70 
Particularly gamma radiations, electron beams as well as microwave radiations are used for 
polymerization. Gamma radiation was used to crosslink the biodegradable hydrogels based 
on an acryloylated poly-aspartamide.71 An environment sensitive bacterial cellulose and 
acrylic acid composite was formed via electron beam. It exhibited higher swelling ability and 
the degree of swelling increased as the pH of surrounding medium increased.19 Similarly 
temperature-sensitive poly (N-isopropylacrylamide) PNIPAAm hydrogels were prepared by 
microwave irradiation using Mars-5 microwave accelerator.72 However the domestic 
microwave ovens are more convenient source of microwave radiation to create the chemical 
crosslinking among a variety of monomers and polymers. A copolymer hydrogel of k-
carrageenan (kC) and acrylamide (AAm), has been synthesized in aqueous medium at pH 7 
in the presence of the initiator potassium persulfate (KPS), by microwave irradiation using 
LG make domestic microwave oven.73 
2.2.1.4 Crosslinking using enzymes 
An emerging and interesting approach for formation of hydrogels is based on enzyme-
catalyzed crosslinking reactions. The enzymes from various sources, such as microbial 
Transglutaminase and mushroom tyrosinase provide a method for creating gels and may offer 
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interesting opportunities for in situ applications. The ability of these two enzymes to catalyze 
the formation of gels from solutions of gelatin and chitosan was observed and compared.74 
Similarly, hydrogels were synthesized from glutaminamide-functionalized poly (ethylene 
glycol) (PEG) and poly (lysine-co-phenylalanine) using transglutaminase (TG) in the 
presence of calcium ions as cofactors. The covalent crosslinking occurred by formation of an 
amide linkage between the carboxamide groups of peptidyl glutamine residues and primary 
amine groups of lysine residues.75 
Enzyme-mediated redox chain initiation involving glucose oxidase (GOX) was employed in 
a dip-coating technique to polymerize multiple, three-dimensional hydrogel layers using mild 
aqueous conditions at ambient temperature and oxygen levels.76 
Dextran hydrogels were formed in situ by enzymatic crosslinking of dextran-tyramine 
conjugates and their mechanical; swelling and degradation properties were evaluated. These 
results demonstrated that enzymatic crosslinking is an efficient way to obtain fast in situ 
formation of hydrogels. These dextran-based hydrogels are promising for use as injectable 
systems for biomedical applications including tissue engineering and protein delivery.77 
2.2.2 Physical crosslinking methods 
Most of the crosslinkers used for covalent crosslinking in hydrogel synthesis may induce 
toxicity if found in free traces before administration. To overcome this problem purification 
and verification step is needed. To avoid the use of crosslinking agents by physical 
crosslinking techniques have been investigated for the designing of hydrogel networks.  
 
 
 
2.2.2.1 Crosslinking by ionic interactions 
Various polymers that can be crosslinked by ionic interactions hence form hydrogels using 
this method. As covalent crosslinking requires multifunctional molecules as crosslinking 
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agents, the ionic crosslinking requires multivalent counter-ions as crosslinkers to link 
polymeric chains.  Chitosan based hydrogels were obtained by crosslinking of this chitosan 
with glycerol-phosphate disodium salt.78 
Alginate is a well-known example of a natural polymer that can be crosslinked by ionic 
interactions. It is a polysaccharide that can be crosslinked by calcium ions at room 
temperature and physiological pH. Alginate gels have been used in both drug delivery and 
cell encapsulation applications in the beads form usually produced by dripping alginate 
solution into a CaCl2 bath.79 For hydrogel preparation, the presence of ionic groups in 
polymer is not compulsory for ionic crosslinking. For example, dextran, which lacks ionic 
binding sites for cations, forms a hydrogel in the presence of potassium ions. However, this 
dextran /potassium gel is unstable in water and therefore is less suitable for drug delivery 
purposes.80 
2.2.2.2 Crosslinking by crystallization 
Apart from ionic interactions or hydrophobic interactions in physical cross-linking of 
hydrophilic polymers in hydrogel formation, crystallites can act in physical cross-links in 
block-copolymers and even in homopolymers. The dextran hydrogels were prepared by the 
process of crystallization. Dextrans are soluble in water, but precipitation was observed in 
concentrated aqueous solutions of low molecular weight dextran (dextran 6000). The kinetics 
of the precipitation process showed that the rate of precipitation is accelerated by increase in 
concentration of dextran solutions, stirring and the presence of salts. Depending on the 
precipitation time, microspheres or gels were obtained. The precipitates were insoluble in 
water at room temperature, but readily dissolved in boiling water. IR spectroscopy and 
modulated differential scanning calorimetry (DSC) demonstrated that the precipitates were 
crystalline.81 
A novel hydrogel system in which crosslinking was established by stereocomplex formation 
between lactic acid oligomers of opposite chirality has been developed. Poly L-Lactic acid 
(PLLA) and Poly D-lactic acid (PDLA) are semi crystalline materials. Each stereoisomer has 
a melting temperature of around 170 ºC. Interestingly, in blends of high molecular weight 
PLLA and PDLA a phase of a higher melting point (around 230 ºC) was observed.82 This is 
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attributed to the formation of racemic crystallites, also called stereocomplexes and was first 
described by Ikada et al.83 
2.2.2.3 Crosslinking by hydrogen bonds 
A spontaneous formation of hydrogel was observed by mixing of two water-soluble 
phospholipids polymers, such as poly (2-methacryloyloxyethyl phosphorylcholine-co-
methacrylic acid) (PMA) and poly (2-methacryloyloxyethyl phosphorylcholine-co-n-butyl 
methacrylate) (PMB), in aqueous medium at room temperature without any chemical 
treatment. The gelation mechanism, effects of ions on gelation and dissolution behavior were 
determined. The spectroscopic analysis and FT-IR analysis revealed that carboxyl groups in 
methacrylic acid (MA) formed dimer when two polymer solutions were mixed, and the 
results of the rheological study showed dissociation of carboxyl groups caused dissolution of 
the hydrogel. The hydrogen bonds are only formed when carboxylic acid groups are 
protonated. Thus, the gelation occurred due to the formation of dimers by hydrogen bonding 
which acts as a physical cross-linking of polymer chains.84 
Poly (vinyl alcohol) (PVA) hydrogels interacting with DNA mediated by hydrogen bonds 
(PVA/DNA hydrogel) were developed using ultra-high pressure (UHP) technology. The goal 
was to create a new method of gene delivery by controlled release of DNA.85 
Poly (acrylic acid) and poly (methacrylic acid) forms complexes with poly(ethylene glycol). 
These complexes are held together by hydrogen bonds between the oxygen of the 
poly(ethylene glycol) and the carboxylic group of poly(meth)acrylic acid, whereas for 
poly(methacrylic acid) hydrophobic interactions also play a role.86 
Asymmetric bolaamphiphilic sugar-based crown ether hydrogel were synthesized and their 
gelation ability with and without alkylammonium ions was investigated. Particularly, the 
gelation was drastically enhanced by addition of alkylammonium ions, which could result in 
stabilization due to the intermolecular hydrogen bonding and electrostatic interactions.87 
2.2.2.4 Crosslinking by protein interactions 
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Another novel method in producing hydrogels involves the crosslinking by protein linkages. 
It can be either by using genetically engineered proteins or crosslinking by antigen–antibody 
interactions. 
A hydrogel self-assembling method driven by the interaction between recombinant tax 
interactive protein-1 (TIP1) with the PDZ domain [(PDZ is an acronym combining the first 
letters of three proteins — post synaptic density protein (PSD95), Drosophila disc large 
tumor suppressor (Dlg1), and zonula occludens-1 protein (zo-1)] in a molecule, which is 
fused to each end of the triangular trimeric CutA protein (CutA-TIP1), and a PDZ domain-
recognizable peptide which is covalently bound to each terminus of four-armed 
poly(ethylene glycol) (PDZ-peptide-PEG). Genetic manipulation based on molecular-
dynamic simulation generated a cell-adhesive RGD (Rat Genome Database) tripeptidyl 
sequence in the CutA loop region [CutA(RGD)-TIP1]. In this way, an approach was 
developed for in situ hydrogel formation enabling cell entrapment via biospecific interaction 
between protein and peptide at physiological pH and temperature.88 
An antigen sensitive hydrogel was prepared by Miyata et al. in which an antigen (rabbit IgG) 
was grafted to chemically crosslinked polyacrylamide in the presence of antibody as an 
additional crosslinker. The hydrogel had poor swelling characteristics in the presence of free 
antigen due to the replacement of polymer-bound antigen, resulting in the release of the 
antibodies and thereby decreasing crosslink density.89 
2.3 Characterization of hydrogels 
Hydrogels are usually characterized for their morphology, the crosslink density and the 
structural integrity (porosity, pore size and its distribution), the ultimate capacity to absorb 
liquids (swelling property) as well as their elasticity. Various techniques have been 
investigated to investigate the crosslinking interactions among the polymers90 as could be 
seen in figure 2.               
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                     Figure 2. Methods of Characterization of hydrogels  
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2.3.1 Scanning electron micrography (SEM) 
SEM photomicrographs of the polymers are taken in order to investigate and compare their 
surface morphology. The texture is analyzed by SEM to ensure that hydrogels, such as based 
on starch, retain their granular structures.91 
The morphology of the poly (methacrylic acid)/poly (N-isopropylacrylamide) 
interpenetrating polymeric networks (IPN) was studied with both conventional SEM and 
cryogenic SEM experiments. Cryogenic SEM was used as a new approach to visualize the 
IPN morphological behavior in its swollen state. The pH and temperature influence on the 
IPN morphology was studied. The results showed that a decrease in pH and increase in 
temperature resulted in a drastic decrease in the pore size of the IPNs.92 
2.3.2 X-ray diffraction (XRD) 
This is another technique used to describe the retention or deformation of the crystalline 
structure of polymers during the processing pressurization process. Characterization and drug 
delivery behaviour of starch-based hydrogels prepared via isostatic ultrahigh pressure 
(IUHP). Szepes et al.91 characterized and investigated the drug delivery behaviour of starch-
based hydrogels prepared by ultrahigh pressure. The changes in structure and morphology of 
potato and maize starches were determined by X-ray diffraction examinations of the samples 
using D4 Endeavour diffractometer. The crystalline structure of maize starch was sensitive to 
UHP, so it was changed, while potato starch pressurized in aqueous medium remained stable 
and retained its original X-ray pattern.   
The X-ray diffraction patterns of a copolymer hydrogel of kC-graft-PAAm, k-carrageenan 
(kC) and acrylamide (AAm) were observed. A considerable modification was noticed in the 
polysaccharide, leading to a change in molecular association in the formed of hydrogel when 
compared with kC and AAm.70 
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2.3.3 Magnetic Resonance Imaging (MRI) 
MRI uses a powerful magnetic field, radio frequency pulses and a computer to produce 
detailed pictures at cellular and molecular level. Proton Magnetic Resonance Imaging (MRI) 
has been used to study the physical changes of hydroxypropyl methylcellulose (HPMC) 
hydrogels due to microwave irradiation of the polymer. The proton one-dimensional images, 
derived from relaxation, spin density and diffusion-weighted spin-echo experiments, provide 
insights on the dynamics of water and the motional state of the polymer inside the hydrogels. 
The obtained results indicated that the microwave irradiation causes the breaking of the 
HPMC polymer–hydrogen bonding network in HPMC powder which influences the 
dynamics of water and polymer chains within its hydrogels.93 
Proton Magnetic Resonance (PMR) imaging in a thermo reversible gel using Bruker MSL-
300 FT-NMR spectrometer measured volume-phase-transition. This was demonstrated in the 
lower critical solution temperature ( LCST) polymer poly (N- isopropylacrylamide) which is 
swollen in water. The swelling ratios in the axial and radial directions were the same after the 
thermal collapse.94 
2.3.4 Fourier Transform Infrared Spectroscopy (FTIR) 
Fourier transform infrared (FTIR) spectroscopy is an established tool for the structural 
characterization; any change in the morphology of hydrogels changes their IR absorption 
spectra. The structure and properties of the superabsorbent hydrogels synthesized by graft 
copolymerization of acrylic acid (AA)/acrylamide (AM)/2-acrylamido-2-methyl-1 
propanesulfonic acid (AMPS) onto sodium carboxymethylcellulose (CMC) and 
montmorillonite (MMT) were evaluated where the intermolecular interaction and 
morphological change of the hydrogels were characterized by Fourier Transform Infrared 
(FTIR) spectroscope. It was shown that superabsorbent hydrogel product comprises a 
crosslink structure of MMT and CMC with side chains that carry carboxylate, carboxamide 
and sulfate.95 
The fractions of dissociation of acrylic acid (AAc) units within hydrogel in response to 
changes in pH and ionic strength of external aqueous solution were determined by FTIR-
ATR spectroscopy. The swelling response of hydrogels to the changes in external pH and 
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ionic strength was governed mainly by the ionic osmotic pressure due to the accumulation of 
diffusible ions within hydrogels.96. 
2.3.5 Thermal Analysis  
DTA and DSC measure, respectively, the temperature difference and the heat flow difference 
between a sample and a reference material (subjected to the same temperature variation in a 
controlled atmosphere). DTA detects any change in all categories of materials, whereas DSC 
determines the temperature and heat of transformation.  
Differential Scanning Calorimetry (DSC) was used to monitor the reaction scheme of arylic 
based superabsorbing polymers. The heat effects were studied during the polymer synthesis 
in DSC pan as a micro-scale reactor. Two distinct observations, i.e. inhibition period (IP) and 
onset of gel formation were recorded during polymerization. By this the effect of reaction 
temperature and initiator concentration was assessed in the synthesis of superabsorbent 
hydrogels.97 
The DSC technique allows studying the drug release and diffusion from a polymeric device 
to the site mimicking a biological membrane. The drug release from inulin-based hydrogel to 
a biomembrane model was investigated at pH 4.0 and 7.4 by using DSC that appears to be a 
suitable technique to follow the transfer kinetics of a drug from a controlled release system to 
a biomembrane model.98 
2.3.6 Swelling behavior 
The hydrogels were allowed to immerse in aqueous medium or medium of specific pH to 
know the swellability of these polymeric networks. These polymers showed increase in 
dimensions related to swelling. A gelatin based pharmaceutical hydrogels, gelled in minutes 
using oxidized konjac glucomannan (DAK) as a macromolecular cross-linker, and was 
estimated for equilibrium swelling ratio. From the photographs of the hydrogel in both dry 
and swollen state, it was determined that the hydrogels remain in the cylindrical form after 
swelling. However marked volume differences were noticed where the diameter of swollen 
hydrogel was about 4.0 cm, while the diameter of the dry state hydrogel was only 1.5 cm.99 
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The swelling and deswelling kinetics of poly (N-isopropylacrylamide) (PNIPAAm) 
hydrogels separately synthesized by means of microwave irradiation and normal water-bath 
heating. The swelling and deswelling kinetic curves of the PNIPAAm hydrogels were 
measured in water below and above the lower critical solution temperature (LCST), and their 
swelling and deswelling kinetic parameters were estimated. Results showed that in 
comparison to the hydrogel synthesized by the conventional method, the hydrogel 
synthesized by microwave irradiation had larger swelling and deswelling rate constants as 
well as lower swelling/deswelling activation energy due to its higher surface area and larger 
pore sizes, and thus it had faster response behavior.72 
The swelling responses of pH sensitive psyllium and polyacrylamide based hydrogels were 
measured in aqueous medium by gravimetric method. The equilibrium percent swelling (Ps) 
of the polymeric network were calculated as follows: 
                               Ps  =    × 100                       (1) 
 Where Ws and Wd are weights of swollen polymers and dried polymers respectively.100,101 
2.3.7 Gel Fraction 
Gel fraction is mass fraction of the network material resulting from a network forming 
polymerization or crosslinking process. The gel fraction assays are performed to determine 
the level of crosslinking, greater the gel fraction, higher is the crosslinking density. If all 
polymers is in gel fraction (no soluble fraction) and it is completely crosslinked. The degree 
of cross linking is usually dependent on the molecular weight of the polymers. The polymers 
with low molecular weight poorly form gel than one with higher molecular weight. Gel 
fraction was determined in Poly (vinyl alcohol) hydrogels, where Cross-linking does not 
occur entirely and certain PVA macromolecules remain in the network uncross-linked (sol). 
The gel fraction G in hydrogels was estimated by the formula: 
                                   G (%) = × 100                          (2)          
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Where, W1 is the weight of the dried cross-linked sample with sol and Wd is the weight of the 
dried sample after the removing of sol by extraction in water.102-104 
2.3.8 Porosity 
During swelling, the pores located inside the network are rapidly filled with the solvent; atthe 
same time, the polymer region takes up the solvent from the environment, whose extent 
depends on the attractive force between the solvent molecules and the polymer segments.105 
Solvent replacement method was used for porosity measurement. Weighed dried discs were 
immersed in absolute ethanol overnight and weighed after excess ethanol on the surface was 
blotted using blotting paper. Porosity was calculated using the following equation 
                                    Porosity (%) =  × 100                    (3) 
where M1 and M2 are the weights of hydrogels before and after immersion in absolute 
ethanol, respectively. ρis the density of absolute ethanol and V the volume of gel.106 
The decrease in density can be attributed to the increase in porosity. The bulk density of 
dried hydrogels can be determined using picnometer. Certain substances have influence on 
the density and porosity of the hydrogels. Mahdavinia et al.107 studied the effect of CaCO3 
content on the density of the hydrogels. Using the high content of CaCO3 to synthesize 
hydrogel causes the high number of produced pores, and subsequently the density will be 
decreased. 
2.3.9 Rheology  
Hydrogels were evaluated for viscosity under constant temperature of usually 4 °C by using 
Cone Plate type viscometer when a small amount of material was available. For most of the 
experiments a flat-plate measuring geometry (acrylic, 4 cm diameter; gap 1 mm) was used. 
The mechanical strength of the swollen sample of acrylic-based Superabsorbent polymer 
(SAP) hydrogel was measured by a rheological method. The characterization was conducted 
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by a controlled strain rheometer at 25ºC. Dependency of the rheological properties of the 
sample on strain and frequency was investigated.108 
The rheology measurements yield information of the nature of the water–polymer interaction. 
The phase transition behavior of water within the chitosan/polyacrylate hydrogels was 
investigated by means of oscillatory shear rheology. Changes in structure were determined 
by comparing differences in the rheological measurements at temperatures above and below 
freezing.109 
2.3.10 In-vitro Release Studies 
Since hydrogels are the swollen polymeric networks, interior of which is occupied by drug 
molecules, therefore, release studies are carried out to understand the mechanism of release 
over a period of application.110, 111 In-vitro drug release studies can be performed by using 
diffusion cell method. The release rate of the timolol maleate from the stimuli sensitive 
hydrogels was determined by the diffusion process. The samples withdrawn were analysed 
spectrophotometrically at 294 nm for the timolol maleate using Shimazdu Double beam UV-
Visible spectrophotometer.112 First-order model, Higuchi square root time model, Hixson–
Crowell model, Weibull distribution, Korsmeyer–Peppas model, etc, are used to evaluate the 
dissolution profiles of the samples.113,114 
2.3.11 In-vivo Evaluation 
In-vivo studies are conducted on prepared optimized hydrogel formulation (test) and on 
marketed formulation (standard). A wide range of acute, sub-chronic and chronic toxicity 
studies are conducted, using various routes of administrations in different species. The 
animal treatment should be complied with the Principles of Laboratory Animal Care 
formulated by the National Society for Medical Research. The biocompatibility and 
degradation of the Dacron matrices impregnated with gelatin- chondroitin sulphate (ChS) 
gels was studied after implantation in subcutaneous pockets in rats. Chemically cross-linked 
gelatin-ChS gels showed a mild tissue reaction, and almost complete degradation within 18 
weeks of implantation. Before in vivo implantation, the Dacron samples, as such or 
impregnated with gelatin or gelatin and ChS, were sterilised by γ irradiation.115 
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In vivo evaluation on the long-term is now necessary to confirm their biocompatibility and 
establish their life-time. Moreover, the inter-subject variation is more significant in the in 
vivo study than in vitro skin permeation experiments. It was confirmed by study designed to 
investigate the in vitro and in vivo skin absorption of capsaicin and nonivamide from 
hydrogels.109 
2.4 Hydrogels for pharmaceutical and biomedical applications 
Hydrogels are promising candidates for controlled release devices, bioadhesive devices, or 
targetable devices of therapeutic agents. The excellent hydrophilic properties, high swelling 
ratio and biocompatibility, have led them widely applicable in biomedical / pharmaceutical 
area as antibacterial materials, tissue engineering, biosensors and sorbents for the removal of 
heavy metals.116-120 These water-swollen, crosslinked biomedical materials are efficient 
carriers for the development of novel pharmaceutical formulations for the delivery of drugs 
(peptides and proteins), as targeting agents for site specific delivery and as components for 
the preparation of protein or enzyme conjugates. They have gained considerable existence in 
drug delivery through parenteral, ocular, rectal, vaginal, dermal and nasal routes.121, 122 
2.4.1 Transdermal drug delivery  
Water-based polymeric gels offer several advantages over traditional oleaginous bases in 
terms of ease of application, cosmetic acceptability (colorless and water-washable) and 
desirable drug release characteristics.123 Drug delivery to the skin has been traditionally 
conducted for topical use of dermatological drugs to treat skin diseases, or for disinfection of 
the skin itself. In recent years, a transdermal route has been considered as a possible site for 
the systemic delivery of drugs. The possible benefits of transdermal drug delivery include 
that drugs can be delivered for a long duration at a constant rate, that drug delivery can be 
easily interrupted on demand by simply removing the devices, and that drugs can bypass 
hepatic first-pass metabolism. Furthermore, because of their high water content, swollen 
hydrogels can provide a better feeling for the skin in comparison to conventional ointments 
and patches. Versatile hydrogel-based devices for transdermal delivery have been proposed 
so far.122 
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The hydrogel membranes mainly composed of three kinds of latex particles within 
carboxymethyl cellulose (CMC) matrix were prepared for the purpose of transdermal drug 
release. These microgels were poly (acrylic acid-cosodium acrylate), poly (acrylic acid-co-2-
ethylhexyl acrylate) and poly(N-isopropyl acrylamide), which were developed to give the 
membrane a higher swelling ratio, a better adhesive property and a thermo-responsive 
behavior, respectively. Gel particles of PNIPAAm or its copolymers underwent deswelling 
above lower critical solution temperature (LCST), creating more space for the membrane to 
absorb more water and in turn increasing the swelling ratio. Also, they simultaneously 
expelled caffeine to the highly swollen CMC matrix, thus increasing the caffeine-release 
rate.124 
A transdermal system for delivering selegiline using a hydrogel-based drug reservoir and a 
rate-controlling membrane (Solupor polyethylene membranes) was designed.  Both the R- 
and S-forms of selegiline were examined in this study to elucidate the stereoselectivity of 
skin to selegiline. The experimental results suggested that Solupor can be used as a substrate 
to control the permeation of selegiline. The amount of drug permeating across the skin can be 
reduced by the membranes.125 
Hydrogels are used for local drug delivery in the control of wound healing. Nanocomposite 
hydrogel wound dressing was prepared using combination of polyvinyl alcohol hydogel and 
organoclay, i.e. Na-montmorillonite. The results showed that the nanocomposite hydrogels 
could meet the essential requirements for the reasonable wound dressing with some desirable 
characteristics such as relatively good swelling, appreciated vapour transmission rate, 
excellent barrier against microbe penetration and mechanical properties.126 
2.4.2 Orally administered hydrogels 
The orally administered hydrogels are used for peroral and oral drug delivery and drug 
delivery. It leads the drug to mouth (oral cavity), stomach, small intestine, or colon. Drug 
delivery to the oral cavity can have versatile applications in local treatment of diseases of the 
mouth, such as periodontal disease, stomatitis, fungal and viral infections, and oral cavity 
cancers. Long-term adhesion of the drug containing hydrogel against copious salivary flow, 
which bathes the oral cavity mucosa, is required to achieve this local drug delivery. A 
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bioadhesive tablet or hydrogel-based ointment can also be utilized for the topical treatment of 
certain diseases in the oral cavity. Chitosan-based hydrogels have been recognized as 
excellent candidates for oral delivery due to their mucoadhesive properties. Chitosan 
hydrogels have been developed for the local release of a number of other drugs in the oral 
cavity. In addition to the released drugs, the chitosan polymer itself has shown antifungal 
activity. For instance, chitosan hydrogels and films were able to limit adhesion of the 
common pathogen Candida albicans to human buccal cells.127 
The Chitosan based matrix has been used as a reliable colonic controlled-release system for 
the release of 5-aminosalicylic acid (5-ASA) or diclofenac sodium (DS) and introduced into 
enteric-coated capsules for controlled release to the colon.128 Alginate-N, O-carboxymethyl 
chitosan hydrogels with calcium for oral delivery of protein drugs to different regions of the 
intestinal tract e.g., for duodenal targeting, small intestine targeting, or colon targeting.129 
Colon specific hydrogels of polysaccharides have been specifically designed because of 
presence of high concentration of polysaccharidase enzymes in the colon region of GI 
(gastrointestinal) tract. Drugs loaded in such hydrogels showed tissue specificity and changed 
in the pH or enzymatic actions that cause liberation of drug.130 
2.4.3 Ocular delivery 
In comparison to other ophthalmic formulations such as suspensions and eye ointments, the 
hydrogels may offer better feeling, with less gritty sensation to patients. In particular, in-situ-
forming hydrogels are attractive as an ocular drug delivery system because of their facility in 
dosing as a liquid and their long-term retention property as a gel after dosing. 
 Fast forming hydrogels prepared by crosslinking a poly (ethylene glycol) (PEG)-based 
copolymer containing multiple thiol (-SH) groups were evaluated for the controlled ocular 
delivery of pilocarpine and subsequent pupillary constriction. A strong correlation between 
pilocarpine release and pupillary response was observed. In conclusion, the current studies 
demonstrate that in situ forming PEG hydrogels possess the viscoelastic, retention and 
sustained delivery properties required for an efficient ocular drug delivery system.131 
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 In situ forming poly (ethylene glycol) (PEG)-based doxycycline hydrogels were developed 
and evaluated for their wound healing efficacy in rabbit corneas in organ culture. The 
doxycycline-PEG hydrogels accelerated corneal wound healing after vesicant injury offering 
a therapeutic option for ocular mustard injuries. Histology and immunofluorescence studies 
showed a significant reduction of matrix metalloproteinase-9 (MMP-9) and improved the 
healing of vesicant-exposed corneas by doxycycline hydrogels compared to a similar dose of 
doxycycline delivered in phosphate buffered saline (PBS, pH 7.4).132 
2.4.4 Subcutaneous delivery 
Biocompatibility is a prerequisite requirement to overcome undesirable body responses, such 
as inflammation, carcinogenicity and immunogenecity. Due to their high water content, 
hydrogels are generally considered as biocompatible materials. They also cause minimal 
mechanical irritation upon in-vivo implantation, due to their soft and elastic properties and 
possess broad acceptability for individual drugs with different hydrophilicities and molecular 
sizes; and unique possibilities (crosslinking density and swelling) to manipulate the release of 
incorporated drugs.133,134 
Some of these may offer an advantage for the delivery of certain delicate drugs, such as 
peptides and proteins. The high-strength injectable Pluronic hydrogels were synthesized by 
enzyme-mediated cross-linking for controlled drug delivery. They showed controlled 
erosion, bio-adhesion, thermo-sensitivity, and injectable properties, ideal along with in situ 
depot formation in the tissue. They can possibly be utilized for sustained delivery of 
therapeutic proteins, genes, and chemical drugs.135 The poly (β-amino ester) (PAE) as a duo -
functional group for synthesis of the novel sensitive injectable hydrogel is used for controlled 
drug/protein delivery. Furthermore, the cationic nature of PAE is utilized to make the ionic 
complexes with anionic biomolecules loaded into the hydrogel such as insulin.136 
The hydrogels could target drugs to specific body sites and control the release of drugs for 
prolonged periods of time. For this they can be used as promising drug delivery systems for 
treating various types of cancers. Injectable chitosan hydrogels have been synthesized for 
localised cancer therapy using paclitaxel as a model drug.137 
 
  41 
2.4.5 Rectal and vaginal delivery 
The bioadhesive characteristics of hydrogels make them a valuable way to overcome the 
shortcomings of conventional suppositories, such as uncontrolled drug release and 
insufficient retention in the rectum. Once in the rectal cavity, the development of 
mucoadhesiveness would help to immobilize the hydrogel for a required period of time thus 
prolonging the drug release for local or systemic use.  
A thermosensitive hydrogels was formulated which was based on poloxamer 407, a 
thermosensitive polymer, and hydroxypropylmethylcellulose (HPMC), a bioadhesive 
polymer, intended for the rectal delivery of quinine in children. In consideration to the 
therapeutic applications, the formulations should be in the liquid state at ambient temperature 
(generally 25 ºC), should gel at body temperature (37 ºC) and should be adhesive on the 
rectal mucous membrane.138 The temperature sensitive and mucoadhesive pluronic-based 
hydrogels were designed, which were capable of retaining their rheological and 
mucoadhesive properties after dilution with vaginal fluids. It enables them as promising 
formulations for the vaginal administration of drugs.139 
2.4.6 Hydrogels for tissue engineering 
When designing suitable biomaterials for tissue-engineering applications, biological and 
chemical parameters are frequently taken into account. The hydrogels, due to their swelling 
properties, can be made to resemble the physical characteristics of soft tissues. Hydrogel 
materials also generally exhibit high permeability and good biocompatibility making these 
materials attractive for use in cell encapsulation and tissue engineering applications. Due to 
the biocompatibility, permeability and physical characteristics, hydrogels are good 
candidates as biomaterials for use in many medical applications, including tissue 
engineering. Hydrogels may be useful for manipulation of tissue function or for tissue 
regeneration or replacement. The use of photopolymerization in the preparation of hydrogels 
is advantageous in comparison with conventional crosslinking methods because liquid 
hydrogel precursors can be delivered and crosslinked to form hydrogels in situ in a minimally 
invasive manner such as by injection. This process also gives one spatial and temporal 
control over the conversion of a liquid to a gel, so that complex shapes can be fabricated.140 
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Cellulose is a major extracellular matrix component of plant cells, composed of poly (1,4´ -
anhydro-b-β-D-glucopyranose). Being an abundant naturally occurring polymer, it is 
renewable, as well as biodegradable and derivatizable for a large number of biomedical and 
pharmaceutical applications. Cellulose based materials including bacterial cellulose are of 
increasing interest in tissue engineering. They have been utilized in wound healing,141 
artificial kidney, artificial blood vessels, bone, cartilage and cardiovascular tissue 
engineering etc.142-146 
2.5 DRUG  
Captopril, (2S)-1-[(2S)-2-Methyl-3-sulphanylpropanoyl] pyrrolidine-2-carboxylic acid an   
angiotensin-converting enzyme (ACE) inhibitor was chosen as a drug to be loaded into the 
hydrogel formulation. Its chemical structure is shown in the figure. 
 
 
Figure 3.Chemical structure of captopril 
          (C9H15NO3S, MW = 217.3) 
 
It is widely used as an antihypertensive drug and for the management of congestive heart 
failure because of its effectiveness and safety. It has low toxicity and commonly prescribed 
patients suffering from chronic illness. Therefore, a long term therapy is needed for their 
treatment. Commercially, it is available as immediate release tablets of 12.5- 50 mg. It is 
available in market with following brand names.   
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      Table 1.  Commercially Available brands of Captopril             
                     Brand names                       Manufacturers 
                       Capoten               Glaxosmithkline 
                       Captil           Werrick Pharmaceuticals 
                       Capoten              Bristol-Myers Squibb 
                       Captolane                      Sanofi-Aventis 
                       Captoril            Benson 
                       Acepril                      BMS (United Kingdom) 
                       Acepress            BMS (Italy) 
                       Cesplon            Esteve (Spain) 
                       Dilabar            Qualigen (Spain) 
 
Captopril has been a drug of choice in hypertension management and also effectively used 
for congestive heart failure. There are almost 25% people among the world’s population 
suffering from hydpertension.147,148 Captopril is successfully used for hypertensive patients 
but its antihypertensive effect remains for a period of 6–8 hours. For maintaining minimum 
effective concentration three to four CAP administrations are required. For this reason, 
usually 25-100 mg drug is needed for successful medication of hypertension and heart 
disorders. In some conditions, for therapy of heart failure an initial dose of 6.25 mg is needed 
three times a day. Therefore, development of a controlled release drug delivery system for 
CAP would be beneficial; hence once daily formulation will be needed to achieve significant 
effects, providing an optimum drug concentration, minimizing drug fluctuations and adverse 
drug effects.  
Captopril is a suitable candidate for controlled release drug delivery systems due to its short 
elimination half-life of less than 2 hours.149 However, it is not easy to develop an oral 
controlled release formulation of captopril, due to its in-vitro and in-vivo stability concerns. 
The drug being freely soluble in water and physiological aqueous solutions may undergoes 
the problems like dose dumping as well as burst phenomena from controlled/sustained 
release drug delivery systems.150 Moreover, its bioavailability is also affected in presence of 
food and higher intestinal pH.  
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Captopril has been formulated in both rapid and slow release drug delivery systems either for 
its fast availability into blood circulation to attain peak plasma concentration in lesser time or 
to be available for longer period of time. For its instant availability, sublingual tablets were 
prepared, which was an effective way for lowering the arterial blood pressures in emergency 
situations. Hence, there were rapidly available therapeutic levels of drug as compared to 
other orally administered captopril tablets.151 
In treating hypertension and heart failure long term management is required by 
antihypertensive drugs. In this context, there is a need to develop controlled release dosage 
form, where dissolution rate should be controlled. For this reason, various researchers have 
prepared the controlled release formulations such as floating matrix tablets, gastroretentive 
systems, microcapsules, and nanoparticles. Martinez et al prepared the in-vitro sustained 
release floating tablets of captopril by using metalose SH 4000 SR/ Sodium bicarbonate. The 
floating tablets were prepared to prolong the gastric residential time and to avoid the 
degradation by higher pH of intestine.152 Polymeric matrices were formulated to control the 
release rate of captopril using various polymers such as, Hydroxypropyl methyl cellulose 
(HPMC), Sodium carboxy methyl cellulose (NaCMC) and ethyl cellulose (EC). This work 
was concerned to study the effect of polymers and surfactants on release of captopril.153 
In another work, the captopril was entrapped in albumin based biodegradable microparticles 
formulated by Dandagi et al.154 by using emulsification- heat stabilization technique. Its in-
vitro analysis had shown the drug release upto 24 hours and in-vivo evaluation proved its 
successful targeting to lungs, liver, kidneys and spleen. Similarly Cellulose propionate (CP) 
microparticles were prepared by solvent evaporation technique for controlled release of 
captopril. They were proven as useful products in gradually decreasing systolic blood 
pressure throughout 24 hour time period in comparison to reference solution.155 Captopril-
loaded microspheres have also been prepared by solvent evaporation method, using Methocel 
and Eudragit RS as release-controlling factors and to evaluate captopril release. Microspheres 
and micropellets of captopril have also been prepared with different polymers (chitosan, 
ethyl cellulose, sodium alginate and Hydroxy propyl methyl cellulose) through the 
techniques of microencapsulation. Polyacrylamide-co-methylcellulose (PAAMA-co-MC) 
hydrogels loaded with captopril were prepared and evaluated for their controlled release 
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characteristics. The sustained releases of captopril from cyclodextrin nanoparticles have also 
been investigated.156 
As already mentioned that the hydrogels are not only overcomes the shortcomings of 
conventional dosage forms but also have advantages over other controlled release 
formulations like microparticles and matrix tablets. Because of their cross-linked polymeric 
network they have ability to entrap drugs and protect them from unfavorable physiological 
environments. Captopril loaded into hydrogel formulations may remain stable and released 
for longer periods of time.   
2.5.1 Physical properties 
Captopril is a white or almost white crystalline powder. These white crystals melt at about 
88°C, which recodifies and melt again at 105°C or 106°C. It is freely soluble in water, in 
methylene chloride and in methanol and also dissolves in dilute solutionsof alkali 
hydroxides. It has a characteristic sulfide-like odour.157,158 Captopril is not hygroscopic under 
ordinary conditions. Above 40°C, captopril shows extraordinarily high water solubility.159 
2.5.2 Captopril Stability 
In solution, this product undergoes an oxygen facilitated, first order, and free radical 
oxidation at its thiol to yield captopril disulfide. Hydrolysis at the amide linkage occurs only 
under forcing conditions. Oxidation is delayed using lower pH, chelating agents, higher 
concentration, degassing, minimizing headspace, and incorporation of antioxidants. No 
degradation is seen in methanol (40μg/ml) for up to 2 weeks at 5 °C. It shows maximum 
stability below pH 4; however in the absence of oxygen it remains stable at relatively higher 
pH values. 160 Captopril contains a sulphydryl group that results in its self-dimerization, rapid 
formation of disulfide conjugates with endogenous thiol-containing compounds (cysteine, 
glutathione) and plasma protein binding. Therefore, during in-vivo evaluation, the detection 
or measurement of free captopril concentration needs molecule derivatization or an addition 
of chemical stabilizer in biological or in vitro samples to prevent captopril disulphide 
formation. Various Flouresence or UV active agent such as N-(1-pyrenyl) maleimide (NPM) 
and p-bromophenacyl bromide (p-BPB), have been used as chemical stabilizers. The 
formation of Captopril disulfide can be controlled by lowering the pH below 4, adding 
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chelating agents (EDTA) or antioxidants. Dithiothreitol (DTT) added to the plasma samples 
successively reconstitutes captopril converted to disulfide, by increasing free thiol content 
from human serum albumin. 
2.5.3 Pharmacokinetics 
Captopril, after oral administration, is rapidly absorbed from stomach and small intestine.  
Approximately 75% of orally administered captopril is absorbed in fasting conditions.  After 
oral ingestion of a single dose the maximum blood level and therapeutic effect is observed 
after 45–90 min. By presence of food in stomach Bioavailability is reduced to 25-30%, 
therefore the drug should be administered one hour before meal. When enters into blood, 
nearly 25% of captopril is binds to plasma protein. Captopril is partly undergoes metabolism 
and about 95 % of the absorbed drug is excreted in urine, where 40-50 % is unchanged and 
the remaining is captopril disulfide.161 
2.5.4 Clinical Uses 
Therapeutic benefits of Captopril are due to its vasodilatory effects as well as inhibition of 
some renal function activities. The following are its main uses in various clinical conditions: 
i) A widely acceptable and drug of choice for treating Hypertension. 
ii) It has been approved by FDA for the treatment of cardiac disorders like 
congestive heart failure, left ventricular dysfunction and post-myocardial 
infarction.  
iii)  Captopril has an additional advantage to preserve the function of kidneys during 
diabetic nephropathy. The effect of captopril on creatinine clearance, protein-urea 
and metabolic controlled in diabetic neuropathy were determined. In addition of 
controlling blood pressure alone, captopril provides protection against 
deterioration of renal function in patients with insulin dependent diabetic 
nephropathy.162 
iv) Captopril also possesses mood elevating characteristics and has shown in some 
patients. This is indicative of its antidepressant effect. However, it has not been 
reported in formal clinical trials.163 
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v) Additionally, this compound has also been investigated to possess cytotoxic 
activity for use in the treatment of certain types of cancer such as in treating lung 
tumor. The impact of this drug on cell proliferation, apoptosis, and angiogenesis 
has been evaluated.164 
2.5.5 Adverse drug reaction (ADR) 
1) The adverse drug reaction (ADR) profile of all ACE inhibitors is almost similar to 
one another. Captopril like other ACE inhibitors commonly cause cough, which is 
attributed to increase in bradykinen plasma level.165 
2) Unlike most of the other ACE, captopril usually causes rash. 
3) Due to oral administration of this drug, taste alterations have been noticed in many 
cases.  It may impart a characteristic metallic taste and in some situations it leads to 
taste loss. This effect is associated with sulfhydryl group present in Captopril.166 
4) Other adverse effects of captopril include proteinuria, angioedema, hyperkalemia, 
tetragenicity, postural hypertension, agranulocytosis, leukopenia and in some cases it 
may be responsible to acute renal failure.167 
 
2.6 Excipients and Formulations 
In this research work, two polymers and two monomers were used which are given as 
following:  
The polymers used were: 
i. Hydroxypropyl methylcellulose (HPMC) and  
ii. Polyvinyl Alcohal (PVA),  
The monomers were: 
i. Acrylic acid and  
ii. 2-acrylamido-2-methylpropane-sulfonic acid (AMPS).   
They were cross-linked in different combinations and proportions for preparing three types of 
hydrogel formulations. 
I. Hydroxypropylmethylcellulose-g-polyvinyl alcohol-co-poly(acrylic acid) 
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II. Polyvinyl alcohol-co-poly (\2-acrylamido-2-methylpropane-sulfonic acid) 
III. Hydroxypropylmethylcellulose-g-poly (Acrylic acid-co-2-acrylamido-2-
methylpropane-sulfonic acid) 
The method used for developing the above polymeric network was free radical 
polymerization, using potassium persulfate (KPS) as initiator and N, N-Methylene-bis-
acrylamide was used as crosslinking agent in a hydrothermal water bath. The hydrogel 
formulations were also synthesized under influence of microwave radiations. A pH- sensitive 
hydrogel semi-IPN hydrogel formulation was prepared by crosslinking of HPMC with PVA 
and acrylic acid. It was prepared to protect the drug from exposure to unfavourable 
physiological conditions and enables drug release for longer periods of time. The other 
formulation was a gastroretentive hydrogel comprising of PVA and AMPS to avoid any 
instability of captopril at higher intestinal pH.  Moreover, a superabsorbent hydrogel was 
synthesized by using HPMC, acrylic acid and AMPS, to release the drug throughout its 
passage from gastrointestinal tract. Hence, the drug would be available at both lower and 
higher pH. 
2.6.1 Polymers and monomers 
Polymers are macromolecules with molecular weights, consisting of repeated units of 
monomers. Monomers are polymerized by different techniques and results in formation of 
polymers. A large number of polymers of different grades have been used and are being used 
in the development of various pharmaceutical formulations, such as coated tablets, matrix 
tablets, microcapsules and hydrogels. They can be natural polymer (cellulose, carrageenan, 
collagen, guar gum, alginate etc) synthetic polymers (polyvinyl alcohal, polyvinyl 
pyrollidone, polyethylene glycol, polyethylene oxide, polymethacrylate, polyacrylic acid etc) 
as well as semisynthetic polymers (Hydroxypropyl methylcellose, Carboxymethylcellulose, 
methyl cellulose, chitosan etc).  Usually, the semi-synthetic polymers are derived from 
natural sources. The polymers derived from natural origins are more biocompatible with 
physiological envoirnment. Cellulose and its derivatives are widely accepted among research 
groups because of their eco-friendly properties. Cellulose can be degraded by several 
microorganisms (bacteria and fungi) in air, soil and water.168 
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Cellulose-based polymeric networks can be synthesized either by using chemical agents or 
high energy radiations such as electron beam, gamma radiations or even microwave 
radiations. The selection of chemical agents (Cross-linkers and initiators) depends upon the 
characteristics of cellulose derivatives such as aldehydes, urea derivatives, multifunctional 
carboxylic acids and epichlorhydrin. Usually the crosslinking occurs in water or aqueous 
solutions but in some cases it also occurs in dry state such as crosslinking of cellulose by 
polycarboxylic acids via condensation polymerization without water and requires reasonably 
higher tempratures.169,170 In comparison to crosslinking reactions involving chemical agents, 
use of high energy radiations have attracted the attention of researchers as it is easily 
controlled and involves lesser amounts of chemical agents. Radiation induced crosslinking 
has an additional advantage in biomedical research fields as they sterilize the product. In this 
way, crosslinking and sterilization occur simultaneously; therefore, use of radiations is 
beneficial with respect to health and environmental safety. High energy radiations cause 
scission of polymer chains and many cellulose derivatives can be crosslinked under influence 
of mild intensity of radiation. It can take place in both solid form as well as aqueous solution 
of polymers.171-174 The crosslinking is dependent upon amount of polymer and radiation dose 
that can either be intensity or exposure time. The microwave heating of many polymers has 
influence on their properties such as cellulose derivative; Hydroxypropyl methylcellose 
(HPMC) used in food production makes a question about effect of radiation on polymer. 
2.6.1.1 Hydroxypropyl methylcellose (HPMC) 
Hydroxypropyl-methylcellose (HPMC) or Hypromellose is a white or slightly off-white 
tasteless, odourless powder. It is soluble in water and when dissolved, it forms a viscous 
colloidal solution.175-177 It is semisynthetic, viscoelastic and inert non-ionic cellulose ether. In 
solution, it does not react with salts or metals and there is no intake of ionic charges. Hence, 
it does not exhibit any sort of reaction during and after preparation of Pharmaceutical 
preparations. One of its other significant characteristic is its stability in both acids and 
alkaline medium, even for long term storage. The aqueous solutions of HPMC are resistant to 
enzymatic degradation and the formed products have better stability than material produced 
by starch, dextrin and other natural polymers.178,179 
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HPMC is one of the most successfully used polymers in preparing different oral drug 
delivery systems.180,181 In pharmaceutical industry, it is used in manufacturing of both coated 
and controlled release matrix tablets. Depending on its grade, it can be either used as binder 
or as a component with ability to prolong the release of medicinal agent in digestive tract. 
Moreover, it is commonly used as lubricant in ophthalmic preparations and has numerous 
applications in cosmetic industry and in many other commercial products.  It also serves as 
structural and storage material in plants.182-185 
HPMC comprise of polymeric backbone of cellulose and during its synthesis cellulose fibers 
are heated with a caustic solution, which are then reacted with methyl chloride and propylene 
oxide. The obtained product is fibrous material, which is finally purified and ground to a fine, 
uniform powder. HPMC is a linear polymer comprising of repeated units of glucose which 
are joined together by β-1, 4 glucosidal bonds with the functional groups (–OH, -CH3, and -
OCH2CHOHCH3) attached to basic unit of HPMC. Additional networks of hydrogen bonds 
link the polymer chains with one another.186 
Hydroxypropyl methylcellose consists of functional groups in various ranges, 3-12% of 
Hydroxypropyl groups and 19-30% of methoxyl group (-OCH3). Its chemical name is 
Propylene glycol ether of methylcellulose Hydroxypropyl methylcellulose.187 Its structural 
formula is presented in the figure 4.  
 
                                       Figure 4. Chemical structure of HPMC 
Hydroxyproplymethylcellulose is propylene glycol ether of methylcellulose. As illustrated 
from its chemical structure in figure, that  substituent  ‘R’ can either be –H or –CH3 as well 
as –CH2CH(CH3) OH.  Because of different proportions of methoxyl and hydroxypropyl 
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groups in the structure of polymer, it is available in numerous grades, which are categorized 
according to USP in terms of measuring viscosity in 2% aqueous solution at 20°C by using a 
Ubbelodhe type of viscometer. The other way to differentiate HPMC grades is on basis of 
thermal gelation temperature by drying at 105°C for 2 hours. The determination of apparent 
viscosity specifies the chain length of polymer and categorizes it into HPMC of lower or 
higher viscosity grades.188 
The HPMC polymer on exposure with water swells and forms a viscous, colorless and 
transparent gel product. Due to its high swelling capability, it has an important effect on the 
release of loaded/ incorporated drug. The water or biological fluids diffuse the formulation 
that causes relaxation in polymer chain and consequently volume expansion occurs.189 This 
resultantly leads to release of entrapped drug from polymeric device.  
The mechanism of drug release from pharmaceutical drug delivery systems containing 
HPMC is dependent upon their designing and particular characteristics. In dry systems such 
as matrix tablets, there is low coefficient of diffusion. On the other hand, in highly swollen 
systems i.e. hydrogels, diffusion coefficient is of high magnitude as in case of pure water. 
Upon contact with water, the HPMC swells leading to changes in polymer and the drug 
diffuses out of the hydrogel formulation.188 
HPMC has been used by many research groups in preparing different controlled release 
formulations such as matrix tablets, microspheres and hydrogels. Hydroxypropyl 
Methylcellulose Matrices containing naproxen and naproxen sodium were prepared, their 
structure and hydration characteristics were determined.190 In that work, the effect of 
molecular weight of polymer on the drug release mechanism was measured. Carbamazepine 
loaded HPMC and Chitosan microspheres were prepared by spray drying technique, where 
different grades of low, medium and high molecular weight polymers were used to study 
their effect on release profile.191 HPMC has been used in preparing alginate/hydroxypropyl-
methylcellulose gel beads, which were loaded withbovine serum albumin (BSA). HPMC was 
successful in making a suitable carrier system for controlled release of albumin, by 
improving its release rate in physiological saline solution.192 In another work HPMC was 
grafted with acrylic acid with aim of obtaining copolymeric hydrogelprepared by in situ 
emulsifier-free emulsion polymerization using benzyl peroxide as an initiator.193 Davaran et 
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al.194 prepared HPMC hydrogels with polyethylene glycol (PEG), which were found to be a 
promising drug delivery system for delivering 5-amino salicylic acid to the colon for 
treatment of ulcerative colitis. Thermo-Sensitive HPMC/PNIPAAm Hydrogel were prepared 
for oral drug delivery of 5-fluorouracil. Being a thermo-responsive., the swelling behavior of 
the formed hydrogels was dependent upon temperature changes, where swelling ratios 
reduced with increasing temperature. It was also concluded that drug release was dependent 
on the amount of HPMC in the prepared hydrogel.  
2.6.1.2 Poly(vinyl alcohol) (PVA) 
 
Polyvinl alcohal was discovered in 1924, and since that time it has been widely used in 
variety of scientific researches due to its desireable characteristics such as its bio inertness 
and non-carcinogenicity.196 It is a synthetic polymer composed of 1,3-diol linkages [-CH2-
CH(OH)-CH2-CH(OH)-] or 1,2-diols [-CH2-CH(OH)-CH(OH)-CH2-]. This variation in its 
microstructure depends upon the polymerization conditions for vinyl ester precursor. Due to 
stability concerns polymer is not simply formed by polymerization of vinyl alcohol; firstly, 
polyvinyl acetate is prepared by polymerization of vinyl acetate and then converted to 
polyvinyl alcohol.197 Its structural formula is given below in figure 5. 
 
                                       Figure 5. Chemical structure of PVA,  
                                                       Molecular formula: (C2H4O) n 
 
Polyvinyl alcohal is available in both powdered and granular form. It is white or creamy 
white in color and possess no odour. Its melting point ranges from 220 °C - 240 °C.  It is a 
water soluble polymer, but practically insoluble in organic solvents. However, it is soluble in 
water at room temprature, but its solubility in water is increased at higher temperatures. PVA 
4% solution at room temperature has viscosity range of 35-50 cp. In FTIR spectrum 
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Polyvinyl alcohal shows characteristic peaks at wavenumber (cm-1) 3300, 2941, 1456, 1329, 
1142, 1089, 921, 844 and 620.198, 199 
Due to its flexibility and high tensile strength, it has numerous applications in pharmaceutical 
industry and biomedical fields. It has an excellent adhesive, film forming and emulsifying 
characteristics. It exhibit resistance to solvents, grease and oil as well as also to act as barrier 
to oxygen and aroma. PVA has Poisson's ratio between 0.42 and 0.48, means it is close to 
incompressible.200 
Studies on the mechanism of dissolution and changes in crystallinity and swelling behaviour 
of PVA and its physical gel-forming capabilities, have been carried out.201,202 PVA has 
various applications such as in making controlled drug delivery systems, membrane 
preparation, transdermal patches, tendon repair, contact lenses as well as stabilizer in 
emulsions. PVA is used as viscosity enhancer in ophthalmic preparations for prolonging the 
contact time of drug with eye.203-206 Due to biocompatibility of PVA, its hydrogels have been 
reported to resist cell adhesion and adsorption of protein.207, 208 PVA hydrogels have been 
formed by various techniques like physical crosslinking using freeze-thaw processes, using 
chemical agents (initiator and crosslinker), or physical treatments by radiations. The most 
common synthesis of PVA hydrogels is free radical crosslinking involing the use of various 
crosslinking agents such as glutaraldehyde, N, N’- Methylene bis-acrylamide (MBAAm), etc. 
However, PVA hydrogels crosslinked with acrylic acid have also been prepared by 
microwave radiations. Rapid synthesis of three dimensional PAA/PVA network was 
prepared in aqueous solution by this technique.109-211 
The swelling behavior and drug release mechanism of poly(vinyl alcohol) hydrogel have 
been investigated by Varshosaz et al. The kinetics of swelling and drug release depending on 
amout of polymer as well as crosslinking density and percentage of drug loading were 
studied. The effect of structural properties of polymeric network on drug release was also 
determined.212 The use of photo-crosslinkable PVA hydrogels as tissue engineering scaffolds 
has been studied bySchmedlen et al. because of their mechanical properties, elasticity and 
tensile strength of PVA hydrogels they can be effectively utilized in soft tissue applications. 
They are preferred over PEG photopolymerizable hydrogels due to availability of more 
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active sites for bioactive molecules. The mechanical characteristics of PVA are dependent 
upon number of functional groups available for crosslinking.213 Cavalieri et al.214 prepared 
hydrogel microparticles based on cross-linking of poly (vinyl alcohol) and methacrylate 
PVA-MA, in presence of dextran T70 to evaluate the capability of formed microdevice for 
drug delivery. Doxorubicin was loaded as model drug and its cytotoxic effect on colon 
cancer cells was analyzed. Electro-responsive polyvinyl alcohol (PVA) hydrogels were 
prepared by solution-casting using glutaraldehyde as crosslinking agent. They were loaded 
with sulfosalicylic acid and studied the effect of electric field on the rate of drug release.215 
2.6.1.3 Acrylic acid (AA) 
Acrylic acid also commonly known aspropenoic acid is widely used monomer in hydrogel 
preparations. It is synthesized from propylene, that is well known gaseous byproduct of oil 
refineries, Althouth, it is not the basis of acrylic acid synthesis but it can be referred as 
derivative of ethylene in which one of hydrogen atom has been substituted with carboxylic 
group.  There also exist natural sources of acrylic acid as it has been detected in rumen fluid 
of sheep and also produced by some species of marine algae.216 The chemical structure and 
formula of acrylic acid are presented in figure 6.  
 
                                           Figure 6. Chemical structure of Acrylic acid 
 
Acrylic acid serves as a basic substance for its various derivatives such as acrylamine, 
acrylonitrile and acrylic esters. At room temperature, glacial acetic acid is transparent and 
colourless liquid miscible with water, possessing sharp penetrating odour resembling the 
odour of acetic acid. It freezes to crystalline form at lower temperature; hence it should be 
stored above its melting point i.e. 13.5 °C. It has a boiling point of 141°C at 101kPa and 
density 1.045 g/ml at 25 °C. Acrylic acid can be explosive as it has tendency to polymerize 
spontaneously. Therefore certain measures should be adopted during its storage, most 
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importantly is selection of suitable container of glass, ceramic or stainless steel and using a 
polymerization inhibitor (hydroquinone monomethyl ether).217,218 
Several precautionary measures should be adopted while working with acrylic acid monmer 
because of its toxic and irritating effects. Acrylic acid causes irritation and has corrosive 
action on skin and the respiratory tract. High and prolonged exposure results in pulmonary 
edema. Eyes should be protected as it can cause severe and irreversible injury of eyes. 
Acrylic acid, after oral administration in rats has LD50 value of 340 mg/kg. 
Acrylic acid has number of industrial applications, where its primary use, accounting for is in 
the production of resins and acrylic esters (about 67% of its total usage), that are utilized in 
coatings and as adhesives. One of its most common and important application is in producing 
superabsorbent polymers. Other uses are in oil treatment and water treatment chemicals.219 
On other side, it has a demerit in creating environmental pollution. The acrylic acid released 
to the environment usually enters the water resources. Due to its miscibility with water and 
its vapor pressure, its removal is not possible remains in water. From atmosphere it can be 
cleared by rain and if comes to contact with soil, it enters surface or ground waters.220 
Acrylic acid monomers polymerize by reacting at their double bonds and form high 
molecular weight homopolymer known as polyacrylic acid. Acrylic acid also combines with 
its derivative monomers (acrylamides, vinyl, acrylonitrile, butadiene and styrene) and 
resultantly produces copolymers. These homopolymers and copolymers are utilized 
pharmaceutical industry and daily life such as, in manufacturing coatings, plastics, paints and 
adhesives.  Poly (acrylic acid) is brittle, hygroscopic and colorless solid having glass 
transition temperature 106°C. At high temperature range of 200-250°C, it loose water and 
become crosslinked water insoluble polymer anhydride. It finally decomposes at temperature 
approximately 350°C.218 Poly(acrylic acid) (PAA) or Carbomer  is a well-known ionic, 
hydrophilic, water permselective polymer. It has higher affinity to physiological medium of 
colonic mucosa than for mucosal tissue in stomach or small intestine.221,222  PAA is an 
anionic polymer, hence at pH 7 or above its side chains will lose their protons and attain 
negative charge. By this phenomenon, the polymer will be able to absorb water, many times 
of its original weight. 
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Poly-acrylic acid and its copolymeric hydrogels have been successfully used as carriers in 
controlled drug release technology because of their biocompatibility, biodegradability and 
many other unique characteristics. In addition, the pH responsive nature of acrylic acid 
polymers makes them a promising candidate in colon specific drug delivery and controlling 
the drug release for longer period.223 PAA hydrogels are fragile, in order to add strength PAA 
is polymerized and crosslinked with other polymers. Acrylic acid has been crosslinked with 
all kinds of polymers (natural, synthetic or semisynthetic), resulting promising drug carriers.. 
Shin et al prepared an interpenetrating polymer network (IPN) hydrogels with dual 
characteristics, exhibiting both pH responsiveness as well as thermosensitivity. It was 
synthesized by crosslinking poly (acrylic acid) (PAAc) with poly(vinyl alcohol) (PVA) and 
incorporated with indomethacin.224 Kadłubowski et al.225 prepared hydrogels by 
photocrosslinking of poly(acrylic acid) (PAA)  with polyvinylpyrrolidone (PVP). The 
resulting polymeric network was a pH-sensitive drug delivery system hydrogels for glucose 
oxidase. In another work, acrylic acid was crosslinked with a cellulose derivative, 
carboxymethyl cellulose. An acrylic acid/carboxymethyl cellulose (AA/CMC) 
superabsorbent hydrogel was prepared in aqueous solution by glow-discharge electrolysis 
plasma, using N,N′-methylenebisacrylamide (MBA) was used as a crosslinking agent.The 
superabsorbant was senitive to pH and salt concentration, and a reversible swelling and 
deswelling behavior was investigated.226 
2.6.1.4 2-Acrylamido-2-methylpropane sulfonic acid (AMPS) 
2-Acrylamido-2-methylpropane sulfonic acid (AMPS) is a highly reactive sulfonic acid 
acrylic monomer. Figure 7 shows chemical structure of AMPS. 
 
Figure 7. Chemical Structure of AMPS, 
                 Molecular formula, C7H13NO4S 
 
It is prepared by reaction of acrylonitrile, oleum and isobutylene, in aqueous solution.The 
AMPS monomer is a propanesulfonic acid having substitution at the C2 position with a 
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methyl group and an acrylamido moiety. It contains an unsaturated vinyl group and a 
terminal sulfonic acid, which are its reactive sites. AMPS is also available as its sodium and 
ammonium salts which are formed by its neutralization with sodium hydroxide or ammonium 
hydroxide, respectively.227 
AMPS monomer appears as white crystalline powder or granular particles having water 
possessing hygroscopic character. The melting point of this solid has been determined as 
Melting point 195 °C (383 °F; 468 K). Its density is 1.1 g/cm3 (15.6 °C) and soluble in 
water having solubility of about 1×106 mg/L at 25°C.228, 229 
In recent years, 2-Acrylamido-2-methylpropane sulfonic acid (AMPS) has attracted the 
attention of pharmaceutical and other scientific researchers because of its thermal stability, 
resistance to hydrolysis, water solubility and ability to impart a remarkable swelling behavior 
in hydrogels. Its thermal and hydrolytic stability is due to the presence of sulfomethyl and 
dimethyl groups which in combination create a steric hindrance to amide functionality. This 
high swelling character is attributed to its highly ionizable sulfonate groups that make it a 
strongly hydrophilic compound.230-234  Dissociation of AMPS is not dependent upon specific 
pH; hence AMPS derived hydrogels are able to swell at all pH ranges.235,236 However, these 
hydrogels exhibit higher swelling ratio at lower pH in comparison to neutral or alkaline pH.  
Due to the presence of vinyl group in AMPS, it can be polymerized or crosslinked under the 
influence of high energy radiations. Increasing the concentration of AMPS in reaction 
medium provides more reactive vinyl groups, consequently, higher radiation assisted 
polymerization could occur. Therefore, crosslinking during AMPS based hydrogel 
formulation depends upon content of AMPS, which causes an increment of ionizeable 
functional groups resulting higher electrostatic repulsion that leads to expansion of polymeric 
network system.237 After hydrogel synthesis, unreacted residual monomer can be easily 
removed by washing with water.238 
It is synthetic monomer used in combination with number of polymers altering their 
physicochemical characteristics. AMPS has been used in preparing hydrogels by crosslinking 
with broad range of synthetic polymers, natural polymers, derivatives of natural polymers as 
well as with other monomers such as acrylamide (AAm) and acrylic acid.  These hydrogels 
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have applications in biomedical fields like controlled release drug delivery and 
superabsorbants for removal of heavy metal ions from aqueous solutions. Sulfonic acid in 
present in AMPS has ability to ionize completely in aqueous solutions. Due to this 
characteristic, AMPS inhibits the undesirable precipitation of mineral salts including iron, 
aluminum, calcium, magnesium, barium, zinc and chromium.AMPS/Polyvinyl alcohol 
(PVA) hydrogels have been synthesized by gamma radiation.239 In another work, 
Carboxymethyl cellulose (CMC) was crosslinked with AMPS along with other monomers.95 
Durmaz et al.240 prepared and characterized 2-acrylamido-2-methyl-1-propane sulfonic acid -
co- acrylic acid (AMPS/AA) hydrogels. They were synthesized by radical polymerization in 
the presence of N,N′-methylenebisacrylamide (MBA) as the crosslinking agent using 
potassium persulfate (KPS) as initiator. 
2.6.1.5 Potassium persulfate  (KPS) 
Potassium persulfate (KPS) also named as potassium peroxydisulfate is an inorganic 
compound. This salt is an odorless, white solid powder with a molar mass 270.322 g/mol and 
melting point 1067°C. Its density is 2.477 g/cm3 and is highly soluble in water with 
solubility of 5 g/100 mL at 20 ºC. It is commonly used as initiator to initiate polymerization 
reactions. It can be synthesized by electrolysis of cold solution of potassium hydrogen sulfate 
in sulfuric acid under influence of high current density.241,242 
 
Figure 8. Chemical Structure of Potassium persulfate , Molecular formula= K2S2O8 
Potassium persulfate is a thermal initiator widely used in polymerization or crosslinking 
process for preparing hydrogels. KPS and other thermal initiators possess high activation 
energy (125-160 kJ•mol-1), therefore the polymerization reactions are usually occur at higher 
temperatures ranging from 60ºC to 90ºC.243 The initiation of polymerization is first step of 
hydrogel synthesis, during which there is formation of an active center that further starts 
polymerization in monomer units or crosslinking of polymers. In this process, firstly the 
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initiator creates radicals, which are then transferred to monomer, resulting in generation of 
polymer chain.  All kinds of initiators cannot be used for every monomer and polymer. For 
example, radical initiators are best suited for initiation on carbon-oxygen double bond in 
aldehydes and ketones as well as carbon-carbon double bond of vinyl monomers.244 As 
initiator KPS has been used in many polymerization processes such as in preparing   
polytetrafluoroethylene and styrene-butadiene rubber, which are important commercially 
available materials.245 It has been utilized in preparing hydrogels for drug delivery and other 
useful scientific procedures. Acrylic acid, acrylamide, methacrlyic acid and many other 
monomers as well as polymers have been polymerized and crosslinked, respectively.246-249 
Being an oxidizing agent, KPS is used in oxidation of many products in organic chemistry, 
for instance in oxidation of phenols.250 
2.6.1.6 N,N'-Methylenebisacrylamide (MBAm or MBAA) 
 N,N'-Methylenebisacrylamide is a white crystalline powder, very  slightly water soluble 
with water solubility of 0.01-0.1 g/100 mL at 18 ºC. It is incompatible with strong acids, 
strong bases and strong oxidizing agents. It is a cross-linking agent used for formation of 
polymers and in crosslinking of polymers in hydrogel synthesis. Bisacrylamide is used for 
SDS-PAGE in biochemistry because it is one of the compounds of polyacrylamide gel.251 
The chemical structure of MBA is shown in figure 9. 
 
       Figure 9. N,N'-Methylenebisacrylamide (MBAm), Molecular formula C7H10N2O2 
Bisacrylamide polymerizes with various monomers, among them one of the commonly used 
is acrylamide. MBAm is capable of creating cross-linkages between polyacrylamide chains, 
therefore; creating a strong polymeric network rather than unconnected linear chains of 
polymer. An optimum concentration of MBA should be used for polymerization and 
crosslinking due to its stability concerns. It has been investigated that by using very low 
concentration of crosslinker, its methylene group by hydrolytic degradation is converted to 
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formaldehyde. By using crosslinker concentration above 0.3- 0.6 %, crosslinking density was 
increased and degradation was controlled for several days (upto 10 days). Further increasing 
the content to 1% or above, it remained stable and no degradation was observed for longer 
periods.252,253 N,N-methylenebisacrylamide has been used as crosslinking agent for preparing 
biomedical hydrogels with potential for utilization controlled drug release or enhancing 
mechanical strength of bone substitutes.254 Ray et al.255 prepared pH sensitive poly (acrylic 
acid-co-acrylamide)/MBA nanosized hydrogel colon-specific delivery of 5-fluorouracil. The 
hydrogel drug delivery systems, as those based on N-isopropylacrylamide (NiPAAm) and 
itaconic acid (IA), were prepared by using N,N-methylenebisacrylamide (MBA) as 
crosslinking agent.The concentration of MBA used was ranging from 2.0- 4.0 wt.% with 
respect to monomer concentration. The hydrogels were successfully synthesized by MBA, 
loaded with Lipase and its controlled release was investigated under mild conditions. These 
hydrogels were responsive to both temperature inside tract and pH of its media.256,257 
Aims and Objectives 
In Pharmaceutical technology, the research study has objectives related to betterment of the 
health care system to improve the quality of life. The goals of this study are briefly discussed 
as below: 
1) The aim of this work is to detect the possibility of using mixtures of polymers as prolong 
drug release systems using Captopril (CPT).  
2) This will determine the compatibility and usefulness of the polymer combinations being 
used in Hydrogel formulation. 
3) The formulation will be prepared using a Radical graft polymerization technique and 
evaluated by in vitro and in vivo studies. 
4) This research project will contribute to the rational drug therapy.  
5) This will be a promising study to ensure the safe and efficacious administration of the 
drug providing more effective treatment. A suitable fraction of drug will be available for 
treatment, thus minimizing the adverse drug reactions related to conventional drug 
delivery systems. 
6) This research study will also have a contribution towards cost effective treatment. 
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Synthesis of Hydroxypropyl methylcellulose-
graft- poly (vinyl alcohol)-co-poly(acrylic acid) 
hydrogels for the Controlled Release of 
captopril and its in-vitro Evaluation 
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Summary 
Background of the Study 
A microwave induced irradiation synthesis, was proposed for the preparation of 
Hydroxypropyl methylcellulose-graft-poly(vinyl alcohol)-co-poly (acrylic acid) hydrogels 
for the controlled release of Captopril, an antihypertensive drug.  
Methods 
The hydrogels were separately synthesized by using microwave irradiation method and 
conventional water-bath heating method. Chemical groups, thermal stability and surface 
morphology of these hydrogels were characterized by FT-IR, DSC and SEM. Swelling ratios 
of the gels were measured gravimetrically in the pH range from 1.2 to 7.4.  
Results 
Micrographs obtained from scanning electron microscopy (SEM), revealed that the gels 
synthesized using microwave irradiation had more porous structure; therefore, they had 
higher swelling ratios in comparison to hydrogels synthesized by water-bath method. 
Thermal analysis (DCS and TGA), FTIR and XRD determination had confirmed the 
formation as well as stability of the new polymeric network. 
Conclusion 
A stable network of Hydroxypropyl methylcellulose (HPMC), poly (vinyl alcohal) (PVA) 
and acrylic acid was developed in shorter time period under influence of microwave 
radiations. The formed hydrogels could be an efficient drug carrier for controlled delivery of 
captopril for hypertension management. 
Keywords: Hydroxypropyl methylcellulose, poly(vinylalcohal), acrylic acid, microwave  
radiation, captopril 
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3.1 Introduction 
The crosslinking of polymeric materials prevents the dissolution of hydrophilic polymer 
chains / segments into the aqueous environment.258,259  These swellable polymeric materials 
have been widely recognized as the stable carrier for drug delivery systems, because of their 
ability to simulate biological tissues. Hydrogels being biocompatible materials have been 
investigated to protect the drug, from in-vivo environment e.g, enzymatic degradation, 
unfavorable pH or other hostile conditions.33 
Development and designing of multi-component polymeric blends has become the subject of 
great interests because such materials possess an efficient hybrid performance superior to 
their individual components.260 In various hydrogel formulations more than one polymer are 
crosslinked to form semi-interpenetrated polymer network (semi-IPN). Semi-IPN is a 
technique of formulating a stable polymeric network of at least two polymers with an 
additional non-covalent interaction.261 It is attractive in producing synergistic properties from 
the component polymers to provide combined physical and mechanical properties to the 
hydrogels for use in drug delivery. When a hydrophilic gelling polymer is interpenetrated 
with a relatively hydrophobic gelling polymer, the resultant IPN hydrogel is expected to have 
an improved capability of immobilizing a drug. Hydrogels based on natural polymers exhibit 
poor mechanical strength, which limits their usefulness.262 Hence, blends of judicially 
selected natural and synthetic polymers over comes this short coming by improving the 
strength. It combines the biocompatibility of biological component with physical and 
mechanical properties of the synthetic components. A combination of natural and synthetic 
polymers has been found to be useful in enhancing the release of short half‐lived drugs under 
physiological conditions. Grafting of vinyl monomers onto natural polymers such as 
cellulose and its deivatives has been widely accepted.263-265 
To improve the synthesis of hydrogel as well as their properties, many researchers tried to 
use a variety of novel methods, including e-beam radiation, microwave radiation, photo-
initiated polymerization and plasma-induced grafting. The radiation crosslinking of polymers 
avoid the use of additional chemical reagents as they have ability to crosslink water-soluble 
polymers in their aqueous solution, without using initiators or using low quantity of 
initiator.266-268 In cases of biomedical applications, it allows the simultaneous synthesis and 
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sterilization of the product. High-energy radiation causes the generation of radicals that leads 
to scission on the polymer chain. This has been also investigated for cellulose and as well as 
its derivatives.269-271 Microwave radiation possess special heating energy, having significant 
advantages over the conventional thermal methods for preparing hydrogels. Due to the rapid 
and uniform penetration properties, microwave energy can instantaneously absorbed and 
directly heat the entire volume of a material.272 The microwave irradiation has been 
successfully used in recent years for preparing useful polymeric devices for drug delivery. In 
a research work, a guar-g-polyacrylamide hydrogel was prepared by microwave radiations, 
without using the radical initiator.273 In another work, the temprature sensitive hydrogels 
were prepared separately by microwave irradiation and conventional water bath heating 
method. Both formulations were characterized by FT-IR, DSC and SEM and compared by 
the results, which showed that microwave radiations shortened the preparation time, 
improves the yield and swelling.72 Similarly, PVA/PAA hydrogels were prepared, where 
acrylic acid was modified with PVA in the synthesis of polymeric matrix under the influence 
of microwave radiations.211 The effects of varying power and exposure of microwave 
radiations have been investigated in the grafting of methyl methacrylate on bamboo 
cellulose.274 
Hydroxypropyl methylcellulose (HPMC), one of the most widely used cellulose derivative as 
hydrogel-forming polymer with numerous industrial applications such as, in the production 
of coated and controlled release tablets, as a component of body lotions, ointments etc. It also 
serves as structural and storage material in plants.275, 185 
Polyvinyl Alcohol (PVA) possesses the strength, high water retaining ability, long-term 
temperature and pH stability. It is polymerized and crosslinked with other monomers and 
also with polymers to strengthen the hydrophilic systems.276 
Acrylic acid (AA) has been extensively used monomer in hydrogel synthesis because AA is 
relatively economical and easily polymerized to a higher molecular weight polymer277 by 
various formulation techniques. 
In this work, microwave irradiation method, is used for hydrogels synthesis. The hydrogels 
were synthesized respectively by microwave irradiation method and conventional 
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hydrothermal method. The porous structures of the hydrogels synthesized using two different 
methods were compared, and discussed the effects of hydrogel structures on its swelling. 
3.2 MATERIALS & METHODS 
3.2.1 Chemicals  
Hydroxypropyl-methyl cellulose (2600-5600 cps), PVA, 99% hydrolyzed, Mw, 85,000 - 
124,000 (Aldrich, product of USA), Acrylic Acid (Sigma Aldrich-Netherlands), N, N-
Methylene-bis-acrylamide, 98% (Fluka-Switzerland), Potassium persulphate (AnalaR, BDH-
England), Potassium dihydrogen phosphate (Merk- Germany), All the solvents used were of 
analytical grades. Deionized distilled water was obtained from our laboratory. 
3.2.2 Preparation of Hydrogel 
The hydrogel was prepared by free radical polymerization, using thermostatic water bath and 
microwave raditions 
3.2.2.1 Method using Thermostatic Water Bath 
Various quantities of polymers (HPMC and PVA) were added in distilled water and stirred at 
80ºC for 1 h. Then the HPMC solution subjected to nitrogen purging for about 30 min and 
potassium persulfate (0.5% W/W) was added to initiate the reaction by generating free 
radicals. After that the reactants was cooled down to 30ºC and MBA as cross-linking agent 
dissolved in acrylic acid (AA) was added under magnetic stirring. Final volume was adjusted 
by addition of deionized distilled water. After that, the above mixture was poured in test 
tubes and heated in water bath at 50°C, 55°C, 65°C and 75°C for 30min, 1h, 2h and 3h, 
respectively. Then, the tubes were cooled to 25°C and hydrogels were taken out and cut in 
the form of discs of nearly 8mm long. They were then thoroughly treated with ethanol and 
distilled water mixture (50:50) for removing catalysts and uncross-linked monomer till the 
pH of solutions after washing becomes nearly same as before being used. After washing 
process, the hydrogel discs were air dried for overnight and then transferred to oven at 45°C 
for 4 to 5 days until they attain a constant weight.  
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3.2.2.1.1 Hydrogel Formulations prepared using different concentrations of Acrylic acid  
and crosslinking agent 
The following were the suitable quantities of acrylic acid and crosslinker (MBA) to be 
further used in the formulations as shown in table 1 and table 2, respectively. Among these 
three M2 was selected on the basis of visual appearance and stability of discs during swelling. 
After selecting the appropriate concentration of acrylic acid, the concentration of crosslinking 
agent was varied. MBA, 1% of monomer concentration was considered to show better results 
and stability.  
   Table 1. Hydrogel Formulations using different concentrations of Monomers 
Formulation 
Code 
     Polymer 
(HPMC and PVA, 
50:50)g/100g 
     Monomer 
(Acrylic acid)  g/100g 
Crosslinker 
MBA, mol% of Monomer 
       M1          2              20             1 
       M2          2              15             1 
       M3          2              10             1 
 
  Table 2. Hydrogel Formulations using different concentrations of Crosslinker 
Formulation 
Code 
     Polymer 
(HPMC and PVA, 50:50)  g/100g 
Monomer 
(Acrylic acid) g/100g 
Crosslinker 
MBA, mol% of  
monomer 
C1 2 15 0.5 
C2 2 15 0.75 
C3 2 15 1 
C4 2 15 1.25 
 3.2.2.1.2 Hydrogel Formulations using different proportions and concentrations of 
Polymers 
Both polymers (HPMC and PVA) were used in various ratios. HPMC, a cellulose derivative 
was crosslinked with PVA to form semi- IPN as shown in table 3. Among these 
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formulations, the ratio of these polymers used in P1 was consdidered more suitable on the 
basis of swelling. Hydrogels with varying polymer concentration are presented in table 4.  
Table 3. Hydrogel Formulations using different ratios of PVA and HPMC 
Formulation 
Code 
Polymer (2g/100g) 
(HPMC:PVA) 
Monomer (g/100g) 
(Acrylic acid) 
Crosslinker(MBA), 
mol% of Monomer 
P1 3:1 15 1 
P2 2:1 15 1 
P3 1:1 15 1 
P4 1:2 15 1 
P5 1:3 15 1 
 
Table 4. Hydrogel Formulations using different concentrations of Polymers 
Formulations by Conventional Thermostatic water bath method 
Formulation Code Polymers, g/100g 
(HPMC and PVA, 3:1) 
 
Monomers, 
g/100g 
Crosslinking agent, 
mol % of monomer 
concentration 
F1 0.5 15 1 
F2 1 15 1 
F3 1.5 15 1 
F4 2 15 1 
F5 2.5 15 1 
F6 3 15 1 
 
3.2.2.2 Hydrogel formulation prepared by Microwave Radiation     
The above mentioned traditional heating method was used that let the reaction to take place 
in the thermo-stated water bath for longer periods of time. On the other hand, rapid synthesis 
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of Hydrogels was performed by using microwave radiations. In order to make comparison of 
both methods, same proportions of polymers and monomers were taken. The whole mixture 
was placed in Electrolux domestic microwave oven and it was first irradiated by electrical 
power of 100 W for 5 minutes. Then, after an interval of one minute, it was further exposed 
for 5 minutes at 180 W and finally, after one minute interval, the material was treated for 
another 5 minutes with maximum power output set at 300 W. After that, the hydrogels 
formed were cut into discs and treated with ethanol/ water mixture as previously described in 
the above method.  
Crosslinking reactions during hydrogel formation involve chemical or physical interaction 
among functional groups of the components. In present work, crosslinking of both polymers 
(HPMC and PVA) with acrylic acid in the presence of crosslinking agent (MBA) could be 
presented as shown in figure 1.  
Hydrogels prepared using different ratios of polymers and monomers by microwave 
radiation) have been presented in table 5. The hydrogel formulations synthesized using 
conventional water bath have been donated by ‘F’, while polymeric networks developed 
under influence of microwave radiations are named as ‘R’. The ‘R’ hydrogels were prepared 
with the same ratio of components as that for ‘F’ hydrogels, involving exposure to different 
doses of radiations.  
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                            Figure 1. Crosslinked HPMC-g- PVA-co Poly (AA) Hydrogel 
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Table 5. Hydrogels using different concentrations of Polymers and radiation dose 
Formulations by Microwave Radiations 
Formulation 
Code 
Exposure time at 
300W (min) 
Polymers 
(HPMC and 
PVA)  g/100g 
Monomers, 
g/100g 
( Acrylic acid) 
Crosslinking agent, 
mol % of monomer 
concentration 
R1 5 0.5 15 1 
R2 5 1 15 1 
R3 5 1.5 15 1 
R4 5 2 15 1 
R5 2.5 1.5 15 1 
R6 7.5 1.5 15 1 
R7 10 1.5 15 1 
 
3.3 In vitro Evaluation 
3.3.1 Fourier Transform Infrared Spectroscopy (FT-IR) 
FT-IR spectrophotometer (Bruker, Tensor 27) was used to record the spectra of hydrogel, 
HPMC, acrylic acid and AMPS. The hydrogel samples were ground by the help of cutter as 
well as pestle and mortar. The components and crushed hydrogel samples were then analysed 
in wavelength range of 4000 to 500 cm-1. 
3.3.2 Scanning Electron Microscopy (SEM) 
SEM images were taken to investigate the surface morphology of super-absorbent hydrogels 
using a scanning electron microscope (Quanta 250, FEI).  Both drug free formulations and 
drug loaded samples were ground and scanned at different magnifications to observe the 
microscopic surface of dried hydrogels. It is therefore performed, to assess the capability to 
adsorb and entrap the drug into their polymeric network.  
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3.3.3 X-Ray Diffraction (XRD) 
X-Ray Diffraction analysis determines the crystallinaty and amorphous properties of the 
substances. It investigates the interaction of components or polymers and drug. Xpert Pro 
diffractometer (Panalytical) diffractometer used to record x-ray diffraction. The XRD 
patterns of pure drug and drug loaded formulation were measured at room temperature by 
scanning at angle 5-50° (2 Theta), scanning speed of 20/ min-1. 
3.3.4 Thermal analysis 
Thermal analysis was recorded by thermogravimetric analysis (TGA) and differential 
scanning calorimetry (DSC) using Q5000 series (TGA instruments) and Q2000 series (TA 
instruments), respectively.  The hydrogel samples were crushed into powder form using 
pestle and mortar and passed through a mesh no. 50. For measuring TGA, 1- 4 mg of ground 
sample was placed in platinum pan connected to microbalance and heated upto 500°C at a 
rate of 20°C/min in nitrogen atmosphere. To record DSC, hydrogel samples (1 to 3mg) along 
with HPMC, AMPS and acrylic acid were placed in aluminum pan crimped with an 
aluminum lid  and heated from 0-500°C at the same rate used for TGA.   
3.3.5 Swelling Study  
The swelling of hydrogels was measured at different pH (1.2, 4.5 and 7.4) at room 
temperature. Dried discs of hydrogels were accurately weighed and immersed in swelling 
medium i.e. 0.1 M USP phosphate buffer solution. Hydrogel discs were weighed at regular 
intervals of time and before weighing they were placed on filter paper to remove excess of 
solution from the surface. The hydrogels were weighed for a period until they attain 
equilibrium. The swelling ratio was calculated as: 
                                             S =                                     (1) 
Where, ws is the weight achieved after swelling and wd denotes the weight of dry hydrogel 
discs. The percentage equilibrium swelling was determined by equation given below: 
                                     % ES =                               (2) 
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Where, weq is the equilibrium weight and wd is the initial weight of hydrogels before swelling 
study. 
3.3.6 Drug loading 
Hydrogels were loaded with drug (captopril) using absorption method by immersing the dry 
discs of hydrogels in 100ml captopril solution (1% w/v) comprising of phosphate buffer 
solution and methanol (50:50). The dics were swollen till they achieved equilibrium, then 
taken out and dried in oven at 40°C to their constant weights. The amount of drug loaded in 
hydrogels was measured by extracting them with the methanol/ phosphate buffer solution in 
the same ratio used for drug loading. The extraction was done repeatedly at regular intervals 
and each time with freshly prepared solution until no drug remains in the extracting solution. 
All samples of drug solutions used during extraction procedure were analyzed for drug 
contents. The caliberation curve of captopril was drawn by preparing its various dilutions to 
determine the drug concentration spectrometrically at λmax of 205nm. The amount of 
captopril loaded in hydrogels was calculated by following relation. 
                                            Amount of drug = WD – Wd       (3) 
Where WD and Wd represents weights of dried hydrogel discs after and before immersion in 
drug solution, respectively.17 
3.3.7 Determination of Gel Fraction 
Dried hydrogels were extracted at room temperature in distilled water for 7 days. The 
extraction process was done to remove any sol that may be present in the hydrogel. The 
extracted hydrogels were then dried again in the oven at 60ºC until a constant weight is 
achieved. The percent gel fraction (%G) will be calculated using the equation as below: 
%GF=              (4) 
where wi and we are the dry weight of the sample before and after extraction, respectively. 
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3.3.8 Drug Release 
Drug release measurement was carried out by dissolution process using 0.1 M USP 
phosphate buffer solutions of lower and higher pH values (pH 1.2 and pH 7.4). The dried 
hydrogel discs loaded with captopril were placed in 500 ml buffer solution (dissolution 
medium) maintained at 37°C, agitated by a paddle stirrer at a speed of 50 rpm. Then, the 
samples were taken out at specific time intervals and drug released was measured by UV-
spectrophotometer at λ max of 205nm. 
3.3.9 Drug release kinetics 
Drug release models were used to determine the mechanism of drug release as given below: 
Zero order kinetic models 
It relates the drug delivery systems, where the rate of drug release does not exhibit 
concentration dependency. It is represented as: 
                               M0 - Mt = Kt                                         (5) 
Where, M0 isthe initial quantity of drug, Mt is the fraction of drug released at time t and K is 
proportionality constant.  
First order kinetic models 
The first order kinetics describes the concentration dependent release of drug and is 
represented by the following equation: 
                              Log M0   − Log Mt  = K1t/2.303                (6)           
Where, M0 is the initial amount of drug, Mt is the drug concentration released at time t and 
K1release constant. 
Higuchi Model 
Higuchi model can be presented by a simplified equation as: 
                             Q = KH t1/2                                                         (7) 
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Where, Q represents the fraction of drug released at time t and KH is Higuchi constant. 
Korsmeyer- Peppas model 
Korsemeyer-Peppas model is described by a simple empirical equation to describe the 
Fickian and non-Fickian drug release from polymeric drug carriers, given as following: 
                                         Mt/M∞ = K tn                         (8) 
Where, ‘K’ is kinetic constant that incorporates the geometric and structural properties of the 
hydrogels and other drug carriers.  Mt/ M∞ represents the drug fraction released at time t and 
n is release exponent. When the value of n is 0.45, it indicates Fickian release order and for n 
= 1, represents case II transport mechanism. On the other hand, n value between 0.45 and 1 
corresponds to non- Fickian diffusion.  
Weibull model 
The dissolution and release process was described by an equation expressing the fraction of 
drug accumulated ‘M’ in dissolution medium at time t given as: 
  
Where, a defines the dependency on time, b denotes the shape parameter of dissolution curve 
and the other parameter ‘Ti’ represents the lag time before dissolution process. 
3.4 Results and Discussions 
3.4.1 FT-IR 
The structure and formation of crosslinkage among the polymers were investigated by 
spectra recorded using FT-IR spectroscopy. In figure 2, spectrum of HPMC (a) shows an 
absorption band at 3444.60 cm-1 is assigned to stretching frequency of the hydroxyl (-OH)  
group. Another band at 1373.63 cm-1 is due to bending vibration of –OH. Other stretching 
vibration bands related to C-H and C-O were observed at 2929 cm-1 and 1055.52 cm-1, 
respectively. The noted peaks of pure HPMC were similar to observations of Wang et al.278 
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               Figure 2. FT-IR Spectra of HPMC (a),  PVA (b), Acrylic acid (c) HPMC/PVA-
co-  AA hydrogels, F1  (d) and R1 (e) 
In PVA’s FT-IR spectrum (b), at 2941.43 cm-1 stretching –CH2 groups in alkanes, 1089.38 
cm-1 characteristic C–OH stretching, and a wide-strong absorption peak at 3286.82 cm-1 due 
to O-H stretching was observed.  
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The spectra of HPMC-g-PVA-co-AA polymeric network suggests the formation of 
intermolecular hydrogen bonding due to carboxylic acid groups of acrylic acid as observed 
by the appearance of an absorption peak at 1716.99 cm-1 in (d) and 1706.39 cm-1  in (e) . 
These peaks noted were similar to peaks observed by Debajyoti et al.279 and Pillai et al.280 
In figure 2 the hydrogel spectrum (d) and (e) indicates the shifting of -OH vibration band of 
HPMC from 3444.60 cm-1 to 3400.16 cm-1 and 3392.11 cm-1, respectively. This was 
observed due to formation of hydrogen bonds confirming that -OH groups of HPMC and 
PVA have reacted with -COOH groups of acrylic acid.  
Hydrogels prepared by both methods, (conventional water bath and microwave radiation) 
exhibited OH- stretching due to hydrogen bonding and carboxylic vibrations and CO- 
because of  intramolecular bonding in the same regions. At the same time, it could be clearly 
seen that the FTIR spectra shapes of the hydrogels R and F were similar. It suggested that the 
use of microwave irradiation method could successfully crosslink the HPMC/PVA-co-acrylic 
acid polymeric network. 
3.4.2 SEM 
Scanning electron microscopy (SEM) was performed to study the morphology of hydrogels. 
Figure 3 shows fractured surface morphology of drug loaded and drug free hydrogels. The 
surface roughness and porosity of both types of hydrogels (F and R) could be compared from 
their SEM images. From the SEM micrographs of surfaces of the air-dried gels R and F, it 
can be seen that the surface of gel F was denser and rather smooth containing few cavities 
and small spherically shaped protrusions. In comparison, the surface of R hydrogel 
formulation is rough with some deep and interconnected pores. In comparison to F hydrogel, 
the R hydrogel formulation had more uniformly porous network structures as shown in figure 
3 (B). The uniformity in porosity was due to rapid and instantaneous penetration of 
microwave energy throughout the surface.272 Hence, R hydrogels would facilitate the 
diffusion more easily into hydrogel matrix during swelling process. 
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  Figure 3. SEM Micrographs of Drug free (A and B) and Drug loaded (C and D) 
HPMC/PVA-co-acrylic acid Hydrogels prepared by Microwave Radiation and 
Conventional water bath method, with same ratios of Polymers 
(Hydroxypropyl-methylcellulose and Poly(vinyl alcohol)  and acrylic acid. 
 
Figure 3 (C and D) shows hydrogels loaded with captopril as model drug, which is entrapped 
and adhered on the surface of matrix. Higher quantity of drug could be loaded into the 
formulations produced by microwave radiations as it shown figure 3 (C and D) showing drug 
loaded R and F hydrogels, respectively.  
From SEM images, it was observed that the application of microwave irradiation to prepare 
semi-IPN created the hydrogels more porous than the gels synthesized by using water bath 
  78 
heating method. These observations were relevant to the work done by Zhao et al.,72 who 
prepared thermo-sensitive poly (N-isopropylacrylamide) (PNIPAAm) hydrogels using 
microwave radiations in terms of morphological analysis. 
3.4.3 XRD 
The X-ray powder diffraction patterns of pure drug are compared with drug-loaded 
hydrogels. X-ray diffractograms of Captopril, drug free Hydrogels and drug-loaded 
Hydrogels are presented in figure 4. Figure 4 (B) and figure 4 (C) presents the diffraction 
pattern of F3 and R3 formulations, respectively. Figure 4 (D) and 4 (E) show the 
diffractograms of their respective drug loaded formulations.  
The XRD scan of pure captopril had shown characteristic sharp and intense peaks between 0° 
and 50° (2θ) due to its crystalline nature (Figure 4 A), The appearance of a sharp peak at 2θ= 
27.79° is the characteristic of captopril. The diffractograms of hydrogels not containing the 
drug was dense with only two marked peaks at nearly 2θ= 44° and 2θ= 49°, in both F3 and 
R3 formulations. This similarity was due to same constitutions of F3 and R3 hydrogels. 
It was observed from the diffractograms in both formulations (R3 and F3) that the drug free 
(B and C) and hydrogels loaded with captopril (D and E) had a variation in diffraction pattern 
due to entrapment of drug.  However, in drug loaded hydrogels, the peaks were of less 
intensity and diffraction pattern was dense in comparison to that of pure drug in figure (A). 
Therefore, crystallinity of captopril was decreased after its entrapment into polymeric 
networks, indicating the amorphous dispersion of drug into the hydrogels. The resultant 
evaluation on the basis of XRD analysis was in relevance with observations made by 
Manjanna et al.281 In that research work, Aceclofenac Sodium was loaded into 
Polysaccharide hydrogel beads. Another related work was done by Giri et al.,282 where 
diltiazem hydrochloride was loaded into cross-linked biodegradable IPN hydrogel beads of 
pectin and modified xanthan gum. They had also noted similar diffraction patterns of pure 
drug, drug free hydrogels and drug loaded hydrogels. 
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      Figure 4. X- Ray Diffraction patterns of Captopril (A), Drug free Hydrogels ( B and C) and Drug  
loaded  Hydrogels ( D and E) 
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3.4.4 Thermogravimetric analysis (TGA) and Differential scanning calorimetry (DSC) 
The grafting of HPMC/PVA-co-AA semi interpenetrating network was supported by 
thermogravimetric analysis TGA. Figure 5 represents the comparative TGA patterns of 
individual components (HPMC, PVA and AA) as well as the crosllinked polymeric networks 
(hydrogel formulations R1 and F3). 
 TGA thermogram of HPMC shows decomposition at 265°C and continues upto 350 °C, till 
that period there was 78% weight loss due to degradation of the polymer. Similarly, the 
decomposition of Polyvinyl alcohol (PVA), starts at 220°C and continues to 320°C, showing 
70% weight loss. The decomposition of pure acrylic acid starts at nearly 80°C and complete 
mass loss was observed at 189.50°C.   However, TGA of the grafted product F3 is different 
having three stage of weight loss between 30°C and 500°C.  
 
       Figure 5. TGA thermograms of HPMC , PVA , AA (Acrylic acid), F3 hydrogel 
and R1 hydrogel 
The first stage of weight loss starts at 80°C and continues up to 260°C, during which there 
was 15 % weightloss due to the loss of adsorbed and bound water. The second stage begins 
from 260°C to 360°C and this stage corresponds to 40 % weight loss. The third stage from 
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350°C to 500°C may contribute to the decomposition of different structure of the graft 
copolymer. At 490°C and 475°C there was complete weight loss of HPMC and PVA, 
respectively, whereas their copolymer had 80% weight loss at that temperature. These 
observations indicate the thermal stability of formed hydrogels in comparison to individual 
polymers and monomers (PVA, HPMC and acrylic acid). TGA thermograms determined in 
present work, indicate similarity to TGA patterns of Graft copolymer of chitosan with acrylic 
acid under microwave irradiation by Huacai et al.,283 where thermal degradation was in three 
stages. Similar observations on basis of thermal analysis were also evaluated by Bao et al.95 
and Thakur et al.284 
The DSC endothermic peaks of pure HPMC, PVA, AA and cross-linked polymeric network 
were in accordance with TGA thermal patterns. DSC is a well-known and established method 
often used as a qualitative technique for characterization of polymeric drug delivery systems. 
It determines the physicochemical changes in either enthalpy or heat capacity of a crystalline 
drug in the polymer matrix during the manufacturing process.  The thermal behavior of pure 
Captopril, drug loaded R1 (DR1) and F3 (DF3) Hydrogels characterized by DSC are 
presented in figures 6a and 6b.  
The thermogram of pure Captopril showed a sharp endothermic peak at 106°C followed by 
corresponding melting point. However, in DSC thermogram of Drug loaded samples DR1 
and DF3, peaks were observed at 288.28°C and 265.29°C, respectively. The appearance of 
these peaks suggested that the drug loaded hydrogels showed an increase in the exothermic 
peak temperature as presented in figures 6 a and 6 b. The extra obvious peak of drug (106°C) 
was not observed in any type of the prepared hydrogels containing drug. The thermal 
stability of hydrogels was maintained after the incorporation of captopril. No marked change 
in thermal behavior of drug was indicated from the DSC thermogram of drug loaded 
hydrogels. It is indicated that captopril is uniformly dispersed into the polymeric network of 
HPMC, PVA and acrylic acid. This thermal evaluation of drug loaded hydrogels is in 
relevance to that determined by Manjanna et al.281 
The TGA and DSC thermograms of both hydrogel formulations synthesized by different 
microwave radiations (R1) and conventional water bath (F3) were almost similar as could be 
clearly seen in figures 5 and 6. Hence, it means that the grafting of these polymers by both 
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methods increases the thermal stability of the polymers. These results are corresponding with 
the earlier findings of Zhao et al.72 
 
    Figure 6a. DSC thermograms of captopril, drug free F3 hydrogel and drug loaded F3    
hydrogel (DF3) 
 
          Figure 6b. DSC thermograms of captopril, drug free R1 hydrogel and drug loaded  R1   
hydrogel (DR1) 
  83 
3.4.5 Swelling Study 
The effect of using different proportions of HPMC and PVA on swelling capacity of 
hydrogels have been presented in figure 7 (a, b and c) at three levels of pH (1.2, 4.5 and 
7.4), respectively. Similarly, the effect of crosslinking agent (MBA) on swelling at these 
pH values are presented in (d, e and f) in figure 7. Alteration in swelling ratio observed 
with different concentration of acrylic acid are shown in figure 7 (g). Higher swelling ratios 
were observed at higher pH values. 
Effect of Polymer’s proportions 
The hydrogel P1 contains highest amount of HPMC among other hydrogel formulations 
containing same concentrations of acrylic acid and crosslinker. The swelling ratio is 
decreased by using higher amounts of PVA as it is lowest in P5 hydrogels with HPMC and 
PVA content in a ratio of 1:3. On the other hand, hydrogel P1 had HPMC and PVA content 
in a ratio of 3:1 (inverse of P5 content ratio). It indicated that HPMC has greater swelling 
capacity in comparison to PVA. 
Effect of crosslinker concentration 
It can be observed from the figure 7 (d, e and f) that increasing concentration of 
crosslinking agent leads to decrement in swelling power of hydrogels. This is because, it 
increases the grafting of polymers and monomer crosslinking. Due to higher concentrations 
of MBA, the crosslink density increases that makes the hydrogels lesser spaces for 
incorporation of  aqueous solutions, which results in lower swelling ratios. These results 
were similar to earliaer observations of Huacai et al.,283 who determined an increment in 
percent grafting of chitosan-g- acrylic acid hydrogels with increasing amount of MBA that 
decreased the swelling behavior. 
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Figure 7. Effect of polymer’s proportion, MBA and acrylic acid concentrations on swelling 
ratio 
  85 
Effect of acrylic acid concentration 
Figure 7(g) shows that by increasing the concentration of acrylic acid create an 
enhancement in swelling ratio. Hydrogel formulations M1, M2 and M3 have the same 
amounts of components except acrylic acid. M1 contains acrylic acid 20% w/w exhibit 
higher swelling tendency in comparison to M2 and M3 containing lower amounts of 
monomer. The noted results were according to swelling pattern observed by Ranjha et al.281 
where, swelling tendency of pectin/acrylic acid hydrogels was higher in formulations 
containing higher amounts of acrylic acid.  
3.4.6 Comparative Swelling of F and R hydrogels 
Swelling ratios of the synthesized gels were measured gravimetrically at the pH 1.2, 4.5 
and 7.4 in phosphate buffer. The swelling of hydrogels is dependent upon the presence of 
hydrophilic groups (ionizable functional groups). PVA and HPMC contain high hydroxyl 
groups that make this polymer highly interactive with water. The carboxylic groups of 
acrylic acid were mainly responsible for swelling tendency in hydrogels. When the pH is 
increased, the COOH was ionized and deprotonated to a negatively charged COO --. As a 
result, the electrostatic repulsion causes the swelling of hydrogel and greater expansion of 
the network thus gives a high swelling ratio. The swelling ratios of hydrogels noted were 
similar to swelling measurements performed by Gemeinhart et al.286 for poly (acrylamide-
co-acrylic acid) super porous hydrogels. The swelling study was also relevant to work done 
by Shah et al.287 Therefore, the carboxylic groups associated with acrylic acid made the 
coploymeric system a pH responsive that could be observed from swelling characteristics. 
Effect of polymer concentration and radiation dose on swelling ratio at various pH were 
studied to evaluate the swelling with respect to time.   
As shown in figures 8 and 9, hydrogels containing higher amount of polymer show lesser 
comparative swelling ratios. R1 and F1 comprising lower amount of polymer exhibited 
higher swelling behaviour as compared to the other formulations. As the quantity of 
polymer increases in the hydrogels, the value of their swelling ratio decreases. Generally, a 
more porous matrix provides more space to accommodate larger quantities of water.288 As 
shown in figures 3 (SEM images), the R hydrogels had more porous structure than the F 
hydrogels, therefore, it would have higher water uptake. As a result, the hydrogels prepared 
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by microwave radiation method show better swelling characteristics in comparison to 
conventional methods. Thus, microwave radiations develop uniform crosslinking and a 
more porous polymeric system than simple water bath heating method. It could be seen 
from comparative swelling ratios of R4 and F4 formulations in figure 10, which depicts 
higher swelling of R4 formulation at pH 1.2 and pH 7.4. 
 
Figure 8.Swelling ratios of the Semi IPN hydrogels synthesized by Microwave Radiations 
 
 
     Figure 9. Swelling ratios of the Semi IPN hydrogels synthesized by Conventional 
Water bath Method 
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Figure 10. Comparative Swelling ratios of the hydrogels (R4 and F4) 
Hydrogel synthesized at higher dose always have lower swelling ratio probably due to the 
higher crosslink density which resist the swelling of matrix. The comparative swelling ratios 
of hydrogels treated finally at 300W for 2.5, 5, 7 and 10 minutes are presented in figure 11. 
 
Figure 11. Comparative Swelling ratios of the hydrogels prepared at different radiation doses 
It is also observed that hydrogels prepared at 300W for 5 min (R1, R3 and R4) had higher 
swelling ratio as compared to the hydrogel with final exposure of 7.5 min (R6) and 10 min 
(R7) but swells less than R5 treated for 2.5 minutes. It had been already determined by Wan 
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et al.,274 that increasing the exposure time of microwave radiation increases the grafting of 
polymers and ultimately higher crosslinking in polymeric network. This may be concluded 
from the lower crosslink density of hydrogel which formed a porous structure and thus 
allowed the water molecules to diffuse easier, hence faster response time. 
3.4.7 Gel Fraction 
The percent gel fraction was determined for formulations with different concentration of 
polymers (HPMC and PVA), monomer (acrylic acid) and crosslinking agent (MBA). The 
values of percent gel fraction are presented in table 6. 
Table 6. Percent gel fraction of formulations with different amounts of components 
Formulation code Wi (g) We (g) % gel fraction 
F1 0.321 0.277 86.3 
F3 0.328 0.289 88.1 
F5 0.326 0.295 90.4 
M3 0.313 0.269 85.9 
M2 0.318 0.284 89.3 
M1 0.324 0.301 92.9 
C2 0.311 0.276 88.7 
C3 0.315 0.286 90.7 
C4 0.322 0.302 93.7 
 
The amount of polymer, monomer and crosslinker are among the main factors affecting the 
gel fraction of hydrogels. It could be observed from the figures 11, 12 and 13 depicting the 
effect of concentration of polymer, monomer and crosslinker on per cent gel fraction. 
Increasing the concentration of these components increases the value of %GF. 
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Figure 12.Effect of polymer concentration on %GF. 
 
Figure 13.Effect of monomer concentration on %GF. 
 
Figure 14.Effect of crosslinker concentration on %GF. 
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Figure 11 indicates that by increasing the concentration of polymer (HPMC and PVA, 3:1) 
from 0.5% to 2.5%, an increment in value of %GF has been observed from 86.3% to 90.4%, 
respectively. In comparison to polymer concentration, the monomer quantity used has more 
influence on gel fraction due to its relatively higher concentrations used in hydrogel 
formation. Figure 12 shows that by increasing the amount of acrylic acid from 10% to 20%, 
percent gel fraction was increased from 85.9% to 92.9%. Moreover, crosslinker’s 
concentration has similar effects on percent gel fraction because of enhancing crosslinking 
interaction of acrylic acid with polyvinyl alcohol, which are then interacted with 
hydroxypropyl methyl cellulose. Yoshii et al.289 and Roberta et al.290 had used the same 
technique for determination of percent gel fraction and obtained similar results of higher %G 
with increasing concentration of constituents.  
3.4.8 Drug loading and release studies 
The hydrogel discs exhibiting greater swelling accommodated higher amounts of drug. The 
amount of captopril loaded in hydrogel formulation and percent drug release at acidic pH and 
higher pH has been presented in table 7. The dissolution study of captopril was performed at 
pH 1.2 and pH 7.4 as shown in figure 15 and figure 16. The drug release at both pH (1.2 and 
7.4) was observed for a period of 24 hours, where USP phosphate buffer was used as 
dissolution medium. Drug release measured is directly related to swelling studies where 
relatively more amount of drug was loaded and ultimately released in formulations exhibiting 
more swelling tendency. 
             Table 7.  Amount of Captopril loaded and percentage of drug release at 
pH 2 and pH 7.4 
Formulation 
code 
Amount of captopril loaded 
(mg) per 0.3 gram of dry 
hydrogel discs 
% release of captopril 
(for 24 hour period) 
pH 1.2 pH 7.4 
F1 98.13 31.54 82.15 
F2 95.08 29.49 80.06 
F3 89.58 26.88 78.57 
F4 83.50 24.72 75.79 
R1 104.5 35.65 87.92 
R2 97.81 32.84 85.01 
R3 92.28 28.96 83.56 
R4 86.8 26.45 78.54 
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It could be clearly observed from table 7, that hydrogels possessing higher swelling ratios 
had entrapped more quantity of drug. R1 and F1 had same ratios of polymers (HPMC and 
PVA), acrylic acid and crosslinking agent, but they were prepared using different techniques. 
The captopril loaded in R1 formulation was 104.5 mg in 0.3 gram dry hydrogel disc, whereas 
it was 98.13 mg in F1 formulation, hence, relatively higher amount of captopril was loaded. 
This difference could also be noticed in other formulations prepared using microwave 
radiations (R2, R3 and R4) and conventional water bath (F2, F3 and F4).  
These variations are may be due to uniformity in porous structure and presence of larger 
voids in R hydrogel formulations, leading to higher and more uniform dispersion of drug in 
polymeric network.  Moreover, factors such as polymer concentration, monomer 
concentration and other factors affecting swelling behavior of hydrogels directly affect drug 
loading and release. 
The cumulative percent drug release from hydrogel formulation F2 and R2 have been 
presented in figure 15 and figure 16. The drug release pattern at both lower pH 1.2 and 
higher pH 7.4, could be seen from the figures 15 and 16.  
A similarity in release pattern was observed, as both formulations were releasing more drugs 
at higher pH values. At pH 1.2, the cumulative percent drug release was 29.49% in F2 and 
32.84% in R2 hydrogels, while at pH 7.4, drug release were 80.06% and 85.01% for F2 and 
R2 formulations, respectively. These values of percent drug release are also mentioned in 
table 7. Therefore, the drug release is dependent upon the pH sensitivity imparted due to 
presence of acrylic acid in hydrogels. The cumulative percent drug release is in 
correspondence to the results obtained by swelling study. 
 
  92 
 
Figure 15. Captopril released upto 24 h from HPMC/PVA-co-AA hydrogel (F2) in solutions 
with pH 1.2 and pH 7.4 
 
 
         Figure 16. Captopril released upto 24 h from HPMC/PVA-co-AA hydrogel (R2) in 
solutions with pH 1.2 and pH 7.4 
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The drug release was evaluated by the application of zero order kinetics, first order kinetics, 
Higuchi model, Korsmayer-Peppas model and Weibull model. The values of release coefficient R2 
and K calculated by these kinetic models are presented in table 8. The captopril released from F and 
R hydrogel formulations were best fitted into the kinetic model having value of R2 close to 1. 
          Table 8: Determination of coefficient (R2), K and release exponent of various drug release kinetic   
models 
Sample 
code 
pH Zero order 
kinetics 
First order 
kinetics 
Higuchi model Korsmeyer Peppas 
model 
Weibull 
model 
R2 K R2 K R2 K R2 K n R2 
F1 1.2 0.9719 1.84 0.7215 0.165 0.9969   4.83 0.9913 3.23 0.703 0.7012 
7.4 0.9874 3.96 0.5248 0.263 0.9876 14.81 0.9967 13.57 0.5488 0.8955 
F2 1.2 0.9767 1.69 0.702 0.156 0.9963 4.33 0.996 3.54 0.598 0.669 
7.4 0.989 3.94 0.5274 0.261 0.9901 14.586 0.9979 12.022 0.609 0.8905 
F3 1.2 0.9811 1.45 0.7674 0.134 0.9917   3.54 0.9968 3.37 0.5221 0.7395 
7.4 0.9843 3.76 0.539 0.2557 0.9902 13.793 0.9971 13.88 0.496 0.8835 
F4 1.2 0.9736 1.42 0.7598 0.158 0.9955   3.06 0.9864 1.952 0.7042 0.7775 
7.4 0.99 3.59 0.6252 0.238 0.9844 11.56 0.9966 9.93 0.579 0.8774 
R1 1.2 0.9815 1.83 0.7362 0.169 0.9928   5.12 0.9954 4.2945 0.587 0.7544 
7.4 0.9812 4.179 0.5054 0.2668 0.9921 15.92 0.9968 15.58 0.5118 0.8804 
R2 1.2 0.9632 1.86 0.7083 0.1674 0.9975   4.93 0.9881 3.59 0.659 0.6939 
7.4 0.9896 3.85 0.5239 0.262 0.9882 14.814 0.9973 13.4 0.556 0.8983 
R3 1.2 0.9805 1.61 0.7532 0.1513 0.9929   4.03 0.9963 3.54 0.56 0.5894 
7.4 0.9817 4.02 0.5267 0.26 0.9912 14.472 0.9956 15.02 0.479 0.8771 
R4 1.2 0.9761 1.48 0.7024 0.135 0.9949   3.52 0.9965 3.33 0.524 0.7314 
7.4 0.9877 3.64 0.5642 0.25 0.9876 13.194 0.9983 12.6 0.525 0.8896 
 
As shown in table 8, the value of drug release coefficient (R2) calculated by zero order was ranging 
from 0.97 to 0.99. Similarly, the values of R2 calculated by Higuchi model and Korsmeyer Peppas 
model were in that range. Hence, it could be observed that all captopril loaded hydrogel formulations 
prepared were following zero order kinetics, Higuchi model and Korsmeyer Peppas model in terms 
of drug release. The mechanism of drug release was indicated by the values of n i.e. release 
exponent. By fitting of recorded data to Peppas model, it was investigated that approximately all 
hydrogel formulations in spite of having different concentrations of polymer and monomers were 
following non- Fickian mechanism of drug release as presented in Table 8. The value of n in all 
cases were more than 0.45 but lesser than 1. 
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Conclusions 
The above discussion concludes that use of microwave irradiation is more efficient technique 
for hydrogel synthesis for the components used in this study. It can remarkably shorten the 
reaction time required for polymer crosslinking from several hours to few minutes in 
comparison to conventional hydrothermal method. The polymeric network HPMC-g-PVA-
co-poly (acrylic acid) was prepared successfully by induction of microwave radiations. The 
hydrogels formed by using this method had comparatively higher swelling tendency and drug 
loading. Therefore, microwave assisted hydrogel synthesis developed a promising drug 
carrier that could be effectively utilized for delivering captopril for longer time period in a 
controlled manner. It could be a suitable candidate to prove its worth in the treatment of 
hypertension and certain other heart disorders.  
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Synthesis and in-vitro characterization of 
Hydroxy propyl methylcellulose-g-poly(acrylic 
acid-co-2-Acrylamido-2-methylpropane 
sulfonic acid) polymeric network for 
controlled release of captopril 
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Summary 
Background of the Study 
A super-absorbent hydrogel was developed by crosslinking of 2-acrylamido-2-methyl-1-
propanesulfonic acid (AMPS) and acrylic acid with hydroxypropyl methylcellulose(HPMC) 
for controlled release drug delivery of captopril, a well-known antihypertensive drug. 
Methods 
Acrylic acid and AMPS were polymerized and crosslinked with HPMC by free radical 
polymerization, a widely used chemical crosslinking method. N,N'-methylenebisacrylamide 
(MBA) and potassium persulfate (KPS) were added as cross-linker and initiator, respectively. 
The hydrogel formulation was loaded with captopril. The concentration of captopril was 
monitored at 205 nm using UV spectrophotometer. Equilibrium swelling ratio was 
determined at pH 2, 4.5 and 7.4 to evaluate the pH- responsiveness of the formed hydrogel. 
The hydrogels were evaluated by FTIR, SEM, XRD, and thermal analysis (DSC and TGA). 
Results 
The formation of new copolymeric network was determined by FTIR, XRD, TGA and DSC 
analysis. The hydrogel formulations with acrylic acid and AMPS ratio of 4:1 and lower 
amounts of crosslinker had shown maximum swelling. Moreover, higher release rate of 
captopril was observed at pH 7.4 than at pH 2, because of more swelling capacity of 
copolymer with increasing pH of the aqueous medium. 
Conclusions 
The present research work confirms the development of a stable hydrogel comprising of 
HPMC with acrylic acid and AMPS. The prepared hydrogels exhibited pH- sensitive 
behavior. This superabsorbent composite prepared could be a successful drug carrier for 
treating hypertension. 
Keywords: Composite, Superabsorbent, Polymerization, Acrylic acid, 2-Acrylamido-2-
methyl-1-propanesulfonic acid, Hydroxypropylmethylcellulose, Initiator, Cross linker, 
Hydrogel. 
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4.1 Introduction 
Drug delivery systems have been known for enhancing therapeutic efficacy, minimizing side 
effects, and improving patient compliance. Among drug delivery systems, hydrogels have 
attracted the interest of biomaterial scientists due to their hydrophilic character and 
biocompatibility.291 Due to their softness and pliable nature, they have tendency to absorb 
higher amounts of water and physiological solutions, these absorbed aqueous solutions are 
capable of retaining water even if subjected to pressure. They have numerous applications as 
drug carriers, water-absorbents and food additives.292 
Superabsorbent hydrogels have an ability to absorb water from 10% to thousands times of 
their dry weight.293 Due to special characteristics, these materials have gained attention in the 
fields of agriculture, waste water treatment,294-296 pharmaceutical and biomedical297,298 and 
biotechnology.299,300 Polysaccharide-based hydrogels are currently attracting much interest 
fortheir unique properties, which are their better biocompatibility, biodegradability, 
renewability, and nontoxicity. Various polysaccharides, such as starch,301 chitosan,302 
carrageenan,303 alginate,304 cellulose and cellulose derivatives305−307 have been used for 
superabsorbent hydrogel formulation. 
In this work, a super-absorbent hydrogel was synthesized by copolymerization of two 
monomers (acrylic acid and AMPS) and their crosslinking with HPMC using potassium 
persulfate to initiate the reaction and MBA as crosslinking agent.  
Hydroxypropylmethylcellulose (HPMC), the cellulose derivative, is a semisynthetic, inert, 
and viscoelastic polymer found in a variety of commercial products. Depending on the grade, 
HPMC is widely utilized in oral solid dosage forms (tablets and capsules) as well as an 
ophthalmic lubricant.308,309 HPMC comprises of repeated units of glucose, linked with one 
another by 1 4-glycosidic bonding, while the polymer chains are attached together by 
hydrogen bonding.310 
Acrylic acid (AA) has been extensively used as monomer in hydrogel synthesis due to 
relatively economical advantage, crosslinking ability as well as rapid polymerization by 
various formulation techniques. It possesses a pH and electrically responsive behavior due to 
ionic repulsion between anionic charged carboxylate groups. It polymerizes to polyacrylic 
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acid (PAA) an established vehicle in controlled release drug delivery.277,311 2-Acrylamido-2-
methyl-1-propanesulfonic acid (AMPS) it has attracted an attention in hydrogel formation 
possess due to presence of sulfonate groups. Strongly ionizable sulfonate groups increase the 
hydrophilicity and ultimately swelling capability of hydrogels. The polymeric network 
comprising of AMPS have ability to swell at all pH ranges, therefore it does not impart a pH-
sensitive behavior to its hydrogel formulation. As stated in literature, it swells rapidly in 
acidic medium and relatively slower at pH higher than 5. AMPS contain both nonionic and 
anionic groups; whereas, AA is an anionic monomer.312 Due to these characteristics acrylic 
acid was combined with AMPS, to release the drug loaded in a controlled manner. The 
hydrogels prepared were observed for their swelling behavior different pH (2, 4.5 and 7.4). 
They were loaded with captopril and its release in was studied by dissolution process at pH 2 
and pH 7.4. Moreover, FTIR, SEM, XRD, DSC and TGA analysis were performed for in-
vitro characterization of super-absorbent composite. 
4.2 MATERIALS AND METHODS 
4.2.1 Chemicals 
Hydroxypropylmethylcellulose (2600−5600 cps, Sigma Aldrich, Netherlands), acrylic acid 
(Sigma Aldrich-Netherlands), AMPS, (99%, Aldrich-product of Germany) N,N-Methylene-
bis-acrylamide (98%, Fluka-Switzerland), potassium persulphate (Analar, BDH-England), 
and potassium dihydrogen phosphate (Merck, Germany) were purchased through local 
commercial sources. Distilled water from laboratory and solvents of analytical grades were 
used. 
4.2.2 Preparation of hydrogel 
The hydrogel was prepared by free radical polymerization, where the polymer (HPMC) in 
varying quantities was added in distilled water and stirred at 80ºC for 1 h. Then the HPMC 
solution subjected to nitrogen purging for about 30 min and potassium persulfate (0.5% 
W/W) was added to initiate the reaction by generating free radicals. After that the reactants 
was cooled down to 30ºC and MBA as cross-linking agent dissolved in acrylic acid (AA) was 
added under magnetic stirring. Then, AMPS previously dissolved in small quantity of water 
was added to above mixture and final volume was adjusted by addition of deionized distilled 
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water. After that, the above mixture was poured in test tubes and heated in water bath at 
50°C, 55°C, 65°C and 75°C for 30 minutes, 1 hour, 2 hour and 3 hour, respectively. Then, 
the glass tubes were cooled to 25°C and hydrogels were taken out and cut in the form of 
discs of nearly 8mm long. They were then thoroughly treated with ethanol and distilled water 
mixture (50:50) for removing catalysts and uncross-linked monomer till the pH of solutions 
after washing becomes nearly same as before being used. After washing process, the 
hydrogel discs were air dried for overnight and then transferred to oven at 45°C for 4 to 5 
days until they attain a constant weight. The whole crosslinking reaction initiated by 
potassium persulfate (KPS), involving interaction among polymer and monomers are 
presented in figure 1. Table 1 shows hydrogels prepared using different concentration of 
components. 
         Table 1. Hydrogels formulations using different amounts of HPMC, AMPS and MBA 
Formulation 
code 
Polymer 
(HPMC) 
g/100g 
Monomers, g/100g Crosslinking agent, 
mol % of each 
monomer’s 
concentration AA AMPS AA/AMPS ratio 
S1 1.0 15 2. 5 6:1 0.6 
S2 1.0 15 3 5:1 0.6 
S3 1.0 15 3.75 4:1 0.6 
S4 1.0 15 5 3:1 0.6 
S5 1.0 15 7.5 2:1 0.6 
S6 1.5 15 3.75 4:1 0.6 
S7 2.0 15 3.75 4:1 0.6 
S8 1.0 15 3.75 4:1 0.8 
S9 1.0 15 3.75 4:1 1.0 
S10 1.0 15 3.75 4:1 0.4 
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                         Figure 1. Crosslinked HPMC-g-poly (AA-co-AMPS) Hydrogel 
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4.3 In vitro Evaluation 
4.3.1 Fourier Transform Infrared Spectroscopy (FT-IR) 
FT-IR spectrophotometer (Bruker, Tensor 27) was used to record the spectra of hydrogel, 
HPMC, acrylic acid and AMPS. The hydrogel samples were ground by the help of cutter as 
well as pestle and mortar. The components and crushed hydrogel samples were then analysed 
in wavelength range of 4000 to 500 cm-1. 
4.3.2 Scanning Electron Microscopy (SEM) 
SEM images were taken to investigate the surface morphology of super-absorbent hydrogels 
using a scanning electron microscope (Quanta 250, FEI).  Both drug free formulations and 
drug loaded samples were ground and scanned at different magnifications to observe the 
microscopic surface of dried hydrogels. It is therefore to assess the capability to adsorb and 
entrap the drug into their polymeric network. 
4.3.3 X-Ray Diffraction (XRD) 
X-Ray Diffraction analysis determines the crystalline and amorphous properties of the 
substances. It investigates the interaction of components or polymers and drug. Xpert Pro 
diffractometer (Panalytical) diffractometer used to record x-ray diffraction. The XRD 
patterns of pure drug and drug loaded formulation were measured at room temperature by 
scanning at angle 5-50° (2 Theta), scanning speed of 20/ min-1. 
4.3.4 Thermal analysis 
Thermal analysis was recorded by thermogravimetric analysis (TGA) and differential 
scanning calorimetry (DSC) using Q5000 series (TA instruments) and Q2000 series (TA 
instruments), respectively.  The hydrogel samples were crushed into powder form using 
pestle and mortar and passed through a mesh no. 50. 
TGA 
For measuring TGA, 1- 4 mg of ground sample was placed in platinum pan connected to 
microbalance and heated till 500°C at a rate of 20°C/min in nitrogen atmosphere. 
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DSC 
To record DSC, hydrogel samples (1 to 3mg) along with HPMC, AMPS and acrylic acid 
were placed in aluminum pan crimped with an aluminum lid and heated from 0-500°C at the 
same rate used for TGA. 
4.3.5 Swelling Study 
The swelling of hydrogels was measured at different pH (2, 4.5 and 7.4) at room temperature. 
Dried discs of hydrogels were accurately weighed and immersed in swelling medium i.e. 0.1 
M USP phosphate buffer solution. Hydrogel discs were weighed at regular intervals of time 
and before weighing they were placed on filter paper to remove excess of solution from the 
surface. The hydrogels were weighed for a period until they attain equilibrium. The swelling 
ratio was calculated as: 
                                     
Where, ws  is the weight achieved after swelling and wd denotes the weight of dry hydrogel 
discs. The percentage equilibrium swelling was determined by equation given below: 
                                
Where, weq  is the equilibrium weight and wd is the initial weight of hydrogels before swelling 
study. 
4.3.6 Drug loading 
Hydrogels were loaded with drug (captopril) using absorption method by immersing the dry 
discs of hydrogels in 100mL captopril solution (1% w/v) comprising of phosphate buffer 
solution and methanol (50:50). The hydrogels were swollen till they achieved equilibrium, 
then taken out and dried in oven at 40°C to their constant weights. The amount of drug 
loaded in hydrogels was measured by extracting them with the methanol/ phosphate buffer 
solution in the same ratio used for drug loading. The extraction was done repeatedly at 
regular intervals and each time with freshly prepared solution until no drug remains in the 
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extracting solution. All samples of drug solutions used during extraction procedure were 
analyzed for drug contents. The calibration curve of captopril was drawn by preparing its 
various dilutions to determine the drug concentration spectrometrically at λmax of 205nm. 
4.3.7 Drug release 
Drug release measurement was carried out by dissolution process using 0.1 M USP 
phosphate buffer solutions of lower and higher pH values (pH 2 and pH 7.4). The dried 
hydrogel discs loaded with captopril were placed in 500 ml buffer solution (dissolution 
medium) maintained at 37°C, agitated by a paddle stirrer at a speed of 50 rpm. Then, the 
samples were taken at specific time intervals and drug released was measured by UV-
spectrophotometer at λ max of 205nm. 
4.3.8 Drug release kinetics 
Various drug release models were used to determine the mechanism of drug release as given 
below: 
Zero order kinetic models 
It relates the drug delivery systems, where the rate of drug release does not exhibit 
concentration dependency. It is represented as: 
M0 - Mt = Kt                                     (3) 
Where, M0isthe initial quantity of drug, Mt is the fraction of drug released at time t and K is 
proportionality constant. 
First order kinetic models 
The first order kinetics describes the concentration dependent release of drug and is 
represented by the following equation: 
Log M0   − Log Mt  = K1t/2.303                (4) 
Where, M0 is the initial amount of drug, Mt is the drug concentration released at time t and 
K1release constant. 
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Higuchi Model 
Higuchi model can be presented by a simplified equation as: 
Q = KHt1/2                                                              (5) 
Where, Q represents the fraction of drug released at time t and KH is Higuchi constant. 
Weibull model 
The dissolution and release process was described by an equation expressing the fraction of 
drug accumulated ‘M’ in dissolution medium at time t given as: 
 
Where,adefines the dependency on time, b denotes the shape parameter of dissolution curve 
and the other parameter ‘Ti’represents the lag time before dissolution process. 
Korsmeyer- Peppas model 
Korsemeyer-Peppas model is described by a simple empirical equation to describe the 
Fickian and non-Fickian drug release from polymeric drug carriers, given as following: 
Mt/M∞ = K tn                          (7) 
Where, ‘K’ is kinetic constant that incorporates the geometric and structural properties of the 
hydrogels and other drug carriers.  Mt/ M∞ represents the drug fraction released at timet and 
nis release exponent. When the value of n is 0.45, it indicates Fickian release order and for n 
= 1, represents case II transport mechanism. On the other hand, n value between 0.45 and 1 
corresponds to non- Fickian diffusion. 
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4.4 Results and Discussions 
4.4.1 FT-IR Spectroscopy 
The structure and formation of cross-linkageamong the polymers were investigated by 
spectra recorded using FT-IR spectroscopy as presented in figure 2. The spectrum(b)  of 
HPMC shows an absorption band at 3444.60 cm-1 is assigned to stretching frequency of the 
hydroxyl (-OH)  group. Another band at 1373.63 cm-1 is due to bending vibration of –OH. 
Other stretching vibration bands related to C-H and C-O were observed at 2929 cm-1 and 
1055.52 cm-1, respectively. 
Spectrum (c) and spectrum (d) represents the FTIR pattern of acrylic acid and AMPS, 
respectively. Acrylic acid shows a characteristic peak nearly 1700cm-1 due to presence of 
carboxylic group. The spectrum of AMPS showed a band at 1666.03 cm-1 related to 
stretching of amide link (–CONH), another band at 1550.03 cm-1 corresponds to bending 
vibration of N-H and  1126.54 cm-1 was due to stretching vibration of -SO3H groups. 
Another peak at 623.02 cm-1 in AMPS spectrum was also related to the -SO3H group. 
In figure 2,the spectrum (a) of HPMC-g-poly(AA-co-AMPS) suggests the formation of 
intermolecular hydrogen bonding due to carboxylic acid groups of acrylic acid as observed 
by the appearance of an absorption peak at 1710.75 cm-1that was not present in individual 
spectra of AMPS and HPMC. The hydrogel spectrum (a) indicates the shifting of –OH 
vibration band of HPMC from 3444.60 cm-1 to 3292.58 cm-1 due to formation of hydrogen 
bonds. Hence, it confirms the crosslinking of HPMC with acrylic acid involving the reaction 
of –OH (of HPMC) with –COOH (of acrylic acid).  In addition, characteristic bands at 
1547.30 cm-1 (C=O stretching vibration of –CONH groups) and 1153.14 cm-1 were attributed 
to stretching vibration of sulfonate (–SO3H) groups of AMPS monomer. The results 
indicated successful grafting of monomers (acrylic acid and AMPS) onto HPMC polymer 
chains. These peaks observed were according to the FTIR spectrum noticed by Wang et al.313 
however slight variation was due to interaction of acrylic acid and AMPS with functional 
groups of polymers. 
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Figure 2. FT-IR Spectra of HPMC-g-poly ( AA-co-AMPS) (a),  HPMC (b), 
Acrylic acid (c) and AMPS (d) 
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4.4.2 SEM 
In order to determine the microstructure and surface morphology of hydrogel formulations, 
SEM images were taken. Scanning electron microscopy is one of the preferred methods to 
characterize the hydrogels in terms of porosity and water retention. The micrographs 
recorded as shown in figure 3 (A and B) show the surface of the drug free and drug loaded 
hydrogels. 
 
Figure 3. SEM images of HPMC-g-poly (AA-co-AMPS) hydrogels, 
without drug (A) and loaded with drug (B). 
 
The SEM images in figure 3 clearly show that hydrogel surface was rough along withmicro- 
spaces for water retention and entrapment ofsolutes. Figure 3 (A) presents drug free hydrogel 
formulation with voids and spaces for accommodation of biological fluids as well as drug 
particles. Theyhad tendencyto exhibit remarkable swelling because of their water absorption 
capability. Moreover, due to the presence of these voids and roughness of surface of 
hydrogels, the captoprilwasloaded into these regions as shown in figure 3 (B).It was 
indicated from the prepared grafted polymeric network HPMC-g-poly (AA-co-AMPS) had 
ability to act as suitable drug carriers for drug delivery. 
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4.4.3 XRD 
X-ray diffractograms of pure captopril and captopril loaded hydrogel formulation are 
presented in figure 4. The diffraction patterns of hydrogels loaded with drug were compared 
with pure drug. The XRD scan of plain captopril had characteristic sharp and intense peaks 
between 0° and 50° (2θ), which were appeared due to its crystalline nature as shown in figure 
4, diffractionpattern (c). 
 
      Figure 4. XRD patterns of captopril (a) and Drug loaded HPMC-g-poly (AA-co-AMPS)   
hydrogel (b) Drug free HPMC-g-poly (AA-co-AMPS) hydrogel 
The appearance of a sharp peak at 2 θ= 27.79° is characteristic of captopril. It could be seen 
in diffraction pattern a, that no peak was observed in cross-linked copolymer. However, 
diffractogram of drug loaded hydrogel was dense like that of drug free hydrogelbutshowing 
peaks with low intensity. Therefore, in comparison to pure captopril, the captopril loaded 
formulations had low intensity and dense peaks suggesting the amorphous distribution of 
drug into polymeric network, as it could be observed from figure 4 diffractogram (b). This 
observation iscorresponding with XRD analysis studied by Rao et al.314, where drug was 
molecularly dispersed in the polymeric matrix of poly(acryl amide-co-2-acrylamido-2-
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methyl-1-propanesulfonic acid-co-acrylamidoglycolic acid) hydrogels. Similar results had 
also beennoted by Kim et al.315 
4.4.4 Thermal analysis 
The grafting of HPMC-g-poly (AA-co-AMPS) polymeric network was also determined by 
theromogravimetric analysis (TGA). The pure acrylic acid decomposition starts at nearly 
80°C and complete mass loss was observed at 189.50°C as shown in figure5, thermogram 
(A). Similarly, the degradation of other monomer AMPS had taken lesser time as can be seen 
in thermogram (B), figure 5. The TGA thermogram (C) of HPMC shows decomposition at 
265°C which then continued till 350°C, during that period 78% of loss in weight was 
observedbecause of polymer degradation. 
In comparison to the individual components, thermogram of the grafted product (D) was 
recorded, where three stages of decomposition from 30°C -500°C were observed. In the first 
stage of degradation, loss of weight started from 114°C to 25°C, there was about 12% weight 
loss during this stage due to loss of absorbed and bound water. Then second stage of weight 
loss started at 250°C and continued to 331.88°C, corresponding to 40% weight loss. Finally 
the third stage beginning from 332°C till 500°C caused the degradation of hydrogel’s 
structure. In case of HPMC, there was complete removal at 490°C, whereas the hydrogel had 
67% weight loss and 33% still remaining at that temperature. A greater thermal stability of 
the formed polymeric network was observed as compared to its individual polymer and 
monomers (HPMC, acrylic acid and AMPS). Hence, the hydrogels prepared were more 
stable and resistant to higher temperatures. 
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Figure 5. DSC and TGA thermograms of acrylic acid AA (A), AMPS (B), HPMC (C), drug 
free hydrogel (D), captopril (E) and drug loaded hydrogel (F) 
 
The alterations in heat capacity as well as enthalpy changes are measured using 
Differential Scanning Calorimetry (DSC). It is a well-known and established technique 
adopted for quantitative assessment of physicochemical variations in heat capacity of 
crystalline drugs, when loaded into hydrogels. The DSC endothermic peaks of pure 
HPMC, AA, AMPS and cross-linked polymeric network were in accordance with TGA 
thermal patterns. The thermal behavior of the pure captopril, drug loaded S3 hydrogel was 
characterized using DSC, as shown in Figure 5 (F).The disappearance of characteristic 
peaks and appearance of other peaks suggests some sort of interaction of drug with 
polymers. Thermogram (E) presenting DSC pattern of pure captopril, shows the 
appearance of sharp peak at 106°C indicating melting point of captopril. This peak of drug 
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was not appeared in DSC thermogram of the drug loaded formulation, whereas two new 
peaks were observed at 225°C and 292°C. 
    Figure 6. DSC thermograms of a) drug free and b) drug loaded and c) pure drug 
It could be clearly suggested that the drug loaded Hydrogels showed an increase in the 
exothermic peak temperature (Figure 6). The extra obvious peak of drug (106 °C) was not 
observed in drug loaded hydrogels. It suggests that captopril was molecularly dispersed in 
different hydrogel matrix without changing its thermal behavior, indicating the stability of 
drug and drug loaded hydrogel formulation.The resultant DSC analysis isaccording to 
observations of Kim et al.315and Manjanna et al.281 
4.4.5 Swelling Study 
Swelling ratios of the synthesized gels were measured gravimetrically at the pH from 1.2, 4.5 
and 7.4 in phosphate buffer. The swelling of hydrogels is dependent upon the presence of 
hydrophilic groups. Hydroxypropylmethylcellulose interact with water due to its –OH 
groups. The hydrogel swelling is enhanced by increasing the amount of AMPS. This high 
swelling property of AMPS is attributed to the presence of strongly ionizable sulfonate 
groups that create charge repulsion among the grafted chains. The sulfonate groups present 
have better hydrophilicity than carboxylate groups. The carboxylic groups associated with 
acrylic acid impart a pH responsiveness that prevents the abrupt swelling of copolymeric 
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system due to AMPS. Increasing the pH of buffer solution made ionization of carboxylic 
groups, which ultimately generates repulsive forces responsible for swelling behaviour of 
hydrogels containing acrylic acid. 
Effect of polymer concentration 
Hydrogels containing higher amount of polymer show lesser comparative swelling ratios As 
shown in figure7, S3 comprising lower amount of polymer swell more as compared to S6 and 
S7 formulations. As the quantity of polymer increases in the hydrogels, the value of their 
swelling ratio decreases. 
 
 Figure 7. Percent equilibrium swelling (%ES) of formulations at different 
pH containing different concentrations of HPMC 
Effect of Cross-linking agent 
The graphic presentation of swelling ratios in figure 8 (a) and percent equilibrium swelling in 
figure 8(b) elaborates the effect of different concentrations of MBA on swelling behavior. By 
increasing the amount of crosslinking agent there was decrement in swelling ratio. Increasing 
the crosslinker amount leads to increment of crosslinking density due to higher interaction 
among the components and ultimately reduces the porosity. Hence, the structure of hydrogels 
become dense having lesser spaces to accommodate aqueous solutions. On the other hand, 
the hydrogels comprising less amounts of MBA were able to swell more due to lower 
crosslinking density. The formulation S10 containing the lower quantity of crosslinker 
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exhibited highest swelling ratio among other formulations.Various quantities of MBA, 0.09% 
w/w, 0.12% w/w and 0.15% w/w were added for S3, S8 and S9, respectively. S3 containing 
lesser amount of crosslinking agent exhibit higher percent equilibrium swelling (% ES) as 
shown in figure 8 (b). 
 
Figure 8(a). Comparative Swelling ratios of the hydrogels with 
different concentrations of crosslinking agent 
 
                          
       Figure 8(b). Percent equilibrium swelling (%ES) of formulations at 
different pH containing different concentrations of 
MBA 
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Effect of AMPS concentration 
The result of varying the ratio of acrylic acid to AMPS is demonstrated in Figure 9 (i) and 9 
(ii). By increasing the amount of AMPS in formulation enhanced the swelling, which reached 
maximum as the mass ratio of AA to AMPS was 4:1. Further increase of AMPS content led 
to a decrement of swelling ratio. By increasing the amount of AMPS, number of hydrophilic 
groups such as -CONH and -SO3H increased accordingly. As a result, the synergistic effect 
produced by-CONH and -SO3H on AMPS, together with that of -COOH on AA increased,316 
which brought about great enhancement of absorbency of aqueous solution. 
However, when the mass ratio of AA to AMPS was below 4:1, which mean that AMPS 
content is over one-fifth of total monomers, swelling decreased in respect that the 
electrostatic repulsion between ions weakened and the three-dimensional network 
compacted. In addition, as AMPS contained quaternary carbon atoms and -SO3H groups 
which were enormous in size, stretching of polymer chains would be obstructed and 
absorbency would decrease accordingly. The subsequent decrease in swelling ratio of 
hydrogels can be ascribed to low reactivity of AMPS monomer.317,318This indicates that the 
monomer grafting onto CMC chains decreases with increasing AMPS/AA molar ratio above 
a certain limit. 
The swelling of formed polymeric network with various ratios of acrylic acid and AMPS was 
relevant to that observed by Zhu et al.,319 where the absorption of aqueous solution was 
dependent upon optimum concentration of AMPS. Further increase in AMPS led to decrease 
in water absorption characteristics and ultimately swelling of hydrogel. However, it was 
varying from results obtained by Zhang et al.320 in terms of swelling behavior with higher 
contents of AMPS than acrylic acid, which could be due to interaction of AMPS with 
polymer i.e. Xylan. In our case the crosslinking was mainly due to interaction of functional 
groups of AMPS and acrylic acid(sulfonic groupsand carboxylic groups) which were then 
grafted on backbones of HPMC. Hence, the swelling characteristics were dependent upon the 
optimum ratio of both monomers in polymeric network. 
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Figure 9(i). Increase in percent equilibrium swelling with increase in AMPS Concentration 
 
 
 
 
                             Figure 9(ii). Decrease in percent equilibrium swelling(%ES)with increase in AMPS 
concentration above 3.75 g (with AA/AMPS ratio 4:1) 
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                       4.4.6 Drug loading and release studies  
The hydrogel discs exhibiting greater swelling accommodated higher amounts of drug. The 
release study of captopril was performed at pH 2 and pH 7.4 as shown in figure 10. The drug 
release at both pH (2 and 7.4) was observed for a period of 24 hrs, where USP phosphate 
buffer was used as dissolution medium. Drug release measured was in correspondence to 
swelling studies where relatively more amount of drug was loaded and ultimately released in 
formulations exhibiting more swelling. 
Table 2. Amount of Captopril loaded and percentage of drug released at pH 2 and pH 7.4 
Formulation 
code 
Amount of captopril loaded (mg) 
per 0.3 gram of dry hydrogel discs 
% release of captopril 
pH 2 pH 7.4 
S1 113.5 32.83 82.57 
S2 118.81 34.75 86.28 
S3 124.28 38.22 88.50 
S4 117.5 33.29 84.39 
S5 109.7 30.84 81.56 
S6 112.55 32.63 82.12 
S7 104.15 28.65 77.68 
S8 119.56 35.16 87.07 
S9 114.31 33.08 83.16 
S10 127.78 44.40 90.01 
 
 
        Figure 10. Captopril released up to 24 h from HPMC-g-poly (AA-co-AMPS) 
hydrogels (S3, S7, and S9) in dissolution media of pH 2 and pH 7.4 
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The drug release kinetics of prepared superabsorbent hydrogels was determined by different 
kinetic models already mentioned. The values of release coefficient R2calculated by kinetic 
models are presented in table 3. The drug release from hydrogel formulations were best fitted 
into the kinetic model having value of R2 close to 1. 
The release exponentnobtained byKorsemeyer-Peppas modelfor the formulations of HPMC-
g-poly (AA-co-AMPS) copolymer containing different components, polymer concentration, 
AA/AMPS ratio and amount of crosslinker are presented in table 4. 
  Table 3. Determination coefficient (R2) of various drug release kinetic 
models for the prepared superabsorbent hydrogel formulations 
Sample 
code 
pH Zero order First order Higuchi Weibull 
S1 2 0.9815 0.7443 0.9954 0.7489 
7.4 0.9934 0.6024 0.9673 0.8986 
S2 2 0.9629 0.6954 0.9959 0.7257 
7.4 0.9956 0.5858 0.9659 0.9198 
S3 2 0.9484 0.5329 0.9961 0.8081 
7.4 0.991 0.5774 0.9822 0.8989 
S4 2 0.9691 0.7125 0.9974 0.7001 
7.4 0.9945 0.5842 0.9683 0.9133 
S5 2 0.9717 0.7269 0.9978 0.7025 
7.4 0.9855 0.5106 0.9931 0.8856 
S6 2 0.9851 0.7503 0.9919 0.7142 
7.4 0.9912 0.5766 0.9816 0.8894 
S7 2 0.9434 0.6957 0.9947 0.6683 
7.4 0.9917 0.5428 0.9842 0.901 
S8 2 0.9633 0.6986 0.9941 0.7366 
7.4 0.9958 0.5912 0.9637 0.9188 
S9 2 0.9758 0.7307 0.9938 0.7743 
7.4 0.9956 0.6003 0.9691 0.987 
S10 2 0.9359 0.4794 0.9845 0.7975 
7.4 0.994 0.5914 0.9775 0.9071 
 
 
 
 
  118 
                 Table 4. Mechanism of drug release by determination of release 
exponent ‘n’ 
Sample 
code 
pH N R 
S1 2 0.59 0.9954 
7.4 0.72 0.9855 
S2 2 0.47 0.9914 
7.4 0.73 0.9871 
S3 2 0.56 0.9962 
7.4 0.59 0.9989 
S4 2 0.55 0.9957 
7.4 0.69 0.987 
S5 2 0.63 0.9957 
7.4 0.58 0.9979 
S6 2 0.79 0.9977 
7.4 0.64 0.9869 
S7 2 0.54 0.9795 
7.4 0.63 09952 
S8 2 0.46 0.991 
7.4 0.78 0.9853 
S9 2 0.48 0.9956 
7.4 0.78 0.987 
S10 2 0.61 0.9757 
7.4 0.62 0.9991 
 
The mechanism of drug release was indicated by the values of n i.e. release exponent. By 
fitting of recorded data to Peppas model, it was investigated that approximately all hydrogel 
formulations in spite of using different concentrations of polymer, monomers and 
crosslinking agent were following non- Fickian mechanism of drug release as presented in 
Table 4. The value of n in all cases were more than 0.45 but lesser than 0.85. 
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CONCLUSIONS 
The results and discussion reveal that the developed superabsorbent hydrogel exhibit 
remarkable swelling properties, reasonable stability and smart pH responsiveness. The 
HPMC-g–poly (AA-co-AMPS) polymeric network was successfully crosslinked by a well-
established and widely used chemical crosslinking method, free radical polymerization. The 
formulations prepared by varying amounts of components were then loaded with an 
antihypertensive drug, captopril. The drug entrapped into these hydrogels remained stable 
and was compatible with its components. The hydrogel network was also capable to release 
relatively smaller fraction of drug in acidic medium and more quantity at higher pH. Thus, 
after oral administration, the hydrogel formulation would be capable of exerting the effects 
throughout its retention in the stomach and intestine. Therefore, this can prove its worth as a 
successful and promising drug carrier for the controlled release of captopril, which can be 
used for the treatment of hypertensive patients as well as for the management of cardiac 
disorders. 
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Poly(vinyl alcohol)-co-poly(2-
acrylamido-2-methyl-1-propane sulfonic 
acid) gastro-retentive hydrogel by 
microwave radiation 
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Summary 
Background of the Study 
Hydrogel possessing highly swollen characteristics was prepared by crosslinking of 
poly(vinyl alcohol) (PVA) with 2-acrylamido-2-methyl-1-propanesulfonic acid (AMPS) as a 
drug carrier of Captopril. 
Methods 
Polyvinyl alcohal was crosslinked with AMPS by microwave radiation using N,N'-
methylenebisacrylamide (MBA) as crosslinker and very low quantities of potassium 
persulfate (KPS) as initiator. The captopril was loaded as model drug and its concentration 
was measured at wavelength of 205 nm using UV spectrophotometer. The swelling studies 
were performed at pH 2 and pH 7.4 to determine variation in water retention at low and 
higher pH. This super-absorbent polymeric system was evaluated by FT-IR, SEM, XRD, and 
thermal analysis (DSC and TGA).             
Results 
The crosslinkage of components and synthesis of hydrogel were confirmed by FT-IR, XRD, 
TGA and DSC analysis. The hydrogel formulations with higher contents of AMPS and 
appropriate dose of radiation had shown maximum swelling. Drug release observed was 
relatively higher at pH 2 than at pH 7.4, because of more swelling capacity of AMPS at 
lower pH of the aqueous medium. 
Conclusions 
It was concluded from the current research work that a polymeric device containing 
polyvinyl alcohol and AMPS was developed successfully under the effect of microwave 
radiations. The prepared superporous hydrogel could be a potential candidate as drug carrier. 
 Keywords: Composite, Superabsorbent, Polymerization, 2-Acrylamido-2-methyl-1-propane 
sulfonic acid, polyvinyl alcohol, Initiator, Cross linker, Hydrogel. 
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5.1 Introduction 
In current era of science and technology, the swellable polymeric gels are the subject of keen 
interest among the research groups due to diversity of their applications in various areas of 
pharmaceutical and biomedical fields.321 Hydrogels based on natural polymers are often 
preffered due to their better bioinertness, but they have a drawback of less mechanical 
strength and higher costs.322-328 In comparison, using synthetic polymers overcomes these 
shortcomings and imparts a reasonable strength to polymeric networks.  Among them, PVA 
is most commonly used polymer for preparing various hydrogels such as superabsorbants, 
semi-interpreting networks and superporous hydrogels.329-331 It is a synthetic hydrophilic 
polymer, which exhibit reasonable swelling capability, while maintaining stability of the 
formulation. Other advantages are its non-toxicity, biocompatibility, physical and chemical 
stability. Due to these properties they have been extensively used in controlled release drug 
delivery as well as in medical devices such as implants, artificial pancreas, nanofilteration 
and hemodialysis.332-336 
Many hydrogels prepared containing polyvinyl alcohol in combination with acrylic acid or 
methacrylic acid do not exhibit rapid swelling properties, thus, providing slow drug 
release.337-339 In contrast, some situations desire a fast release of drug, by attaining higher 
swelling in shorter time, for example, Super porous hydrogels.  A gastro-retentive drug 
delivery hydrogel was prepared by PVA and chitosan for controlled release of rosiglitazone 
maleate.340 In the present work, a hydrogel with rapid and high swelling characteristics was 
prepared to entrap an antihypertensive drug; Captopril, for the treatment of hypertension. To 
develop gastroretentive system, PVA was crosslinked with 2-acrylamido-2-methyl-1-
propanesulfonic acid (AMPS), a hydrophilic monomer with strongly ionizable sulfonate 
groups, having tendency to swell at all pH ranges.341-344 It imparts high swellability to 
hydrogels at low pH that could be retained in stomach for longer periods of time, thus 
releasing the drug in acidic medium. This will have a benefit regarding the stability of 
captopril which remains more stable at acidic pH.  
To fulfill the objectives of developing a porous hydrogel network, the PVA was crosslinked 
with AMPS via microwave radiation method. Under the influence of microwaves, highly 
porous structures are formed with uniform crosslinking among the polymeric chains.72 
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Microwaves have ability to initiate crosslinking among polymers, hence very low quantity of 
initiator is required.267,274 The hydrogels were synthesized by exposure to different doses of 
radiation and varying initiator concentration. They were characterized by FTIR, SEM, and 
XRD, thermal analysis (DSC and TGA) as well as swelling and drug release were also 
measured. 
5.2 MATERIALS & METHODS 
5.2.1 Chemicals 
PVA, MW 72000 (Applicap), AMPS, (99%, Aldrich-product of Germany) N,N-Methylene-
bis-acrylamide (98%, Fluka-Switzerland), potassium persulphate (AnalaR, BDH-England), 
and potassium dihydrogen phosphate (Merk- Germany) were purchased through local 
commercial sources. Distilled water was used while produced in the labortary and solvents of 
analytical grades were used. 
5.2.2 Hydrogel Synthesis 
Poly(vinyl alcohol) 1-3% W/W was dissolved in distilled water by continuous stirring at 
80°C for 1 hour. The hot solution was brought to reduced temperature (60°C) and different 
low concentrations (0.05- 0.25% W/W) of initiator were used and stirred for 15 minutes. 
Then, the temperature was further decreased and cooled down to 30°C and finally crosslinker 
(MBA 1 mol % of monomer concentration) was added along with monomer (AMPS) 
solution.  The whole mixture was transferred in a glass tube and placed on turntable of 
Electrolux domestic microwave oven. Various batches of hydrogels were prepared by 
exposing the material at different doses of microwave radiations at electric power of 100 W, 
180 W and 300W. Then, the glass tubes were cooled to 25°C and hydrogels were taken out 
and cut in the form of discs of nearly 8mm long. They were then thoroughly treated with 
ethanol and distilled water mixture (50:50) for removing catalysts and uncross-linked 
monomer till the pH of solutions (which was initially ranging from pH 3-3.5) after washing 
becomes nearly same as pH of washing solution before being used i.e. pH 6.5 to 7. After 
washing process, the hydrogel discs were air dried for overnight and then transferred to oven 
at 45°C for 4 to 5 days until they attain a constant weight. Figure 1 shows the crosslinking 
reaction of PVA and AMPS initiated by potassium persulfate (KPS) with assistance of 
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microwave radiation in the presence of crosslinker (MBA). Table 1 presents hydrogel 
formulations prepared under exposure to different radiation dose and using.concentrations of 
initiator, polymer (PVA), monomer (AMPS).  
 
Figure 1. Crosslinking of PVA and AMPS using MBA as crosslinker under influence of 
Microwave radiation 
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Table 1. Hydrogels formulations prepared by exposure to different radiation doses, initiator 
concentration, amount of polymer and monomer 
Sample code Electric power     
(Watts) 
Concentration of 
initiator 
(% W/W) 
Monomer 
concentration 
(g/100g) 
Polymer 
Concentration 
(% W/W) 
SP1 100 0.25 25 1 
SP2 180 0.25 25 1 
SP3 300 0.25 25 1 
SP4 300 0.15 25 1 
SP5 180 0.15 25 1 
SP6 180 0.05 25 1 
SP7 180 0.15 20 1 
SP8 180 0.15 30 1 
SP9 180 0.15 25 2 
SP10 180 0.15 25 3 
 
5.3 In vitro Evaluation 
5.3.1 Fourier Transform Infrared Spectroscopy (FT-IR) 
FT-IR spectrophotometer (Bruker, Tensor 27) was used to record the spectra of hydrogel, 
HPMC, acrylic acid and AMPS. The hydrogel samples were grounded by the help of cutter 
as well as pestle and mortar. The components and crushed hydrogel samples were then 
analysed in wavelength range of 4000 to 500 cm-1. 
5.3.2 Scanning Electron Microscopy (SEM) 
SEM images were taken to investigate the surface morphology of super-absorbent hydrogels 
using a scanning electron microscope (Quanta 250, FEI).  Both drug free formulations and 
drug loaded samples were ground and scanned at different magnifications to observe the 
microscopic surface of dried hydrogels.  
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5.3.3 X-Ray Diffraction (XRD) 
X-Ray Diffraction analysis determines the crystallinaty and amorphous properties of 
substances. It investigates the interaction of components or polymers and drug. Xpert Pro 
diffractometer (Panalytical) diffractometer used to record x-ray diffraction. The XRD 
patterns of pure drug and drug loaded formulation were measured at room temperature by 
scanning at angle 5-50° (2 Theta) and scanning speed of 20/ min-1. 
5.3.4 Thermal analysis 
Thermal analysis was recorded by thermogravimetric analysis (TGA) and differential 
scanning calorimetry (DSC) using Q5000 series (TA instruments) and Q2000 series (TA 
instruments), respectively.  The hydrogel samples were crushed into powder form using 
pestle and mortar and passed through a mesh no. 50.  
TGA: For measuring TGA, 1- 4 mg of ground sample was placed in platinum pan connected 
to microbalance and heated upto 500°C at a rate of 20°C/min in nitrogen atmosphere. 
DSC: To record DSC, hydrogel samples (1 to 3mg) along with HPMC, AMPS and acrylic 
acid were placed in aluminum pan crimped with an aluminum lid  and heated from 0-500°C 
at the same rate used for TGA.   
5.3.5 Swelling Study  
The swelling of hydrogels was measured at different pH (2, 4.5 and 7.4) at room temperature. 
Dried discs of hydrogels were accurately weighed and immersed in swelling medium i.e. 0.1 
M USP phosphate buffer solution. Hydrogel discs were weighed at regular intervals of time 
and before weighing they were placed on filter paper to remove excess of solution from the 
surface. The hydrogels were weighed for a period until they attain equilibrium. The swelling 
ratio was calculated as: 
                                             S =                                     (1) 
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Where, ws  is the weight achieved after swelling and wd denotes the weight of dry hydrogel 
discs. The percentage equilibrium swelling was determined by equation given below: 
                                   % ES =                      (2) 
Where, weq  is the equilibrium weight and wd is the initial weight of hydrogels before swelling 
study. 
5.3.6 Drug loading 
Hydrogels were loaded with drug (captopril) using absorption method by immersing the dry 
discs of hydrogels in 100ml captopril solution (1% w/v) comprising of distilled water and 
methanol (50:50). The dics were swollen till they achieved equilibrium, then taken out and 
dried in oven at 40°C to their constant weights. The amount of drug loaded in hydrogels was 
measured by extracting them with the methanol/ distilled water in the same ratio used for 
drug loading. The extraction was done repeatedly at regular intervals and each time with 
freshly prepared solution until no drug remains in the extracting solution. All samples of drug 
solutions used during extraction procedure were analyzed for drug contents. The calibration 
curve of captopril was drawn by preparing its various dilutions to determine the drug 
concentration spectrometrically at λmax of 205nm. 
5.3.7 Drug Release 
Drug release measurement was carried out by dissolution process using 0.1 M USP 
phosphate buffer solutions of lower and higher pH values (pH 2 and pH 7.4). The dried 
hydrogel discs loaded with captopril were placed in 500 ml buffer solution (dissolution 
medium) maintained at 37°C, agitated by a paddle stirrer at a speed of 50 rpm. Then, the 
samples were taken at specific time intervals and drug released was measured by UV-
spectrophotometer at λ max of 205nm. 
 
 
  128 
5.4 Results and Discussion 
5.4.1 FT-IR Spectroscopy 
FT-IR spectra of PVA, AMPS and grafted polymeric network were recorded as shown in 
figure 2. In PVA spectrum a characteristic broad band at 3286.82 cm-1 illustrate the O–H 
stretching vibration of hydroxyl group. A relatively smaller peak at 2941.43 cm-1 is attributed 
to C-H stretching of methylene group and 1089.38 cm-1 for characteristic – C– O stretching. 
The observed peaks for PVA were in accordance with that noted by Basak et al.345 where 
3290 cm-1 indicated O-H stretching vibration, 2864 cm-1 for C-H stretching and 1069cm-1 for 
-C-O stretching vibrations. In our work, a reduction in intensity of these stretching vibrations 
was observed after crosslinking with AMPS in the presence of crosslinker (MBA) and 
initiator. Due to reaction initiated by initiator, the double bonds in AMPS as well as 
crosslinker was activated, hence C=C was not remained intact and contributed in bonding 
during crosslinking reaction. In figure 2, the spectrum of AMPS showed a band at 1666.03 
cm-1 related to stretching of amide link (–CONH), another band at 1550.03 cm-1 corresponds 
to bending vibration of N-H and  1126.54 cm-1 is due to stretching vibration of -SO3H 
groups. Another peak at 623.02 cm-1 in AMPS spectrum is also related to the -SO3H group. 
The spectral analysis of PVA-co AMPS hydrogels shows modification in spectra of 
individual components due to their crosslinking resulting in the formation of new bonds. The 
characteristic vibrational peaks of PVA were shifted from 3286.82 cm-1, 2941.43 and 
1089.38 cm-1 to 3214.94 cm-1, 2921.07 cm-1 and 1039.10 cm-1, respectively. Another peak at 
844.49 cm-1 was shifted to 804 cm-1 indicated a reduction in bending vibrations of C – H. A 
characteristic band in AMPS at 1666.03 cm-1 was reduced to 1646.27 cm-1 and 1550.03 was 
shifted to 1544.29 cm-1. A peak at 1155.61cm-1 implies stretching vibration of -SO3H groups 
of AMPS monomer.  In addition, another band at 621.02 cm-1 was due to -SO3H as indicated 
by Osorio-Fuente et al.,346 that the peaks in range 620 to 625 cm-1 confirms the presence of 
sulfonic group (-SO3H). From these FT-IR spectra, it is indicated that AMPS is polymerized 
and successfully crosslinked with polyvinyl alcohol.  
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               Figure 2. FT-IR spectra of PVA, AMPS and PVA-co-AMPS hydrogel 
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5.4.2 SEM 
For the determination of microstructure and surface morphologies of formed graft copolymer 
scanning electron microscopy was performed. The SEM images of hydrogels were taken at 
different magnifications of 800 X and 5000 X in order to visualize their surface roughness 
and presence of pores. Figure 3 (A and B), describes that the hydrogel formulation SP5 
prepared under influence of relatively lower radiation dose had a highly porous surface; 
indicating its ability to absorb higher quantity of water and entrap more solute particles. In 
comparison, the hydrogel SP3 comprising of same amounts of polymer, monomer and 
crosslinking agent as that of SP5 but formed by higher doses of radiation had less porous 
surface. The SP3 hydrogel formulations had cracked surface due to bursting effect at higher 
electric power. Exposure to microwave radiations leads to formation of highly porous surface 
because of their uniformly rapid and instantaneous penetration.272 It was determined by Zhao 
et al.72 who compared the SEM images of hydrogels prepared by microwave radiations with 
hydrogels prepared by conventional water bath method.  
The presence of surface roughness and porous structure are directly related to swelling 
tendency of polymeric network. It indicates the loose crosslinking among PVA and AMPS in 
hydrogel formulation SP5. In hydrogel formulation SP5, there was lesser crosslinking among 
the polymer and monomer due to its exposure to low intensity of radiation (180 W). 
Moreover, the crosslinking reaction was initiated by low concentration of initiator (0.15% 
W/W) under the effect of microwave radiations.  
In comparison to SEM image of SP5 hydrogel, SP3 hydrogel formulation prepared by 
receiving higher radiation doses at electric power of 300 W had dense and tight structure. 
The surface roughness was reduced with lesser porous structure, having lower tendency to 
absorb water and swell in aqueous fluids. This was due to greater crosslinking among the 
components due to intense radiations and relatively higher amounts of potassium persulfate 
(0.25% W/W) as initiator. Moreover, the exposure of hydrogels for same time period at 
electric power 300 W led to formations of cracks as illustrated in figure 3 (C and D).  
  131 
 
Figure 3. SEM images at different magnifications A) SP5 at 800x, B) SP5 at 5000x, 
C) SP3 at 800x, D) SP3 at 5000x, E) Drug loaded SP5 at 5000x, F) Drug 
loaded SP3 at 2500x 
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Hence, it was estimated that SP5 formulation had higher swelling tendency and drug loading 
capacity as compared to SP3 formulation. These results were in accordance to determination 
of grafting among the polymers by Huacai et al.283 and Wan et al.274 They prepared the 
hydrogels were under different powers of microwaves and their moisture absorption was 
evaluated, which was higher in hydrogels receiving lower doses of microwaves. The effect of 
initiator on grafting determined by them was also indicative of porosity and swelling 
behavior.  
The entrapment of solute particles in hydrogels depends upon surface roughness as well as 
porosity is related with quantity of drug loaded. It could be clearly seen from SEM images 
shown in figure 3 E and 3 F for drug loaded hydrogel SP5 and SP3 respectively, that higher 
amount of drug could be loaded in SP5 due to its more porous structure. 
5.4.3 XRD 
The diffraction patterns of hydrogels loaded with drug were compared with pure drug. X-ray 
diffractograms of pure Captopril and drug-loaded Hydrogels are presented in Figure 4. The 
XRD scan of plain Captopril had shown characteristic sharp and intense peaks between 0° 
and 50° (2θ) due to its crystalline nature as shown in Figure 3 diffraction pattern (b). The 
appearance of a sharp peak at 2 θ= 27.79° is the characteristic of captopril.  
In comparison to diffractogram of pure captopril, the Captopril loaded formulations had low 
intensity and dense peaks. The sharp peak of drug were significantly reduced suggesting the 
amorphous distribution of drug into polymeric network, as it can be observed from figure 4 
diffractogram (a).  
Captopril is a crystalline drug and the presence of intense peaks in diffractrogram ‘b’ was 
due to crystallinity of the Captopril. On the other hand, the hydrogels formed by crosslinking 
of polymers usually develop an amorphous structure with denser peaks. After loading of drug 
into PVA-co-AMPS hydrogel, the captopril was entrapped and dispersed in hydrogel 
formulation. The characteristic sharp peak at 2 θ= 27.79° in pure captopril was much reduced 
and broadened in drug loaded hydrogel as could be clearly observed from diffractograms a 
and b. 
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  Figure 4. X-Ray Diffraction patterns of Drug loaded hydrogel SP5 (a) and pure Captopril(b) 
Therefore, the intensity and sharpness of peaks was reduced in captopril loaded hydrogel, only 
indicated the presence of entrapped drug into polymeric networks of hydrogel formulation. The 
resultant evaluation on basis of XRD analysis was in relevance with observations noticed by Giri 
et al.,282 where diltiazem hydrochloride was loaded into cross-linked biodegradable IPN hydrogel 
beads of pectin and modified xanthan gum. Similar diffraction patterns were noted for pure drug 
and drug loaded hydrogels. 
5.4.4 Thermal analysis 
In order to determine the thermal stability and confirmation of crosslinking, thermal analysis was 
performed using Thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC). 
Figure 5 illustrates the TGA thermograms of PVA, AMPS and formed polymeric network. Being 
monomer, AMPS was less stable at higher tempratures, it was decomposed completely at 243°C. 
PVA shows stability upto 227°C, till that temperature there was only 10% weight loss, which was 
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due to loss of water molecules and it was decomposed at about 300°C. At 325°C, weight loss 
observed was 70% that degrades complete structure of the polymer. In comparison, thermogram 
of hydrogel shows a gradual decrement in stability, indicating its enhanced thermal stability. At 
300°C, there was only 25% weight loss and at 489°C still 34% was remaining mass, whereas 
PVA was 0.07% at 477°C. Such different stages of thermal degradation in TGA analysis were 
also evaluated by  by Huacai et al.283  and Bao et al.95 
 
              Figure 5. TGA analysis of AMPS, PVA and hydrogel formulation SP5 
From the TGA thermograms of individual components (PVA and AMPS) and formed 
hydrogel, it could be clearly seen that the developed hydrogel formulation SP5 had 
sufficiently strong crosslinked structure to retain itself for longer time periods. Therefore, 
maintenance of stability in the polymeric network at high temperature in comparison to 
uncrosslinked polymer and monomer was confirmed by TGA.  
The alterations in heat capacity as well as enthalpy changes were measured using Differential 
Scanning Calorimetry (DSC). Figure 6a and 6b show the DSC-TGA thermograms of 
hydrogel and comparative DSC thermograms of drug, drug free hydrogel and drug loaded 
hydrogel. The DSC endothermic peaks of cross-linked polymeric network were in 
accordance with TGA thermal patterns as shown in figure 6a. Both TGA and DSC 
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thermograms indicates that the deterioration of PVA-co-AMPS started nearly at temperature 
250°C.  
 
             Figure 6a. DSC-TGA thermogram of PVA-co-AMPS Hydrogel 
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             Figure 6b. DSC analysis of SP5 without drug, captopril and Drug loaded SP5  
Differential Scanning Calorimetry (DSC) is a well-known and established technique adopted 
for quantitative assessment of physicochemical variations in heat capacity of crystalline 
drugs, when loaded into hydrogels. The thermal behavior of pure captopril, drug free and 
drug loaded SP5 hydrogel was characterized using DSC, as shown in Figure 6b. The 
disappearance of characteristic peaks and appearance of other peaks suggests some sort of 
interaction of drug with polymers. In figure 6b, the thermogram of pure captopril, the 
appearance of sharp peak at 106°C indicated its melting point. This peak of drug was not 
shown in DSC thermogram of the drug loaded formulation. A broad peak from 97°C to 
160°C was appeared in thermogram of drug loaded hydrogel. It suggests that captopril is 
molecularly dispersed in different hydrogel matrix without changing its thermal behavior. 
Both formulations, without drug and drug loaded had shown major endothermic peak at 
about 240°C, which illustrated the stability of formulation after drug loading without any 
marked alteration in thermal stability pattern. These observations are relevant to DSC 
analysis of aceclofenac sodium loaded hydrogels evaluated by Manjanna et al.281 
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5.4.5 Swelling Study 
The swelling ratios ‘S’ and percent swelling equilibrium (%ES) were calculated by 
performing the swelling studies at pH 2 and 7.4. The pH 2 represents the pH of gastric 
medium in the stomach and pH 7.4, the intestinal pH. The current work was aimed to 
develop a gastroretentive hydrogel formulation; therefore, it must exhibit higher swelling 
rates at acidic pH. Greater swelling ratios were observed at pH 2 as compared to swelling at 
pH 7.4 in a same manner as determined by Gupta et al.340 However, it was varying from their 
work due to constitution of polymeric network. Various other factors were affecting the 
swelling/water absorption into the prepared hydrogel formulations are discussed as given 
below: 
Effect of microwave radiation  
In order to provide a proper swelling, the polymers must be sufficiently crosslinked, so that 
the obtained material should not dissolve in aqueous medium. The crosslinking density in 
hydrogels depends upon the power of microwaves received. Figure 7 illustrates the swelling 
ratios of SP1, SP2, SP3 and SP4 hydrogels treated with different intensities of microwave 
radiation. These observations are in correspondence to morphological characterizations 
performed by scanning electron microscopy. The comparison of swelling capability of these 
formulations was observed at lower pH 2 and higher pH 7.4. 
 
Figure 7. Comparative swelling ratios of Formulations SP1, SP2, SP3 and 
SP4 at pH 2 and 7.4 
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The hydrogels treated at 100W were possessing higher swelling than one exposed at 180W, 
both containing same concentration of crosslinker, PVA and AMPS. The hydrogels exposed 
further to increased radiation dose i.e. at 300W exhibited low swelling, due to greater 
crosslinking density among polymers. The high doses above 180W also cause the destruction 
of crosslinked structure, that provide an irregular and lesser swelling than other treated at 
lower frequency of microwaves.  
Hydrogel formulation SP2 (prepared at 180 W) was considered more suitable due to 
sufficient strength to maintain its disc integrity while swelling, so that it could remain stable 
in the stomach for longer periods of time. However, formulation SP1 had shown more 
swelling behavior but lesser mechanical strength due to low crosslinked density. SP3 and 
SP4 hydrogel formulations treated at 300 W were showing lesser swelling ability. Figure 8 
illustrates the effect of microwave radiation on percent equilibrium swelling.  
 
Figure 8. Effect of microwave radiation dose on Percent Equilibrium Swelling  
Figure 8 shows that by increasing the intensity of radiation exposure to hydrogel 
formulations led to decrement in percent equilibrium swelling. Thus, it was observed that 
microwave radiations due to their ability to initiate the crosslinking reactions effect 
crosslinking density and ultimately the swelling of polymeric network. These observations 
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were related to earlier findings of Singh et al.,267 and Wan et al.274 where hydrogels were 
treated with different intensities of microwave radiations and there moisture absorption 
properties were determined, which were inverse of percent grafting. Due to higher grafting, 
the polymeric networks have more crosslinking density that ultimately reduces swelling ratio.  
Effect of Initiator concentration 
Due to ability of microwave radiations to initiate the reaction for crosslinking of polymers, 
lower concentrations of initiator were required. However, increasing the initiator 
concentration increases the crosslinking among polymers and consequently reduces the 
swelling characteristics as shown in figure 9 and 10. Figure 9 illustrates the comparative 
swelling ratios of formulations SP2, SP5 and SP6 at pH 2 and 7.4. These formulations were 
exposed to same radiation dose of 180W as well as comprising of same ratios of all 
components except initiator concentration. 
 
 
Figure 9. Comparative swelling ratios of Formulations SP2, SP5 and SP6 at pH 2 and 7.4 
The hydrogel formulation SP2 containing higher initiator concentration (0.25% W/W) had 
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hydrogel had lesser concentration of initiator (0.15 % W/W). Moreover, highest swelling 
ratio of SP6 hydrogel was observed among other (SP2 and SP5) as it had lesser amount of 
initiator (0.05% W/W). Figure 10 is showing the effect of initiator concentration on Percent 
Equilibrium Swelling. It illustrates that increasing the concentration of initiator decreases the 
percent equilibrium swelling. 
 
Figure 10. Effect of initiator concentration on Percent Equilibrium Swelling 
The resultant reduction in swelling tendency with increasing initiator concentration were 
confirmed earlier by Cheng et al.268 and Wan et al.274 They observed an increment in water 
absorption capacity of hydrogels by using an optimum initiator concentration, under 
influence of microwave radiations. Above, the optimum amounts of initiator the water 
absortion characteristics were showing remarkably decreased. 
Effect of AMPS Concentration 
The effect of monomer concentration on swelling capability was determined that how the 
quantity of AMPS affects the water absorption characteristics of superporous hydrogel 
formulations. SP5, SP7 and SP8 formulations containing different amounts of AMPS but 
same concentration of polymer (PVA- 1% W/W), crosslinker (MBA- 1 mol % of monomer 
concentration), initiator (KPS- 0.15%W/W) and radiation dose were compared in terms of 
swelling ratios as illustrated in figure 11.   
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It was observed that by increasing the amount of monomer AMPS in formulation, there was 
increment in swelling behavior. Variation in swelling ratio among these hydrogel 
formulations (SP5, SP7 and SP8) was due to higher quantity of AMPS.  
 
Figure 11. Comparative swelling ratios of Formulations SP5, SP7 and SP8 at pH 2 and 7.4 
AMPS cause the availability of more sulfonate groups, which increase the hydrophilic 
characteristics in polymeric network.  At acidic pH, a remarkable ability of water absorption 
was noticed because of high ionization of functional groups in AMPS. In addition to 
ionization of sulfonic groups, the hydrogen bonds are also reduced that consequently 
increased the swelling power of the formed superporous hydrogel.  The hydrogel formulation 
SP8 possess high quantity of AMPS (30 % W/W) had shown greater swellability as shown in 
figure 11. In SP5 formulation, AMPS was lesser than SP8, therefore it had shown lesser 
comparative swelling ratio, but it was higher in comparison to SP7 containing 20 % W/W of 
hydrogel formulation. Increment in swelling tendency with increasing AMPS content is 
corresponding to swelling study performed on AMPS based hydrogel by Qudah et al.239 On 
the other hand it was varying from the observations made by Bao et al.,95 where AMPS was 
cross-linked with a carboxymethylcellulose in the presence of acrylic acid and acrylamide, 
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while in the present work, AMPS was only monomer grafted with polymer. Therefore, the 
swelling behavior is dependent upon the amount of AMPS. Figure 12 is showing the effect 
on AMPS concentration on percent equilibrium swelling.  
 
Figure 12. Effect of AMPS concentrationon Percent Equilibrium Swelling 
It could be observed from the figure 12 that by enhancing the amount of AMPS had made an 
increment in percent equilibrium swelling of hydrogel formulations. AMPS created the 
availability of ionizable sulfonate groups in the prepared superporous polymeric network, 
which ultimately led to enhancement of their swelling characteristics. 
Effect of Polymer concentration  
The effect of polymer concentration on swelling behavior was confirmed by comparing three 
hydrogel formulations containing same quantities of monomer, crosslinker, initiator and 
radiation dose but different amounts of polymer. Hydrogel formulations SP5, SP9 and SP10 
were evaluated for their swelling properties as shown in figure 13.  
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Figure 13. Comparative swelling ratios of Formulations SP5, SP7 and SP8 at pH 2 and 7.4   
SP5 formulation had lower concentration of PVA (1% W/W) in comparison to SP9 and SP10 
with PVA concentration 2% and 3%, respectively. A higher swelling ratio of SP5 hydrogel 
was noted than other formulations (SP9 and SP10). SP10 formulation, because of high 
polymer amount had lower swelling than both SP5 and SP9. Figure 14 depicts the effect of 
polymer concentration on percent equilibrium swelling of hydrogels.  
These observations are in correspondence to swelling study by Tyliszczak211 and Minhas et 
al.339 where a decrement in swelling ability of hydrogels was observed by increasing the 
amount of polyvinyl alcohol. However, the results of swelling evaluation were differing from 
work of Hosseinzadeh,347 who observed increase in swelling by increasing PVA 
concentration from 1.2 to 2.4 wt% in PVA-based hydrogels. By increasing further amount of 
PVA created a decrement in absorption characteristics, due to increasing viscosity of reaction 
medium that restricts the movements of PVA chains.  In comparison, in our case, a decrease 
in swelling ratio was noted by increasing the amount of PVA from 1 to 2 wt% in AMPS-
based hydrgels.  
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          Figure 14. Effect of PVA concentrations on Percent Equilibrium Swelling 
Polvinyl alcohol PVA imparts mechamical strength to the polymeric system and possesses 
water absorption characteristics, but its swelling capability is low in comparison to AMPS. 
Hence, by increasing the quantity of PVA in hydrogel formulation, causes a reduction in 
swelling behavior as it could be observed from figure 13 and 14. 
5.4.6 In-vitro drug release studies 
After loading of captopril into the prepared superporous hydrogel formulations, the drug 
release study was performed at pH 2 and pH 7.4 as shown in table 2. The drug release study 
at mentioned pH was performed for a period of 24 hours, where USP phosphate buffer was 
used as dissolution medium. All the formulations were subjected to drug loading and the 
release of entrapped captopril was evaluated. The hydrogel discs possessing higher swelling 
ratio were able to entrap higher quantity of drug. The amount of drug release is according to 
swelling characteristics, where drug loading is directly related to water retention capability of 
polymeric network. The hydrogels which exhibited higher swelling ratio entrapped more 
amount of captopril. 
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    Table 2. Amount of Captopril loaded and percentage of drug released at pH 2 and pH 7.4 
sample 
code 
Amount of captopril loaded (mg) 
per 0.3 gram of dry hydrogel discs 
 % release of captopril 
     pH 2   pH 7.4 
  SP1                   202.5      98.08     72.32 
  SP2                   186.8      85.11     54.26 
  SP3                   169.8      69     47.45 
  SP4                   173.8      73.13     49.56 
  SP5                   189.8      93.21     66.95 
  SP6                   194.7      95.93     70.02 
  SP7                   156.78      56.95     33.73 
  SP8                   199.8      97.38     68.23 
  SP9                   179.67      82.27     55.66 
  SP10                   171.36      73.26     48.85 
 
Hydrogel formulations SP1, SP6 and SP8 were loaded with higher quantity of drug and 
ultimately had shown high amounts of drug release at both lower and higher pH (2 and & 
7.4). Moreover, drug release was higher at acidic pH as compared to pH 7.4. This was due to 
swelling characteristics of AMPS, which is not much dependent on pH of medium. However, 
being an AMPS-based hydrogel it exhibited swelling to greater extent in low acidic pH as 
compared to neutral or higher alkaline pH.   
Figure 15 presents a comparison of three hydrogel formulations SP1, SP5 and SP10. Among 
them, the SP1 hydrogel, the components were loosely crosslinked due to exposure at low 
dose of microwave radiation, therefore it entrapped and released higher quantities of 
captopril. On the other hand, formulation SP10 had shown lower swelling ratio due to higher 
PVA concentration, hence lower drug loading and drug release was observed. Thus, 
relatively more amount of drug was loaded and ultimately released in formulations exhibiting 
more swelling power. The drug release kinetics of prepared superabsorbent hydrogels was 
determined by different kinetic models mentioned in table 3. The kinetic models used were 
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Zero order kinetics,  First order kinetics, Higuchi model, Korsmayer-Peppas model and 
Wilbull model.  
 
 Figure 15. Captopril released up to 24 h from PVAco-AMPS hydrogels  
          (SP1, SP5, and SP10) in dissolution media of pH 2 and pH 7.4 
 
Table 3. Determination of coefficient (R2), K and release exponent of various drug release kinetic models 
Sample 
code 
pH Zero order 
kinetics 
First order 
kinetics 
Higuchi model Korsmeyer-Peppas model Wilbull 
model 
R2 K R2 K R2 K R2 K n R2 
SP1 2 0.8745 5.6976 0.2887 0.3167 0.9716 26.424 0.9853 46.38 0.17 0.7897 
7.4 0.9342 3.5779 0.4773 0.2569 0.9907 13.688 0.9751 17.0869 0.37 0.8113 
SP2 2 0.9523 4.2344 0.3654 0.2920 0.9976 19.968 0.9978 26.9387 0.33 0.8703 
7.4 0.959 2.9744 0.4552 0.2466 0.9914 11.024 0.9855 7.7882 0.7212 0.8429 
SP3 2 0.7901 5.2216 0.2508 0.3005 0.9136 20.596 0.9864 28.0953 0.504 0.722 
7.4 0.9057 2.7629 0.4807 0.2357 0.9834 10.309 0.9841 15.3971 0.644 0.7661 
SP4 2 0.8196 5.3027 0.2702 0.3015 0.9388 21.272 0.9875 33.8937 0.2203 0.7465 
7.4 0.888 2.8506 0.425 0.2471 0.9745 11.571 0.9837 16.3121 0.3081 0.7492 
SP5 2 0.9027 4.8442 0.3018 0.3106 0.9833 24.761 0.9923 40.3292 0.2164 0.8114 
7.4 0.9268 3.5394 0.4 0.2699 0.9908 15.37 0.9871 20.0108 0.35 0.829 
SP6 2 0.8745 5.9259 0.2866 0.3198 0.9716 27.483 0.9853 48.2390 0.1749 0.7898 
7.4 0.9342 3.7212 0.4733 0.2600 0.9907 14.237 0.9751 17.7714 0.3792 0.8115 
SP7 2 0.9765 2.7670 0.5472 0.2335 0.9962 10.381 0.9978 9.2038 0.568 0.8643 
7.4 0.9944 1.3716 0.6247 0.1916 0.9738 5.998 0.9861 4.6877 0.647 0.9277 
SP8 2 0.8745 5.7746 0.288 0.3177 0.9716 28.781 0.9853 47.0076 0.1749 0.7898 
7.4 0.9342 3.6262 0.4759 0.2579 0.9907 13.873 0.9751 17.3178 0.3792 0.8114 
SP9 2 0.9681 4.0971 0.4882 0.2671 0.997 15.574 0.9954 15.8369 0.4907 0.8594 
7.4 0.9917 1.9592 0.5609 0.2274 0.9716 9.843 0.991 7.3925 0.6717 0.9289 
SP10 2 0.9692 3.2586 0.5306 0.2497 0.9865 13.233 0.9814 12.2555 0.54 0.8774 
7.4 0.9879 1.9694 0.6073 0.2160 0.9826 8.474 0.9977 8.7381 0.48 0.8986 
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The results calculated in terms of values of release coefficient and release exponent from 
PVA-co-AMPS copolymer containing different components, polymer concentration, initiator 
concentration and radiation dose. The mechanism of drug release was indicated by the values 
of n i.e. release exponent as presented in table 3. 
The formulations were best fitted into the above mentioned kinetic models when values of R 
were near to ‘1’. There was variation in value of ‘n’ among the formulations prepared. The 
SP7 formulation containing lower monomer concentration, SP9 and SP10 hydrogel 
formulations with higher amounts of polymer were exhibiting non-fickian diffusion 
mechanism of drug release with value of n greater than or equal to 0.45 but lesser than 1. 
Moreover, SP3 formulation receiving higher dose of radiation (300 W) and higher initiator 
concentration were also following non-fickian diffusion. Other formulations with higher 
amounts of monomer and lesser polymer concentration were following fickian diffusion with 
value of ‘n’ less than 0.45. 
Conclusion 
It was concluded from the discussion, that super-porous hydrogels were prepared 
successfully under influence of microwave radiations. Using low concentrations of initiator 
could successfully develop polymeric network of polyvinyl alcohol and AMPS by 
microwave radiations. The formed hydrogel had ability to swell excessively at acidic pH and 
it could be retained in the stomach, releasing captopril at low pH for longer durations of time. 
Therefore, the synthesized copolymer could be a promising candidate as carrier for captopril 
in treating hypertension. 
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In-vivo Evaluation of hydrogel 
formulations for Controlled Release 
Drug Delivery of Captopril 
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Abstract: 
A specific high performance liquid chromatography–ultravoilet spectrometric (HPLC-UV) assay 
was developed for the determination of captopril in plasma. It was conducted on prepacked Hypersil 
C8 column at room temperature using Phosphate buffer: acetonitrile (75:25 v/v) as a mobile phase, 
pH adjusted at 2.8 with o-phosphoric acid and at a flow rate of 1.0 ml/min, while UV detection was 
performed at 205 nm. The retention time was 6.5 min for captopril. The liquid-liquid extraction 
method was used for the detection of captopril. Dithiothreitol was added in extraction medium in 
order to stabilize the captopril extracted from plasma. Standard curve was linear in captopril 
concentration ranging from 50 to 2000 ng/ml. The method had a suitable sensitivity to detect drug at 
low concentrations due to its lower limit of quantification (LLOQ) value noted as 50ng/ml.  Intra- 
batch as well as inter-batch precision and accuracy measured had shown good results.  The 
extraction efficiency of captopril was ranging from 95 to 99.9 %.  The method developed was 
applied for the pharmacokinetic study in 24 rabbits for evaluation of pharmacokinetic parameters of 
captopril. The method was simple, rapid, reliable, specific and sensitive with ability to determine 
drug plasma concentrations from rabbits for longer duration.   
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6.1 Introduction 
Angiotensin converting enzyme (ACE) inhibitors are commonly used for treatment of heart diseases 
such as hypertension and heart failure. Among them, captopril, is an orally active potent ACE 
inhibitor and widely accepted due to its antihypertensive action attained within 45 min to 1 hour 
after oral administration.348-351 The in-vivo analysis of captopril is difficult because of its stability 
concerns; the presence of sulphydrylgroup causes its self-dimerization, resulting in formation of 
captopril disulfide. Moreover, captopril also binds to endogenous compounds such as cysteine, 
glutathione as well as plasma proteins. The captopril disulfide is pharmacologically inactive but it 
may serves as reservoir of active drug due to its reversible conversion to free captopril.352-354  
To overcome the above mentioned problem, the detection or measurement of free captopril 
concentration needs molecule derivatization or an addition of chemical stabilizer in biological 
samples to prevent the formation of captopril disulphide.353 Various Fluorescence or UV active agent 
such as N-(1-pyrenyl) maleimide(NPM) and p-bromophenacyl bromide(p-BPB), have been used as 
chemical stabilizers. The formation of captopril disulfide can be controlled by lowering the pH 
below 4, adding chelating agents (EDTA) or antioxidants.355-358 Dithiothreitol (DTT) added to the 
plasma samples has ability to reconstitutes captopril from its disulfide, by increasing free thiol 
content from serum albumin.359, 360 
For the determination of captopril or its metabolites in blood or plasma, several analytical methods 
have been reported. The most widely investigated are HPLC methods, including HPLC with 
florescence and UV detector,361-365 gas chromatography (GC) or gas chromatography-mass 
spectrometry (GC-MS) techniques, fast solid phase extraction (SFE) or liquid- liquid extraction 
based on several evaporation and concentration steps. Other techniques like enzyme immunoassay 
and radioimmunoassay (RIA) have also been investigated.366-369 The method should be successfully 
applied to accurately measure total captopril concentration on a large number of plasma samples.  
The present work describes a simple HPLC method for the determination of captopril using UV 
detector. The values for LOD, precision of area and linearity show good performance of analysis. 
The pharmacokinetics and the relative bioavailability of captopril were studied using blood samples 
of 24 healthy rabbits. A written approval for required animal study was taken from Pharmacy 
Research Ethics Committee (PREC), The Islamia university of Bahawalpur, Pakistan. 
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The objective of this work was to evaluate the bioavailability of captopril from three controlled 
release hydrogel formulations (SP5, R3 and S3). The High Performance Liquid Chromatography 
(HPLC) method with UV detector, using liquid-liquid extraction was developed and successfully 
utilized for the determination of captopril in plasma.  
6.2 EXPERIMENTAL METHODS 
6.2.1 Instrumentation and analytical conditions  
Agilent 1100 series HPLC system consisted of LC-10 AT VP pump, DGU-14 AM on-line degasser, 
Rheodyne manual injector fitted with a 20 µL loop, and SPD-10 AVP UV–VIS detector and a 
Hypersil BDS C 8 (250 X 4.6 mm) column was utilized for separation. Chromatographic system was 
integrated via Shimadzu model CBM- 102 Communication Bus Module to P-IV computer loaded 
with CLASS-GC software (Version 5.03) for data acquisition and mathematical 
calculations.Centrifuge Machine (Model 4000-China), Vortex Mixer (Seouline BioScirnce-Korea), 
pH Meter (WTW pH 300-Germany), Ultrasonic Bath (Fisher Scientific FS 28 H-Germany), Electric 
Balance (Percia XB 120A), Membrane Filter (Sartorius, 0.45μm filters-Germany),Distillation Plant, 
Micropipettes (Softpet- Finland), Filtration Assembly (Pyrex-France), Distillation Plant (WDA/4 R 
& M England). 
6.2.2 Materials 
Captopril was a gift from Benson Pharmaceuticals, Industrial Area, Islamabad, Pakistan. All organic 
solvents used for the mobile phase and extraction procedure were of HPLC grade. Methanol, 
Acetonitrile, Orthophosphoric acid, Dichloromethane were purchased from Merck (Germany), 
Diethyl-ethyl ether from AnalaR (England) and Dithiothreitol from Sigma (USA). Plasma samples 
were obtained from healthy rabbits maintained under suitable conditions, not receiving any drug 
substance. 
6.2.3 Preparation of the Mobile Phase 
The mobile phase prepared was comprising of 0.1 M Potassium dihydrogen phosphate buffer (75%) 
and acetonitrile (25 %) in proportions. The pH of mobile phase was adjusted to pH 2.8 by 
orthophosphoric acid and filtered through filtration assembly.  
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6.2.4 Stock and working solutions 
Stock solution of 100 µg mL-1 of captopril was prepared by dissolving 10 mg of drugs in100 mL 
volumetric flask using mobile phase as a diluent. Further dilutions were prepared in the range of 50-
2000 ng/ml captopril. Solutions were prepared once and subjected to intra-day and inter-day 
variations of method and analyzed each time before drug analysis in biological samples, stored at 
20°C. Then, 20 µL of these solutions were injected into HPLC system and chromatographed. 
Dithiothreitol (200 mmol/l) solution was prepared at concentrations of 30.84 g/l. It was used for the 
detection of captopril by reconstituting it from its disulfide dimer from plasma samples.  
6.2.5 Drug-plasma solution 
Standard curve was constructed to determine concentration range of captopril in rabbits. Blood 
samples were collected from ear vein of healthy rabbits in heparin containing centrifuge tubes and 
immediately centrifuged at 3500 rpm for 10 min. The supernatant obtained was stored at -20°C. 
After thawing, the plasma was spiked with working solutions to obtain different concentrations of 
captopril for construction of standard curve. All calibration curve samples (non-zero samples), 
except blank plasma, were prepared by spiking blank plasma aliquots of 500 µl each, with 100 µl of 
the intermediary captopril solutions, to yield final plasma concentrations of 50, 100, 200, 400, 800, 
1200, 1600 and 2000 ng/ml.  
6.2.6 Chromatographic Analytical Conditions 
An Isocratic High performance Liquid Chromatography system (Agilent 1100 Series) comprising of 
Quanta Pump and Degasser  was used. Hypersil BDS C 8 (250 X 4.6 mm) column was utilized for 
detection of analytes. The HPLC analysis was performed at ambient temperature, using a flow rate 
1ml/min. The UV-detector was set at λ max of 205 nm. 
6.2.7 Sample Extraction 
Drug was extracted from plasma samples, using liquid- liquid extraction technique. To above formed 
samples for calibration curve, ranging from 50 to 2000 ng/ml, 3mL diethyl ether/dichloromethane 
(65/35) along with 0.04 mL of 200 mM dithiothreitol solution were added and the samples were 
vortex-mixed for 30 to 40 seconds. The tubes were then centrifuged at 3000 rpm for 5min. The 
upper organic layer was carefully removed, transferred to reacti-vials, and evaporated to dryness 
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with a gentle stream of nitrogen in a dry bath at 37ºC. A 100 μL aliquot of mobile phase, comprised 
of phosphate buffer (75%), acetonitrile (25%) and orthophosphoric acid (0.1%), was added to the 
tubes, which were then vortex-mixed for 15 seconds to reconstitute the residue. Then 20 μL were 
injected into liquid chromatography system and the peak areas were noted for each concentration.  
6.3 Method validation 
6.3.1 Specificity  
Plasma samples were collected randomly from three rabbits and three humans (drug free subjects). 
Plasma samples from human and rabbit were taken to determine the extent to which endogenous 
plasma components could affect the retention time of captopril. They were spiked with captopril 
standard solution at three levels of drug concentrations 400 ng/ml, 800 ng/ml and 1400 ng/ml. The 
spiked plasma samples were processed by liquid-liquid extraction procedure and chromatographed 
for determination of peak area and retention time.  
6.3.2 Linearity and Standard Curve Preparation 
Standard curves were constructed using eleven non-zero calibration points ranging from 50 to 2000 
ng/ml. The plasma samples were spiked with drug solutions to obtain final concentration of 50, 100, 
200, 400, 600, 800, 1000, 1200, 1400, 1600 and 2000 ng/ml. These samples were prepared in 
duplicate and subjected to liquid-liquid extraction. Five replicates of all drug concentration of each 
plasma sample were injected into HPLC and Chromatographed. The average of their peak area was 
calculated and standard calibration curves were constructed of both plasma samples (by plotting 
peak area versus concentrations of the samples). Linear least-square regression analysis, with 
weighing fact were of 1/x, was performed to assess the linearity, as well as to generate the standard 
calibration equation: y = ax + b, where y is the peak–area ratio, x the concentration, a the slope and b 
is intercept of regression line. 
6.3.3 Lowest Limit of detection (LLOD) and quantitation (LLOQ) 
The lowest limit of detection (LLOD) is a minimum amount of substance in a sample that could only 
be detected but not necessarily quantitated, while the quantitation limit (LLOQ) is the lowest amount 
of analyte in a sample which can be quantitatively determined properly with an accuracy and 
precision.  
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6.3.4 Precision and accuracy  
The calibration curve samples prepared were taken for assessment of precision and accuracy. The 
intra-batch precision and accuracy was determined among five replicates from each batch (batch 1 
and 2 batch). The average of all concentrations determined in both batches was calculated separately. 
Then, batch 1 and batch 2 were subjected to inter-batch precision and accuracy. Accuracy is 
percantage of mean of values to the reference value as given by equation: 
                                    Accuracy = % mean / Reference                (i) 
Whereas precision is percent coefficient variance (% CV) of standard deviation to mean of values: 
                                      Precision = S.D  /  mean                     (ii) 
6.3.5 Extraction efficacy 
Extraction efficacy (Recovery) was calculated by comparing peak-area of extracted sample of drug 
to that of the unextracted pure drug solutions used for plasma spiking.Three concentrations (50-2000 
ng/ml) of captopril were selected to determine extraction efficiency. The peak area of spiked plasma 
samples were compared with standard diluents, using five replicates of each concentration. 
6.4 Results and Discussions 
The retention time observed by injecting 20µL standard captopril solution into HPLC system was 
6.5 as shown in figure 2. 
                                  
                             Figure 2. Retention time of captopril detected from   
                                           standard drug solution 
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6.4.1 Specificity  
The detection of captopril from rabbit and human plasma samples were compared for their 
respective peak area and retention time. Figure 3 and 4 represent the chromatograms of blank plasma 
sample of rabbit and human, respectively. There was no marked variation observed in peak area and 
retention time of captopril from chromatograms of spiked rabbit plasma and spiked human plasma as 
shown in figure 5 and 6, respectively. The retention time remained in range of 6.4 to 6.5 min in both 
plasma samples.  
                                  
                                 Figure 3. Blank plasma sample of rabbit 
 
                                  
                                  Figure 4. Blank Plasma samples of Human 
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                      Figure 5. Captopril detected from spiked rabbit plasma sample 
 
                  
                      Figure 6. Captopril detected from spiked human plasma sample 
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The peak areas noted from spiked plasma samples from both sources (rabbit plasma and human 
plasma) with three levels of captopril concentrations 400ng/ml, 800ng/ml and 1400ng/ml are 
presented in table 1 as given below.  
    Table 1. Peak area determined from Rabbit Plasma and Human Plasma 
QC sample 
(ng/ml) 
Peak area 
( from Rabbit Plasma) 
( mAU*) 
Average 
Peak area 
( mAU*) 
Peak area 
(from Human Plasma) 
( mAU*) 
Average 
Peak  area 
( mAU*) 
400 362.36 371.27 359.72 364.45 366.23 358.34 359.72 361.43 
800 761.66 770.24 760.29 764.06 756.34 759.45 767.29 761.02 
1400 1359.56 1368.26 1362.35 1363.39 1370.34 1374.31 1353.55 1366.06 
 
It was observed from the retention time and peak area determination (as illustrated by figure 5 and  
figure 6) that there was no marked variation for detection of captopril from both plasma samples 
(rabbit and human). Hence, this method could be specifically applied for detecting captopril in 
plasma samples in human and animal (rabbit). 
The determination of specificity of captopril was relevant to the evaluations made by Rezende et 
al.361 in terms of using, randomly selected normal plasma, hyperlipemic and hemolyzed plasma 
samples from distinct healthy human subjects. However, in the current method, plasma was taken 
from healthy animal (rabbit) as well as human and compared, which resulted in no marked variation 
in retention time of captopril in the presence of endogenous plasma components from both types of 
plasma samples. 
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6.4.2 Lowest Limit of detection (LLOD) and quantification (LLOQ) 
The sensitivity of this liquid-liquid extraction can be evaluated by determination of lowest limit of 
detection (LLOD) and lowest limit of quantification (LLOQ).  By this liquid- liquid extraction 
method, the lowest detection limit of captopril was found as 20 ng/ml. This amount of drug in 
standard solutions and spiked plasma samples could be detected only, but cannot be quantified. The 
lower limit of detection was lower in comparison to the value of LLOD determined by Du et al.370 
and Alves Soares et al.,360 where dithiothreitol in same quantity was added during liquid-liquid 
extraction. The variation in detection was because in that case mass spectrometer was used for 
detection, while in our method the drug was detected by UV detector. However, HPLC-UV 
detection is less senseitive but more simple and could be conveniently performed. 
The other parameter, LLOQ that is the lower limit of quantification, was determined as 50ng/ml. 
Therefore, 50ng/ml was the lowest quantity of captopril that could be measured and effectively 
quantified. For this reason it was considered as lowest concentration in the preparation of standard 
curve and in plasma samples for determination of precision and accuracy. 
6.4.3 Linearity and Calibration Curve  
Figure 7a and 7b show the calibration curves (1 and 2) prepared from spiked plasma samples ranging 
from 50- 2000 ng/ml.  A good linear response to this method was observed in the concentrations 
ranging from 50, 100, 200, 400, 600, 800, 1000, 1200, 1400, 1600 and 2000 ng/ml as shown in the 
calibration curves.The drug concentrations used in preparing standard curve 1 and standard curve 2 
were named as batch 1 and batch 2, respectively.   
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                          Figure 7a. Standard calibration curves prepared from spiked plasma samples of batch 1   
 
                   
                            Figure 7b. Standard calibration curves prepared from spiked plasma samples of batch 2 
Five replicates of each concentration were injected into HPLC and chromatographed in both 
batches (1 and 2). Then, mean of peak area of five replicates of each concentration in a batch was 
calculated and standard curves were prepared for batch 1 and batch 2.  The standard curves, their 
slope, intercept and the correlation coefficient were determined, which could be seen in figure 7a 
and 7b. 
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6.4.4 Precision and accuracy  
Intra-batch accuracy and precision evaluated are presented in table 2 (for batch 1 and for batch 2). 
Accuracy and precision between two batches (batch 1 and batch 2) of plasma samples used for 
calibration curves were determined as shown in table 3. Within run precision and accuracy of five 
replicates of each concentration was calculated in each batch.  
    Table 2. Intra-batch precision and accuracy for captopril determination in spiked plasma samples 
 
 
 
 
 
 
 
                                                                   Analysis of Batch 1 
Drug 
concentration 
(ng/ml) 
Five replicates of  captopril concentrations 
determined in rabbit plasma 
mean Standard 
Deviation 
Precision 
(%CV) 
Accuracy 
1 2 3 4 5 
50 49.223 51.843 46.373 46.893 48.533 48.573 2.1667 4.4608 97.146 
100 88.66 94.43 93.47 90.763 98.153 93.097 3.62 3.8950 93.097 
200 194.57 192.64 177.18 193.43 181.26 187.81 8.0079 4.2636 93.909 
400 390.52 396.70 391.26 382.59 388.34 389.88 5.1073 1.3099 97.471 
600 571.09 587.94 590.82 593.67 596.85 588.07 10.052 1.7093 98.013 
800 763.83 774.18 807.09 786.09 802.05 786.65 18.245 2.3193 98.331 
1000 991.29 998.64 989.48 994.66 986.18 992.05 4.7926 0.4831 99.205 
1200 1174.1 1181.5 1198.0 1175.0 1189.8 1183.7 10.175 0.8595 98.644 
1400 1391.8 1385.0 1395.3 1370.5 1398.0 1388.1 10.990 0.7916 99.155 
1600 1563.0 1568.9 1561.0 1557.8 1570.8 1564.3 5.4272 0.3469 97.771 
2000 1950.6 1946.0 1931.4 1932.3 1939.0 1939.9 8.3953 0.4327 96.996 
 
Analysis of Batch 2 
Drug 
concentration 
(ng/ml) 
Five replicates of  captopril concentrations 
determined in rabbit plasma 
mean Standard 
Deviation 
Precision 
(%CV) 
Accuracy 
1 2 3 4 5 
50 43.963 48.353 50.043 46.373 47.693 47.285 2.2793 4.8203 94.5705 
100 85.263 89.073 90.093 95.083 93.093 90.521 3.7866 4.1831 90.5212 
200 180.07 189.02 191.53 192.30 179.36 186.45 6.2770 3.3664 93.2296 
400 380.82 388.77 394.35 392.59 386.11 388.53 5.3785 1.3843 97.1328 
600 589.33 587.15 578.02 586.01 591.19 586.34 5.0608 0.8631 97.7238 
800 784.63 781.59 787.89 783.19 798.93 787.24 6.20025 0.787587 98.406 
1000 988.46 975.27 987.62 989.25 989.86 986.02 5.463 0.554 98.609 
1200 1163.2 1169.9 1173.2 1178.1 1181.1 1173.1 7.0313 0.5993 97.7634 
1400 1386.0 1387.3 1391.7 1388.2 1392.4 1389.1 2.8249 0.2033 99.2266 
1600 1556.0 1560.4 1569.7 1575.1 1573.4 1566.9 8.3716 0.5342 97.9360 
2000 1931.8 1936.4 1944.1 1937.7 1943.4 1938.7 5.1113 0.2636 96.9368 
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         Table 3. Inter-batch precision and accuracy for captopril determination in spiked plasma samples 
Drug 
concentration 
(ng/ml) 
Average of replicates in Batches (1 and 2) Mean Standard 
Deviation 
Precision 
(%CV) 
Accuracy 
Batch 1 Batch 2 
50 48.573 47.285 47.929 0.910754 1.900214 95.858 
100 93.097 90.521 91.809 1.821507 1.984018 91.809 
200 187.81 186.45 187.13 0.961665 0.513902 93.565 
400 389.88 388.53 389.205 0.954594 0.245268 97.30125 
600 588.07 579.94 584.005 5.748778 0.984371 97.33417 
800 786.65 771.44 779.045 10.75509 1.380549 97.38063 
1000 992.05 982.09 987.07 7.042784 0.713504 98.707 
1200 1183.7 1173.1 1178.4 7.495332 0.63606 98.2 
1400 1388.1 1389.1 1388.6 0.707107 0.050922 99.18571 
1600 1564.3 1566.9 1565.6 1.838478 0.11743 97.85 
2000 1939.9 1938.7 1939.3 0.848528 0.043754 96.965 
 
In batch 1, the values of precision are ranging from 0.34% to 4.4% and and accuracy determined is 
in the range of 93.00% to 99.15%. Similarly, the values of precision and accuracy in batch 2 were 
ranging from 0.26% to 4.8% and 90.53% to 99.22%, respectively.  
The inter-batch precision and accuracy was in the range of 0.04 to 1.98 and 90.8 to 99.18, 
respectively. The results obtained were within the acceptance criteria for precision and accuracy. It 
was assessed from deviation values that were falling in ±15% of the authentic values.371 The 
determination of intra- batch and inter-batch precision and accuracy were according to that 
determined Rezende et al.,361  where intra-batch precision and accuracy (% CV) ranged from 2.49 to 
5.66%, and 97.15 to 105.77%, respectively. Method inter-batch precision (% CV) and accuracy 
ranged from 0.88 to 1.95%, and 98.85 to 104.22%, respectively. Similar findings were observed by 
Alves Soares et al.,360  where liquid- liquid extraction was used for detection of captopril. 
Moreover, the retention time of noted in all chromatograms of different concentrations and within 
batch and among batches was ranging from 6.4 to 6.7 which was near to the retention time of 
captopril determined by Jinsong et al.372 
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6.4.5 Extraction efficacy 
Extraction efficacy (Recovery) was calculated by comparing the peak-area of extracted sample of 
drug to that of the unextracted pure drug solutions used for plasma spiking as presented in table 4. 
The pure Captopril solutions of concentrations (50, 100, 200, 400, 600, 800, 1000, 1200, 1400, 
1600 and 2000 ng/ml) were considered as standard for comparison with spiked plasma samples. 
The peak area of spiked plasma samples were compared with standard diluents, using five 
replicates of each concentration (50, 100, 200, 400, 600, 800, 1000, 1200, 1400, 1600 and 2000 
ng/ml). Their averages were calculated and then comparison was made to determine the 
percentage of drug that could be possibly recovered from spiked plasma samples. The percent 
recoveries of all samples with drug concentrations ranging from 50 to 2000 ng/ml are presented in 
table 4.  
Table 4. Percent Recoveries of different Captopril concentrations from spiked plasma 
 
The values of percent recovery are varying from approximately 95.00% to 99.96%. The mean 
percent recovery of captopril from the spiked plasma samples was 98.13%. These results indicated a 
successful recovery of drug from biological samples, as more than 95% of drug could be detected 
from plasma samples. Therefore, it evaluates the suitability of method for effective determination of 
captopril  from blood after its oral administration. The results of percent recovery were determined 
in accordance to extraction efficiency (% recovery) measured by Rezende et al.361 and Sultan et 
al.273 where percent recoveries of captopril were calculated in the similar manner. 
Drug concentration 
      (ng/ml)   
Peak area of spiked 
plasma 
     (mAU*) 
Peak area of standard 
Solution 
     (mAU*) 
  % Recovery 
 
 
50 28.76 29.62 97.09 
100 73.28 77.37 94.71 
200 168.01 176.43 95.22 
400 370.07 374.29 98.87 
600 568.26 572.39 99.27 
800 766.84 767.13 99.96 
1000 972.24 978.81 99.33 
1200 1163.93 1169.42 99.53 
1400 1368.36 1378.29 99.27 
1600 1544.53 1576.45 97.97 
2000 1920.13 1954.78 98.23 
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6.5 Application of the Method 
The objective of this work was to evaluate the bioavailability of captopril from three controlled 
release hydrogel formulations. The High Performance Liquid Chromatography (HPLC) method 
with UV detector, using liquid- liquid extraction was developed and utilized for the determination 
of captopril in plasma of rabbits. 
Twenty four (24) rabbits weighing 2.0 to 2.5kg were used in this study. They were divided into four 
groups (1, 2, 3 and 4) each group having six rabbits. Animals were starved for 24h prior to 
administration of the drug. Each rabbit in group 1 (Control) was given a single dose of 25 mg pure 
captopril with lactose enclosed  in a hard gelatin capsule, which was ingested with 20 mL water 
orally through a catheter. Rabbits in group 2, 3 and 4 were given hydrogel formulations SP5, R3 and 
S3, respectively. Water was provided during starvation and throughout the experiment. Food was 
withheld for 2 hours following drug administration to prevent drug food interaction, after which 
they were fed at 4h and 10h after dosing.  
Blood samples (3 mL each) were collected into heparin-containing centrifuge tubes at 0, 0.5, 1, 2, 4, 
8, 12,16, 24 hours from the rabbit ear vein following drug administration. Plasma was separated 
witha centrifuge (Heraeus Instrument, Biofuge Primo, Germany) at 3500 rpm for 10 min at room 
temperature and the plasma recanted and stored at –20ºC until assayed for captopril content. Plasma 
captopril concentrations were determined in duplicate by reversed phase liquid chromatography- 
UV. 
Briefly, 3mL diethyl ether/dichloromethane (65/35) was added to 0.5mL plasma with 0.04mL of 
200mM dithiothreitol soltion, and the samples were vortex-mixed for 30 to 40 seconds. The tubes 
were then centrifuged at 3500rpm for 5min at 4ºC. The upper organic layer was carefully removed, 
transferred to reacti- vials, and evaporated to dryness with a gentle stream of nitrogen in a dry bath 
at 37ºC. A 100 μL aliquot of mobile phase, comprised of phosphate buffer (75%), acetonitrile 
(25%) and orthro phosphoric acid (0.1%), was added to the tubes, which were then vortex-mixed 
for 15 seconds to reconstitute the residue. Then 20 μL were injected into liquid chromatography 
system. 
  164 
The drug was eluted with phosphate buffer and acetonitrile (75:25) using orthophosphoric acid to 
adjust the pH to 3. It was filtered by a vacuum filter system equipped with a 0.8 mm filter and was 
degassed by ultrasonic treatment.  
6.5.1 Operating conditions 
The flow rate was 1.0 mL/min at ambient temperature and UV detection was performed at 205 nm. 
The total run time was 10 min and retention time was 6.5 min.  
6.5.2 Plasma Concentrations Profile and Pharmacokinetic parameters of Captopril 
Plasma concentrations of administered pure captopril and drug released from hydrogels 
were calculated from peak area by using Microsoft excel 2010.  
The pharmacokinetic parameter such as maximum concentration  Cmax (ng/ml), time to reach 
maximum concentration, Tmax (hr), elimination half-life ‘t’1/2 el, elinmination rate constant ke (hr-1) 
Area under curve AUC (ng/ml*hr), area under the product of concentration and time AUMC(ng 
/ml*h2), Clearance (L/h) , volume of steady state concentration Vss (L) volume of distribution Vd 
(L), and other parameters mentioned in tables 4 to 27 were calculated using Kinetica 5.0.  
The value of absorption half-life t1/2 (a)  was calculated by method of inspection. From the value of 
absorption half-life t1/2 (a), the absorption rate constant ka was estimated. Following equations were 
used for the calculation of absorption half-life t1/2 (a)   and absorption rate constant ka .                    
 
 
                                 t1/2 (a) =                   (1) 
 
 
 
 
                ka=                  (2) 
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6.5.2.1 GROUP 1 
 
The mean ± standard deviation concentrations of captopril determined in plasma of six rabbits 
(group 1) after oral administration of control are presented in table 5. Figure 8 illustrates mean ± 
standard deviation of plasma concentrations versus time profile of Captopril. The values of mean ± 
standard deviation of Bioavailability and Pharmacokinetic parameters are given in table 6. 
 
                      Table 5. Mean ± standard deviation of plasma concentration (ng/ml) of 
Captopril (free drug) in 6 rabbits in Group 1 
 
S. No. Time (Hrs) 
Concentration (ng/ml) 
Captopril 
1 0 0 ± 0 
2 0.5       442.31 ± 21.70 
3 1       782.18 ± 12.69 
4 2       639.31 ± 21.19 
5 4       363.55 ± 47.93 
6 8       52.288 ± 5.35 
7 12 0 ± 0 
8 16 0 ± 0 
9 24 0 ± 0 
 
 
 Figure 8. Mean ± standard deviation of plasma concentrations vs. time 
profile of Captopril 25 mg plotted on rectangular co-ordinate 
graph, in group 1. 
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  Table 6. Mean ± standard deviation of Bioavailability 
and Pharmacokinetic parameters of Captopril 
administered in   an oral dose of 25 mg (free 
drug) in rabbits of Group 1. 
  
Parameters  Captopril (free drug) 
Cmax (ng/ml)         782.198 ± 12.68 
Tmax  (hr) 1 ± 0 
AUC (ng /ml*h)         3092.25 ± 176.03 
AUMC (ng /ml*h2)         9144.63 ± 682.72 
MRT (hr)    2.96 ± 0.081 
ke (hr-1)  0.425 ± 0.017 
ka  (hr-1)               3.46 ± 0 
Tlast (hr)     2.63 ± 0.0613 
t1/2 el (hr)   1.61  ± 0.066 
t1/2 (a)(hr)                 0.2 ± 0 
Vss (L)  23.94 ± 1.047 
Vd (L) 18.98 ± 1.38 
ClT  (L/h) 8.106 ± 0.48 
R2  0.987 ± 0.012 
HVD (hr)    3.32 ± 0.317 
 
 
 
From the results presented in table 5 and table 6, it can be concluded that maximum level of 
drug concentration was attained in a sample taken after 1 hour of oral administration of 
captopril powder enclosed in hard gelatin capsule, hence time to reach maximum 
concentration tmax was 1 hour. Because of solubility of captopril in aqueous solution and 
administration in powder form, it was immediately dissolved in biological fluids and reached 
its maximum concentration in blood in shorter time. It was detected from the plasma samples 
of rabbits taken upto a time period of 8 hours.  
Similar results were also evaluated by Mallick et al.374 in assessment of bioavailability and 
pharmacokinetic parameters of another drug nifedipine from controlled release micro 
capsules in healthy rabbits. In their research work the control (reference) used was drug 
enclosed in hard gelatin capsules and orally administered in a group of rabbits, as it was used 
in our work for captopril.  
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6.5.2.2 GROUP 2 
The mean ± standard deviation concentrations of captopril determined in plasma of six rabbits 
(group 2) after oral administration of SP5 hydrogel formulation are presented in table 7. 
Figure 9 illustrates mean ± standard deviation of plasma concentrations versus time profile of 
Captopril. The values of mean ± standard deviation of Bioavailability and Pharmacokinetic 
parameters are given in table 8. 
 
               Table 7. Mean  ±  standard deviation of plasma concentration (ng/ml) 
of Captopril released  from  SP5 hydrogel formulation in 6 
rabbits in Group 2 
 
S. No. Time (Hrs) 
Concentration (ng/ml) 
Captopril 
1 0     0 ± 0 
2 0.5  151.49 ± 8.48 
3 1    361.19 ± 17.37 
4 2    485.08 ± 23.36 
5 4   661.85 ± 5.78 
6 8     611.88 ± 11.58 
7 12     378.87 ± 12.19 
8 16     186.31 ± 22.92 
9 24    50.570 ± 5.29 
 
                      
    Figure 9. Mean ± standard deviation of plasma concentrations vs. time 
profile of Captopril released from SP5 hydrogel formulation 
plotted on rectangular co-ordinate graph, in group 2. 
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                 Table 8. Mean ± standard deviation of Bioavailability and 
Pharmacokinetic parameters of Captopril released 
from SP5 hydrogel formulation in Group 2 
  
Parameters Captopril (SP5 formulation) 
Cmax (ng/ml)            661.853 ± 5.79 
Tmax  (hr)  4 ± 0 
AUC (ng /ml*h)            8647.81 ± 133.05 
AUMC (ng /ml*h2)          79382.36 ± 2619.9 
MRT (hr)   9.17 ± 0.195 
Ke (hr-1) 0.165 ± 0.009 
ka  (hr-1)                  0.86 ± 0 
Tlast (hr)    8.41 ± 0.127 
t1/2 el (hr) 4.19 ± 0.28 
 t1/2 (a)(hr)                    0.8 ± 0 
Vss (L)                26.53 ± 0.46 
Vd (L) 17.5 ± 1.13 
ClT  (L/h)   2.87 ± 0.058 
R2   0.999 ± 0.0064 
HVD (hr) 11.82 ± 0.146 
 
It was shown from the data presented in table 7 and 8 that the maximum concentration of 
drug was achieved in 4 hours after oral administration of SP5 hydrogel formulations. The 
average Cmax was 661.85ng/ml, which was lesser than average Cmax (782.19ng/ml) noted after 
oral administration of control.  However, time to reach maximum concentration was 4 hours 
that was higher in comparison control. Area under curve (AUC) and area under the product 
of concentration and time (AUMC) were also increased.  
The results indicated from the estimation of pharmacokinetic and bioavailability parameters 
that the drug was released from the gastroretentive hydrogel formulation SP5 at controlled 
rate and maintained its concentration in blood for longer periods of time. The drug released 
by gastroretentive hydrogel was in correspondence with that observed by Nagarwal et al.,375 
for determination of release of Cinnarizine Hydrochloride in rabbits blood from its 
Gastroretentive Tablet. The pharmacokinetic parameters and bioavailability of Cinnarizine 
Hydrochloride  Gastroretentive Tablet were compared with reference (oral suspension) in 
healthy rabbits in the similar manner. 
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6.5.2.3 GROUP 3  
The mean ± standard deviation concentrations of captopril determined in plasma of six 
rabbits (group 3) after oral administration of R3 hydrogel formulation are presented in table 
9. Figure 10 illustrates mean ± standard deviation of plasma concentrations versus time 
profile of Captopril. The mean ± standard deviation of Bioavailability and Pharmacokinetic 
parameters are given in table 10. 
 
  Table 9. Mean ± standard deviation of plasma concentration (ng/ml) of 
Captopril released from R3 hydrogel formulation in 6 rabbits in 
Group 3 
 
S. No. Time (Hrs) 
Concentration (ng/ml) 
Captopril 
1 0   0 ± 0 
2 0.5   110.5 ± 11.99 
3 1  221.78 ± 31.94 
4 2         381.43 ± 17.1 
5 4         491.09 ± 39.8 
6 8  598.48 ± 15.33 
7 12  512.11 ± 17.63 
8 16  329.25 ± 13.68 
9 24    61.15 ± 11.44 
 
                        
   Figure 10. Mean ± standard deviation of plasma concentrations vs  
time profile of Captopril released from R3 hydrogel 
plotted on rectangular co-ordinate graph, in group 3 
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Table 10. Mean ± standard deviation of Bioavailability 
and Pharmacokinetic parameters of Captopril 
Captopril released from R3 hydrogel 
formulation in 6 rabbits in Group 3  
  
Parameters Captopril (R3 formulation) 
Cmax (ng/ml)           598.48 ± 15.33 
Tmax  (hrs)                    8 ± 0 
AUC (ng /ml*h)       9320.255 ± 222.97 
AUMC (ng /ml*h2)       11295.45 ±  964.66 
MRT (hr)             10.88 ± 0.175 
ke (hr-1)             0.173 ± 0.006 
ka  (hr-1)               0.43 ± 0 
Tlast (hr)             10.03 ± 0.109 
t1/2 el (hr)               3.95 ± 0.16 
 t1/2 (a)(hr)                 1.6 ± 0 
Vss (L)             29.21 ± 0.99 
Vd (L)             15.31 ± 0.704 
ClT  (L/h)             2.678 ± 0.067 
R2           0.9774 ± 0.013 
HVD (hr)             14.94 ± 0.47 
 
The results presented in table 8 and table 10 as well as depicted from figure 10, that time to 
reach maximum concentration Tmax of captopril after oral administration captopril loaded R3 
hydrogel was 8 hour. It was higher than one observed after administering captopril loaded 
SP5 hydrogel in group 2. The maximum concentration Cmax attained (598.48 ng/ml) was 
reduced in comparison to control. The values of mean AUC and mean AUMC were higher 
even when compared to that in group 2. The captopril was released from R3 formulation and 
detected in plasma samples upto 24 hours. It could be evaluated from the data obtained in 
group 3, that captopril was released at slower rate from the controlled release hyfrogel 
formulation R3 and remained available in blood for longer duration. 
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6.5.2.4 GROUP 4 
 
The mean ± standard deviation concentrations of captopril determined in plasma of six rabbits 
(group 4) after oral administration of S3 hydrogel formulation are presented in table 11. 
Figure 10 illustrates mean ± standard deviation of plasma concentrations versus time profile 
of Captopril. The values of mean ± standard deviation of Bioavailability and Pharmacokinetic 
parameters are given in table 12. 
 
  Table 11. Mean ± standard deviation of plasma concentration (ng/ml) 
of Captopril released from S3 hydrogel formulation in 6 
rabbits in Group 4 
 
S. No. Time (Hrs) 
Concentration (ng/ml) 
Captopril 
1 0 0 ± 0 
2 0.5  131.4134 ± 29.31 
3 1       277.95 ± 22.08 
4 2     408.065 ± 14.02 
5 4       557.54 ± 11.92 
6 8   618.8584 ± 8.89 
7 12   512.0184 ± 30.56 
8 16     215.585 ± 29.69 
9 24  0 ± 0 
 
                     
   Figure 11. Mean ± standard deviation of plasma concentrations vs. 
time profile of Captopril released from R3 hydrogel 
formulation plotted on rectangular co-ordinate graph in 
group 4.   
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  Table 12. Mean ± standard deviation of Bioavailability and 
Pharmacokinetic parameters of Captopril released 
from S3 hydrogel formulation in 6 rabbits in Group 4 
 
Parameters Captopril (S3 formulation) 
Cmax (ng/ml)          618.85 ±  8.896 
Tmax  (hr)                   8 ± 0 
AUC (ng /ml*h)        8878.77 ± 149.743 
AUMC (ng /ml*h2)        91632.7 ± 2318.5 
MRT (hr)            10.32 ± 0.188 
Ke (hr-1)            0.145 ±  0.004 
ka  (hr-1)              0.43 ± 0 
Tlast (hr)              7.83 ± 0.045 
t1/2 el (hr)            4.707 ± 0.15 
  t1/2 (a)(hr)                1.6 ± 0 
Vss (L)          29.057 ± 0.64 
Vd (L)            19.13 ± 0.6 
ClT  (L/h)              2.82 ± 0.053 
R2            0.876 ± 0.022 
HVD (hr)            12.76 ± 0.18 
 
The rabbits in group 4 were given captopril loaded S3 hydrogel formulation orally. The drug 
was released at slower rate and attained maximum concentration in 8 hours similar to that in 
group 3, hence Tmax was 8 hour as shown in table 12. The mean of maximum concentration of 
captopril attained was 618.85 ng/ml.  The drug remained detectable for duration of 16 hour 
from rabbit blood. 
The results presented from in vivo studies on rabbits had shown a difference in plasma 
concentration of captopril attained after oral administration of free drug (control) and three 
hydrogel formulations (SP5, R3 and S3) as shown in the figure 12. A clear variation in 
maximum concentration of captopril achieved by control and controlled release hydrogel 
formulations could be seen from the figure. The drug reached its maximum concentration in 
short period of time in case of free drug administered in capsules. In comparison to control, a 
lesser as well as slower drug release was observed from drug loaded hydrogels that was 
dependent upon the swelling characteristics of crosslinked polymeric networks. Drug release 
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pattern from these hydrogels was also varying from one another due to their different 
constitution.   
 
 Figure 12. Comparison of Mean Plasma concentrations vs. time profile of control (free 
drug), Captopril released from SP5, R3 and S3 hydrogel formulation plotted 
on rectangular co-ordinate graph. 
Therefore, the maximum concentration Cmax was reduced while Tmax was increased by hydrogels. 
The value of area under curve AUC (calculated by trapezoidal rule) and elimination half-life were 
higher for controlled release hydrogel formulation. The drug could be available for longer periods 
of time after administration of Captopril loaded hydrogels. Among the hydrogel formulations Tmax 
was 4 hour for SP5 and 8 hr for R3 and S3 formulations, drug was available for 24 hours from 
SP5 and R3 but in S3 formulation it was detectable for relatively shorter periods (16 hours). The 
formulation SP5 was a super porous hydrogel and had gastro-retentive ability due to excessive 
swelling at acidic pH. For this reason the time to reach maximum concentration levels (4 hours) 
was lesser than other two formulations (S3 and R3) having maximum concentration noted at 8 
hour sample. Hydrogels S and R resealed maximum drug concentrations at intestinal pH, hence 
-100
0
100
200
300
400
500
600
700
800
900
0 5 10 15 20 25 30
Ti
m
e
 (
h
o
u
rs
)
Concentration (ng/ml)
Comparative Plasma Concentrations
Free Drug
SP5
R3
S3
  174 
attaining maximum concentration of captopril in 8 hours. All the results obtained were subjected 
to statistical analysis in terms of mean ± standard deviation as presented in the tables 5 to 12. 
Similar patterns of captopril release in rabbits were observed by El-Shabouri et al.376 where 
release of captopril was evaluated from prepared captopril buccoadhesive tablets, which were 
compared with an immediate release captopril tablet as control. A decrement in maximum 
concentration and increment in time to reach maximum drug concentration was observed in the 
controlled release formulations. In the same manner release patterns of other drugs from their 
controlled release formulation have been compared with controls using HPLC analysis. For 
example, prepared sustained release leflunomide microcapsules were compared with 
conventional tablets of leflunomide (control), which had shown similar comparative drug release 
patterns from sustained release formulations.377 In another work, release of theophylline from 
pH-Sensitive hydrogels of Carboxymethyl Chitosan had been evaluated in comparison to a 
commercially available theophylline tablet as control.378 Similarly, an evaluation of the 
pharmacological activity of glipizide was conducted by Abdelbary et al.379 on controlled release 
microcapsules and compared with commercially available immediate release Minidiad® 5 mg in 
normal healthy albino rabbits. Therefore, the controlled release drug delivery systems have 
ability to maintain optimum levels of drug for longer durations of time. 
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CONCLUSION  
In short, it was concluded that the above HPLC method is specific, sensitive, rapid and easy to 
perform determination of captopril. The limit of quantification, small sample volume and 
chromatographic time of this method makes it advantageous for adaptation to routine assay 
requirements and enables simultaneous determination of captopril because of good separation of 
the chromatographic peaks of captopril from plasma peaks. Results were accurate and precise and 
confirmed by the statistical parameters. Reliability, rapidness, simplicity, sensitivity, economical 
nature, good recovery and precision of this method give it advantage over the other reported 
methods. Moreover, the developed method was successfully applied in determination of captopril 
in plasma samples following the oral administration of captopril loaded hydrogels. 
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         Overall Conclusion 
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From the whole research project, including methodologies, techniques, the results obtained and 
entire discussion, it has been revealed that hydrogel formulations were successfully developed 
for controlled release drug delivery of captopril. Swellable polymeric networks with varying 
characteristics were prepared, by free radical polymerization, using different ratios of polymers, 
monomers as well as techniques. A fast technique for hydrogel synthesis was utilized by the 
assistance of microwave radiations, presenting better results in comparison to conventional 
method (using thermostatic water bath). The prepared HPMC/PVA-co-poly(acrylic acid) 
hydrogels had remarkable ability to entrap as well as protect drug and release it at a control rate, 
hence providing an opportunity for drug to exert its required therapeutic effects for prolonged 
durations. The other hydrogel formulations prepared, comprised of HPMC, acrylic acid along 
with AMPS had better swelling capability as compared to HPMC/PVA-co-poly(acrylic acid) 
hydrogels, due to the presence of highly ionize-able sulfonic groups.  
Moreover, the gastro-retentive hydrogel formulations were prepared, which had additional 
advantages of significantly high swelling power and ability to be retained in stomach and 
releasing captopril for longer periods of time at low pH of stomach. Thus, captopril remains 
more stable at acidic pH and relatively lesser quantity will be able to produce enhanced 
therapeutic effect. These gastro-retentive polymeric networks had an optimum strength and 
flexibility to maintain their shape and texture during swelling measurement, drug loading and 
in-vitro drug release study, without any noticeable/apparent breaking. Other in-vitro 
characterization measurements were presenting crosslinking among polymeric networks of 
polymers and monomers as analyzed by FT-IR, porous structure was observed in morphological 
analysis by scanning electron microscopy (SEM). The X-Ray Diffraction had shown amorphous 
distribution or dispersion of crystalline drug in formed cross-linked structures. The thermal 
analysis (TGA and DSC) evaluated the desirable stability of cross-linked polymeric networks as 
well as stability of drug loaded into loaded into these hydrogels. The swelling properties were 
significantly affected by the varying ratios of monomers, polymers and cross linker in each type 
of hydrogel formulation. Radiation dose was an important factor affecting the swelling ratios of 
hydrogels synthesized under their influence, due to their ability to initiate crosslinking 
interactions. The drug loading and release from hydrogels were directly related to their water 
absorption characteristics. 
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HPLC-UV analytical method, using liquid-liquid extraction procedure was developed for 
determination of bioavailability and pharmacokinetic parameters of captopril in plasma samples 
of rabbits. The liquid chromatography method, due to its specificity and sensitivity had ability 
to detect even smaller concentrations of captopril. It was concluded from the in-vivo evaluation, 
that captopril was released from hydrogel formulations at controlled rates and lesser amounts in 
comparison to control. However, the drug remained available in blood for longer durations of 
time hence providing a safe and efficacious amount for useful effects. 
Therefore, the aim of preparing a hydrogel formulation was achieved fulfilling the criteria of 
controlled release drug delivery system successfully by increasing time to reach maximum 
concentration and overall bioavailability of drug. Thus, optimum levels of drug could be 
maintained in blood for required therapeutic effects in the treatment of hypertension as well as 
other heart disorders, reducing the dosing frequency, lower incidence of side effects and 
ultimately improving patient compliance. 
